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ABSTRACT
Several methods for the preparation of 
halogenated and alkylated methylenebisphosphonates have 
been examined. C-Alkyl chloromethylenebisphosphonates 
were prepared by dihalogenation of tetraisopropylmethylene- 
bisphosphonate with sodium hypochlorite and selective 
monodehalogenation with methyl lithium, followed by 
alkylation of the thallium(I) salt and deesterification 
with bromotrimethylsilane and water. Such compounds were 
shown to be inhibitors of influenza A/X49 RNA transcriptase 
activity, and to be significantly better inhibitors of the 
replication of the virus in cell cultrue than either PAA 
or any unalkylated bisphosphonates. The C-benzyl 
analogue was found to show no reduction in affinity for 
calcified tissue over the parent species.
Using the synthetic methodology developed, an 
affinity label was prepared for the virus proteins.
When this was incubated with the virus and reduced with 
[^ Hl-NaBH^, the three virus P proteins were radioactively 
labelled.
Some simple nucleopeptides were prepared as 
models of the VPg-pU linkage in poliovirus vRNA. The 
compounds were best prepared via a phosphorus(III) 
route in analogy to the phosphite triester method of 
nucleotide synthesis.
CHAPTER 1
INTRODUCTION
1.0 GENERAL ASPECTS
The effect of viruses as disease agents were well 
documented long before their actual discovery in the late 
nineteenth century. The term "virus" was coined by 
Beijerinck from the Latin phrase "eontagiun vivum fluidium" 
(living infectious fluid) which he used to describe an 
infectious, but bacteria free, filtrate of tobacco leaf 
sap. Similar filtration techniques were subsequently used 
to prove the viral nature of many of the common diseases of 
the early twentieth century, such as foot and mouth disease, 
chicken pox, smallpox and yellow fever.
Today there are more than a dozen different 
families of viruses known which affect vertebrates, and 
the advent of modern electron microscopy and molecular 
biology techniques has given a great deal of information 
about some of their unique properties.
Viruses, and the related viroids, are the only 
species known to use RNA molecules as their genetic 
material although not all do so (Table 1.0). In general, 
viruses are genetically compact. There are seldom any 
redundant sequences in the genome, and frequently there 
are overlapping sequences.
Viruses have a protein coat which can be 
surrounded by an envelope for further protection of the
Table 1.0 Summary of the structural properties of different RNA and DNA viruses
3genome, and they range in size from about 20 run to 
300 nm in diameter. Unlike bacteria which are essentially 
independent, in that they can prosper in cell free media, 
viruses require a host cell within which to replicate.
Often they do not contain any enzymes within their protein 
nucleocapsids but take over host cell processes for their 
own replication. This makes them very difficult to inhibit 
without interrupting normal cellular functions, but 
progress is being made in this area and new possibilities 
identified.
1.1 CONTROL OF VIRAL DISEASE
The arguments for funding of research aimed at 
controlling viral diseases are obvious. Despite the significant 
advances in recent years, many millions of people suffer from 
illnesses which could be prevented. Effective immunisation 
programs have resulted in the eradication of smallpox, a 
dramatic reduction in the number of cases of poliomyelitis 
in the developed world, and the hope that measles, mumps 
and rubella may soon be under similar control (Assaad and 
Lednyi, 1984).
Drawbacks have been encountered with the administra­
tion of vaccines. Live attenuated vaccines £or instance, 
can produce disease symptoms in immunocompromised patients 
CMelrick, 1980). A number of viruses are capable of 
mutation to render any immunoprophylaxis campaign virtually 
useless. The best known example of such a virus is 
influenza A which will be discussed later. New viral
4diseases have appeared in recent years, such as non A-non B 
hepatitis and acquired immune deficiency syndrome (AIDS), 
necessitating lengthy research programs before prophylactic 
control can be achieved. If, however, a broad spectrum 
therapeutic antiviral drug were available already, treatment 
could begin immediately to control the diseases.
1.1.1 Antiviral Chemotherapy
It is now fifty years since the beginning of 
practical antibacterial chemotherapy, and it is probably 
true to say that currently, antiviral chemotherapy is at 
about the same stage. At that time many antibacterial 
compounds were known, nearly all of them discovered 
serendipitously, but they were too toxic to human cells 
to be used in patients (Geddes, 1985) . Now the same 
scenario can be seen again with antivirals, many are known 
but few have proven effective in humans.
It was originally thought that the intracellular 
nature of viruses rendered them invulnerable to attack, 
and it is this attitude that has meant that the 
development of antiviral compounds has lagged so far 
behind that of antibacterials. A considerable amount of 
research into viral specific processes has shown that 
targets for the rational design of antiviral agents do 
exist. All the antiviral compounds currently known 
however, result from chance discoveries or modifications 
thereof. This study is concerned with methods of 
enhancing the known activity of one such group of compounds, 
the pyrophosphate analogues, against influenza virus, and
5so it is prudent to discuss the nature of this virus and 
methods by which it can be combatted therapeutically.
1.2 INFLUENZA VIRUS
Influenza is a global disease causing epidemics in 
many birds and domestic animals as well as humans. In its 
simplest form, the disease involves infection of epithelial 
cells in the upper respiratory tract. An incubation period 
of one to three days is followed by a fever peak character­
ised by nausea, headache, chills and cough.
All the influenza viruses belong to the orthomyxo­
virus family (Melnick, 1974) and are classified into three 
types. A, B and C. There are some differences between 
the effects of the three types on humans - types B and C 
have not been isolated from animals (Air and Compans,
1983) - but it has recently been suggested that these 
differences are not as great as was first thought (Palese 
and Young, 1983). Influenza A has been the subject of the 
greatest research effort, since it has been responsible 
for each of the worldwide epidemics this century, 
including the pandemic of 1918-19 which claimed over 
20 million lives.
1.2.1 Virion Structure
Influenza is an enveloped RNA virus, the internal 
nucleocapsid being protected by an envelope consisting of 
a matrix protein, a lipid bilayer and glycoproteins 
(Fig.1.2.1). The virions are of non-uniform shape, the
6Fig. 1.2.1 Structure of the influenza virion.
the most common being nearly spherical particles of 
about 100 nm in diameter, but elongated and filamentous 
particles of the same diameter are known.
The surface glycoprotein spikes are made up of 
clusters of protein chains and are divided into two types 
according to their biological properties. The haemag- 
glutinin (HA) proteins appear as three-sided rods whereas 
the neuraminidases (NA) are mushroom shaped with a head 
of four spheres (Varghese, et al. , 1983).
Inside the virion shell, the genetic material
is comprised of eight different molecules of negative 
strand RNA. This segmented genome must be transcribed 
to the complementary mRNAs, a process catalysed by an 
enzyme made up of the four proteins carried within the 
virion particle. These are the three P proteins (PBi, PB2 
and PA) and the nucleoprotein (NP), which is closely 
associated with the genome RNA segments in the virion.
1.2.2 Influenza Virus Replication
1.2.2.1 Initial Stages of Infection
The infectious cycle of influenza viruses is 
variable and dependent on virus strain and host cell.
The latent period is usually from three to six hours and 
peak infectious virus production can be attained after 
only eight hours and may continue for days.
The initial interaction between virus and host 
cell takes place by attachment of haemagglutinin to the 
cell receptors containing neuraminic acid (Nayak, 1977) . 
Neuraminidase has little effect on this stage since it is 
only present in one tenth of the amount of haemagglutinin 
(Kilbourne, et al. , 1968) . When host cell receptors are 
in excess, 70-90% of virus becomes cell associated within 
two hours (White, 1960).
Penetration and uncoating of the virions follow 
adsorption, although none of these processes are fully 
understood. Penetration may be by viropexis or by 
membrane fusion and uncoating could be by release of 
ribonucleoprotein, activation of transcriptase or a combina-
tion of both. Host nuclei play a significant role at an 
early stage and DNA-dependent RNA transcription is 
necessary to produce capped primers for mRNA synthesis.
1.2.2.2 RNA Synthesis
Virus-coded RNA synthesis can be detected 
twenty minutes after infection and takes place in two 
phases. Primary transcription is the formation of the 
mRNAs and secondary transcription, the production of 
progeny RNA molecules.
Transcription of virus mRNA is begun by cleavage 
at a purine residue of a capped oligonucleotide of 10-13 
bases from cellular mRNA. This oligonucleotide serves as 
the primer for the initiation of mRNA synthesis by 
directing the incorporation of a GMP residue complementary 
to the second base at the 3' end of each viral template 
(Lamb and Choppin, 1983), followed by elongation 
according to the template sequence (Fig. 1.2.2.2(i)).
All of these processes are carried out by the viral RNA 
transcriptase complex, a group of proteins of total 
molecular weight 255 000 (Winter and Fields, 1982) 
consisting of the three P proteins, PBi (the larger 
basic P protein), PB2 (the smaller basic P protein) and 
PA (the acidic P protein), along with the nucleoprotein 
(NP). The contribution of each of these proteins to the 
synthesis of the virally-coded mRNA has now been 
extensively studied.
It has been established that the PB2 protein 
recognises the 5'terminal methylated cap structure 
of the cellular mRNA primer, binds to it, and may be
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Fig. 1.2.2.2(1) Priming and synthesis of influenza viral mRNA 
(Krug, 1983).
responsible for its cleavage CKrug, 1983) . PBj appears to 
initiate transcription (Ulmanen, et al., 1981) and so it 
was inferred that PA could be involved in the elongation 
phase of transcription (Lamb and Choppin, 1983). However, 
it has been demonstrated more recently that PBj is most 
likely to catalyse the addition of each nucleotide to the 
growing mRNA chain, since it leads the way as the trans­
criptase complex moves down the nascent chains (Braam, 
et al., 1983). It was also suggested that PB2 becomes
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dissociated from the primer cap soon after 11-15 nucleotides 
have been added to the capped fragments, thus enabling 
all the P proteins to move as a unit (Fig. 1.2.2.2 (ii)). 
Specific roles for PA and NP have not been found and it 
is possible that their role is structural, allowing such 
a switch in the protein conformation to occur.
Fig. 1.2.2.2 (ii) Movement and interaction of the three P proteins
during viral mRNA synthesis (Braam, et at., 1983).
The viral mRNAs have been shown to lack the 
sequence complementary to the 5*terminal 20-30 nucleotides 
of the vRNAs (Hay, et al., 1977). Instead there are 
sequences of poly(A). This is assumed to be due to 
repetitive copying of a short tract of U residues followed 
by termination of transcription (Krug, 1983). This effect 
may be caused by formation of a duplex "panhandle" 
structure extending up to the U-tract, thus blocking 
transcription of the last 20-30 5'terminal nucleotides 
and causing the observed stuttering (Robertson, et al. ,
1981) .
In contrast to virally coded mRNAs, little 
information has been obtained concerning the synthesis 
of progeny vRNA. Full length complementary copies of the 
vRNA segments have been isolated, showing that the 
termination mechanism described above does not operate in 
the case of secondary transcription (Nay, et al. , 1977). 
Production of the complementary transcripts is thought 
to take place without a primer as they have a pppA 
5'terminus and their 5'terminal sequences are complementary 
to the 3'terminal sequences of the vRNA templates (Hay, 
et al. , 1982). These transcripts are thought to function 
as templates for synthesis of new vRNA (Hay, et al., 1977) 
and production of both species is probably catalysed by 
the P proteins. Since capped mRNA primers are not involved, 
it is more likely that a modified PBj protein participates 
in the initiation of synthesis of full length transcripts 
rather than PB2 (Krug, 1983). However, the mechanism of 
such a modification or of the switch from mRNA to full
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length vRNA synthesis are not understood.
1.2.2.3 Organisation of the vRNA Genome and
Protein Function
The virion RNA can be separated by polyacrylamide 
gel electrophoresis into eight segments in the range 
890-2341 nucleotides in length (McGeoch, et al. , 1976) .
Only two of these segments code for more than one protein. 
Segments 1, 2 and 3 code for the P proteins PB2 # PBj and 
PA respectively (Palese, et al. . 1977), the functions of 
which were discussed above.
Segment 4 of the genome codes for the virus 
haemagglutinin (HA) . HA can be cleaved Frotedytically 
into HAX and HA2 (usually held together by disulphide 
bonds) which greatly increases the infectivity of the 
virus since HA is involved with virus attachment to cell 
receptors (Lazarowitz and Choppin, 1975) .
Processing of segment 5 results in the nucleo- 
capsid protein (NP) which in combination with the RNA 
segments, forms the viral ribonucleoprotein (RNP) particles 
found in virions (Compans, et al. , 1972) . It is 
estimated that 20 nucleotides interact with a single 
protein subunit (Lamb, 1983) and it is supposed that 
the RNA is bound to the outside of the RNP structure 
as it is susceptible to ribonuclease digestion (Murti, 
et al. , 1980) . It is the antigenicity of NP which is 
used to distinguish the three influenza virus types A, B 
and C.
RNA segment 6 codes for the glycoprotein, 
neuraminidase (NA) , which can alter the host range of 
the virus by removing sialic acid and exposing HA to
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cleavage (Schulman and Palese, 1977) .
Segments 7 and 8 code for the pairs of proteins 
Mx and M2, and NSj and NS2 respectively using overlapping- 
sequences. Mj, the matrix protein, is the most abundant 
protein in virions and may help to provide a binding 
site for RNP during assembly (Choppin, et al. , 1972) . The 
remaining three proteins are only found in infected cells 
and not in the virion, and their functions are unknown, 
although NSj has been implicated in shut off of host cell protein 
synthesis (Lamb, 1983).
1.2.2.4 Assembly and Release of Virions
The process by which virions are assembled is 
not well understood. It is known that the process takes 
place only at the cell membrane by a budding mechanism.
The cell membrane must be extensively modified by 
replacement of host proteins with viral antigens as 
viral envelopes contain only virally coded proteins 
(Nayak, 1977) . The mechanism of RNP molecule selection 
for packaging remains unclear, but could take place 
either by selective processing by linkage via RNA or 
protein linkers or by random selection, which would 
account for the appearance of hybrid viruses. How the 
RNP molecules are attracted to the budding site is 
unknown.
The final phase of virion release appears to be 
caused by removal of sialic acid from the budding region 
by viral neuraminidase (Klenk, 1974). This action would 
result in there being no site of binding for the 
haemagglutinin and dissemination from the host cell
would ensue, allowing the new virion to move on to infect 
other hosts, continuing the infectious cycle.
1.2.3 Variation in Antigenic Proteins
One of the most striking features of the 
influenza virus is its ability to change its antigenic 
identity. Thus, specific immunity built up against one 
particular strain may not protect against new viruses 
that arise, which may result in epidemic infections 
(Wilson, et al. , 1982). The antigenic change is a 
result of changes in the two surface proteins which in 
turn reflect changes in the parent genes.
There are two mechanisms by which these 
different strains can arise. Antigenic drift involves 
a series of minor point mutations, which leads to amino acid 
sequence changes, altering the antigenic sites so that 
they are no longer recognised by the host's immune system. 
Antigenic shift results from more drastic changes in which 
the gene segments for one or both of the surface proteins 
are shuffled between two viruses by reassortment. There 
is evidence for such a process occurring between influenza 
A viruses of man and animals (Webster, et al., 1971) or 
between two human strains (Bean, et al. , 1980) or two 
animal strains (Gardner and Shortridge, 19791.
Four major antigenic shifts have occurred 
since the virus was first isolated in 1933, each 
coinciding with new influenza epidemics. In 1957, the 
H2N2 subtype (Asian 'flu') replaced the H1N1 subtype.
In 1968 the H2N2 (Hong Kong) virus appeared and in
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1977 the H1N1 subtype made a reappearance. It is not 
clear how these different subtypes arose in each case, and 
most surprising was the re-emergence of the H1N1 strain, 
but it is probable that genetic reassortment is occurring 
constantly, resulting in these virulent new strains 
every 8-15 years (Bean, et al., 1980) .
1.2.4 Influenza Vaccines
Due to the frequent changes in the influenza 
virus antigens, no single vaccine can hope to control the 
disease in the way that smallpox, polio, or other stable 
viruses have been controlled in recent years. Influenza 
vaccines have been prepared though, for the protection 
of those sections of the populations thought to be most 
at risk, and two approaches have been used. The first is 
use of inactivated influenza and two types of formalin- 
killed vaccines are in general use - intact virus and 
ether-treated virus vaccines. The protective efficacy is 
clearly related to the antigenic match of the vaccine 
with the epidemic virus and doubts have been expressed 
as to the long-term cummulative efficacy of these 
types of vaccine (Hoskins, et al. , 1979).
Vaccines have also been prepared using live, 
attenuated virus by various means, but again it has been 
shown that if there has been only a two-step antigenic 
drift between virus and vaccine, poor protection from 
infection is obtained (Wang, 1983) . Thus, new vaccines 
must be constantly prepared to keep up with changes in
the virus.
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1.3 CHEMOTHERAPY OF INFLUENZA INFECTIONS
Even if the present problems formulating an 
influenza vaccine can be overcome, vaccination is a 
primary preventative measure, and gives little hope of treat­
ing the disease once contracted. Ideally a range of anti­
viral compounds would be available which could be used to 
treat patients at risk from complications to infections. 
Several compounds are known to show activity against 
influenza, and some of these are discussed below.
1.3.1 Adamantane Derivatives
Amantadine hydrochloride (1-aminoadamantane 
hydrochloride. Fig. 1.3.1) has been licensed in the U.S.A.
nh2
(i) (Ü)
Fig. 1.3.1 Structures of adamantane derivatives with antiviral 
activity. (i) Amantadine, (ii) Rimantadine.
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for prophylactic treatment of respiratory illnesses due 
to the A2 strains of influenza virus (Asian 'flu')» for 
twenty years. However, the precise mode of action for its 
antiviral effect is still not clearly established. Initial 
studies suggested that the drug inhibited virus penetration 
(Davies, et al. , 1964) but subsequent research has 
indicated that it may be some part of the uncoating phase 
which is affected (Kato and Eggers, 1969). Either way in 
the presence of amantadine, expression of the virus genome 
is prevented and no transcription can be detected (Tilley 
and Kramer, 1981) .
The drug has been used sparingly in clinical 
situations despite it being one of the few available, which 
may be due to a combination of factors. Firstly, 
amantadine is not effective against respiratory tract 
illnesses other than influenza A, and accurate diagnosis 
is not always possible. Secondly, the drug can cause 
side effects such as insomnia, nervousness and halucinations, 
all symptoms of a secondary effect on the central nervous 
system. It is interesting then, that amantadine and some 
other close analogues have been used for treatment of 
Parkinson's disease (Tilley and Kramer, 1981).
Rimantadine (1-(1-aminoethy 1)adamantane,
Fig. 1.3.1) has also been shown to possess antiviral 
activity against influenza A and a number of other 
viruses (Tsunoda, et al., 1966). Its mechanism of action 
is similar to that of its congener but it is reportedly 
more effective (Schulman, 1968) and with less drastic 
side effects (Oxford, 1984) . This has led to it being 
more widely used than amantadine, mainly in the U.S.S.R.
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(Zlydnikov, et al. , 1981).
When given prophylactically, amantadine and 
rimantadine are 50% effective in the prevention of 
infection and virtually 100% effective in prevention 
of clinical illness. When administered therapeutically 
within the first 48 hours of illness, the duration of 
fever can be reduced by one third CDolin, et al. , 1982).
Use of these adamantane derivatives can result in the 
appearance of resistant mutants, and in an attempt to 
overcome this, simultaneous administration of amantadine 
and an inactivated vaccine has been used, a combination 
which has proved an effective prophylactic (Webster, 
et al., 1985).
Another approach has been to use rimantadine in 
combination with interferons. This has the twin 
advantages of overriding the low efficacy and toxic side 
effects of interferon, and enhancing the antiviral effects 
of rimantadine (Hayden, et al. , 1984).
1.3.2 Norakin
Having noted that the anti-influenzal adamantane 
derivatives show activity against Parkinson's disease, 
the reverse approach was tried, and several anticholinergic 
antiparkinsonism drugs were tested as inhibitors of 
influenza in cell culture (Pebster, et al., 1984).
Norakin (Fig. 1.3.2) and some close analogues were shown 
to inhibit influenza A and B viruses. Further studies 
suggested that these compounds act by preventing a conforma 
tional change in the haemagglutinin at acid pH essential
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Fig. 1.3.2 Structure of Norakin.
for cell-virus fusion, although other effects at later 
stages of the virus replicative cycle were not ruled 
out (Ghendon, et al., 1986).
1.3.3 Ribavirin and Analogues
Ribavirin (1-ß-D-ribofuranosyl-l,2,4-triazole- 
3-carboxamide, Fig. 1.3.3) has been shown to exhibit
Fig. 1.3.3 Structures of (i) Ribavirin and (ii) Selenazofurin.
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activity against both DNA and RNA viruses (Smith and 
Kirkpatrick, 1980). Ribavirin 5'-triphosphate is a 
specific inhibitor of the influenza virus RNA polymerase 
in a cell free system (Eriksson, et al., 1977). Under 
the same conditions neither ribavirin nor its 5'-monophosphate 
showed any activity. Thus, it is probable that the 
observed activity of ribavirin in vivo results from its 
phosphorylation by cellular enzymes, and subsequent 
incorporation into viral RNA.
In animals, ribavirin provides reduced mortality 
from influenza, even if administered as late as 72 hours 
post-infection (Chen, et al., 1983) and in clinical trials 
ribavirin shows promise against influenza A and B infections, 
giving reduction in the duration of fever (Chen, et al.,
1983) .
Ribavirin analogues with antiviral activity 
have been described, in which other heteroatoms are 
introduced into the heterocyclic ring portion of the 
molecule (Robins, et al., 1983). Selenazafurin 
(Fig. 1.3.3) has been reported as having greater 
activity against influenza A and B viruses than ribavirin or 
amantadine (Sidwell, et al. , 1985).
1.3.4 Tilorone
Tilorone hydrochloride (Fig. 1.3.4) is a broad 
spectrum, orally active antiviral agent when administered 
prophylactically (Kreuger and Meyer, 1970). In clinical 
trials against influenza A (H1N1 strain) it has yielded 
favourable results and no obvious side effects were seen
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Fig. 1.3.4 Structure of Tilorone.
(Chen, et al. , 1983). The mode of action of tilorone 
has been studied, and it is claimed that it exerts 
its broad spectrum activity by inducing an interferon 
as the active antiviral species (Meyer and Kreuger, 1970).
1.3.5 Metal Chelators
Several metal chelating compounds are known to 
possess antiviral activity against influenza in vitro 
(Hutchinson, 1985). Ethylenediamine tetraacetic acid 
(EDTA, Fig. 1.3.5) inhibits the neuraminidase activity of 
the N1 serotype influenza viruses, probably by forming 
strong complexes with calcium ions, which the enzyme 
requires to function normally (Diramock, 1971).
1,10-Phenanthroline and bathocuprin sulphonic 
acid (Fig. 1.3.5) inhibit the RNA transcriptase activity 
of influenza A and B viruses by forming strong complexes 
with an essential zinc ion (Oxford and Perrin, 1974) . 
However, none of these metal complexing species show
22
Fig. 1.3.S Structures of metal chelating antivirals. (i) EDTA,
(11) 1,10-Phenanthroline, (iii) Bathocuprin disulphonic 
acid.
activity in animal models (Oxford and Perrin, 1977) 
probably due to their highly polar nature preventing 
them from entering cells.
1.3.6 Pyrophosphate Analogues
Phosphonoacetic acid (PAA, Fig. 1.3.6), 
originally synthesised by Nylen in 1924, was the first 
pyrophosphate analogue discovered to possess antiviral 
potential. Its activity was revealed by random 
screening in herpes simplex virus infected cells 
( Shipkowitz, et al., 1973). PAA was subsequently 
shown to inhibit nearly all the viruses of the herpes 
family both in cell culture and in animals (Meyer,
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Fig. 1.3.6 Pyrophosphate analogues (i) PAA, (ii) PFA, (iii)
Carbonylbisphosphonate.
et al. , 1976, Shipkowitz, et al. , 1973).
Further in vivo studies demonstrated that the 
normal cell synthetic machinery of uninfected cells was 
unaffected by PAA whereas synthesis of virus-specific DNA 
was totally inhibited (Overby, et al., 1974) . It was soon 
shown that PAA ewes its activity to inhibition of the 
HSV-induced DNA polymerase (Mao, et al. , 1975).
Despite PAA being a small molecule with little 
scope for optimisation of activity, a number of analogues 
have been prepared which demonstrate the features 
necessary for antiviral action.
In general, if phosphonate or carboxylate 
esters are introduced, activity against HSV-4 is greatly 
reduced (Eriksson, et al. , 1980) although a recent 
report claims that such low molecular weight esters are 
active against HSV-2 in tissue culture (Mao, et al. ,
1985).
Insertion of one or more methylene groups
between the phosphoryl and carboxyl moieties results in
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loss of activity. The homologue without a methylene 
group, phosphonoformic acid (PFA, Fig. 1.3.6), is however, 
a slightly better inhibitor of DNA polymerases than PAA 
(Datema, et al., 1986).
Replacement of either functional group of PAA 
with sulphonyl groups or replacement of the phosphoryl 
group with a second carboxyl also results in compounds 
with no antiviral activity iLeinbach, et al. , 1976). 
Replacement of the carboxyl group with a second phosphono 
group produce methylenebisphosphonate which also lacks 
significant activity(Eriksson, et al., 1980). However, 
substitution at the central carbon atom by various 
electron withdrawing groups, particularly halogens, results 
in compounds which have no activity against herpes viruses, 
but which are good inhibitors of influenza A RNA polymerase 
(Cload and Hutchinson, 1983a).
The only analogues found to inhibit both herpes 
and influenza viruses are PAA, PFA and carbonyl bisphos­
phonate (Fig. 1.3.6). These three compounds have also 
been shown to be inhibitors of the replication of a 
number of other viruses including most recently, 
hepatitis B (Oberg, 1983), HTLV-III (Vrang and Oberg, 1986) 
the retrovirus responsible for the initial AIDS infection - 
and avian myoloblastosis virus (AMV) (Eriksson, et al. ,
1982) . In every case PFA is the most active compound.
Structure-activity relationships for pyrophos­
phate analogues against influenza A virus showed similar 
requirements as were found for herpes viruses in that 
esters were not active (Cload, 1983). It has been shown
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that halogenated methylene bisphosphonates are excellent 
isosteres of inorganic pyrophosphate, their acid properties 
being virtually identical (Blackburn and Kent, 1981), 
and such compounds have proven to be the best inhibitors of 
influenza viruses (Cload, 1983) . Inorganic pyrophosphate 
itself is an inhibitor of influenza and superior inhibitors 
are obtained by replacement of the phosphate groups by 
thiophosphate, a two-fold increase in activity being 
observed for each such replacement, both in enzyme assays 
and cell culture models (Hutchinson, et al., 1985).
Different influenza strains have been shown to 
exhibit different sensitivities to pyrophosphate analogues 
in cell culture (Hutchinson and Naylor, 1985). A similar 
type of strain sensitivity to adamantane derivatives 
has been assigned to differences in the M2 membrane protein 
(Hay, et al., 1985) and the observed variation in 
sensitivity to pyrophosphate analogues may be a result of 
differences in the proteins making up the transcriptase 
complex (Naylor, 1985).
1.4 MODE OF ACTION OF PYROPHOSPHATE
ANALOGUES AGAINST INFLUENZA---
The mode of action of the inhibition of 
influenza viruses by pyrophosphate analogues has been 
investigated quite extensively, and it now seems clear 
that they exert their activity by interacting directly 
on the RNA transcriptase rather than first being 
metabolised to some more active form. For example, it
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had been suggested that in their inhibition of herpes virus 
DNA polymerases, pyrophosphate analogues act as substrates 
for the reverse reaction of polymerisation, and that the 
resultant triphosphate analogues are the active species, 
acting as competitive inhibitors for the natural nucleoside 
triphosphate substrates in the polymerisation reaction 
(Leinbach, et al. , 1976). However, no incorporation of 
radiolabelled PAA into nucleoside phosphates was observed 
in DNA or RNA polymerase reactions and such nucleoside 
triphosphate analogues are neither inhibitors nor substrates 
for the polymerases of herpes or influenza (Cload, 1983) .
In multiple inhibition analyses, pyrophosphate and 
PAA were found to be mutually exclusive inhibitors, showing 
that they both bind to the same site in the polymerase 
(Leinbach, et al. , 1976) , partially explaining why 
isosteres of inorganic pyrophosphate make good inhibitors.
It has been shown that influenza viruses require 
zinc (Oxford and Perrin, 1977) and studies of a range of 
pyrophosphate analogues which inhibit influenza RNA 
transcriptase, have shown a good correlation between the 
inhibitory power of each analogue and its ability to 
chelate zinc ions under physiological conditions (Cload and 
Hutchinson, 1983a) . The superior inhibition of influenza 
A by thiopyrophosphate analogues (Hutchinson, et al. , 1985) 
has been proposed to be due to the greater affinity of 
sulphur for zinc under the Pearson rules for hard and 
soft acids and bases, resulting in thiopyrophosphate 
analogues forming stronger zinc complexes than their 
oxygenated counterparts (Hutchinson, et al. , 1985) .
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Studies on the mode of action of PFA have revealed 
that in the presence of this inhibitor, initiation of 
viral mRNA synthesis takes place as normal, but that 
elongation beyond 12 or 13 bases is prevented (Stridh and 
Datema, 1984). This point of inhibition appears to 
coincide with the time that the RNA transcriptase complex 
becomes dissociated from the primer cap, and begins 
to move down the nascent RNA chains (Section 1.2.2.2), 
and so it is possible that a structural change in the 
proteins at this stage allows interaction of pyrophosphate 
analogues with the complex through an essential zinc ion, 
thus blocking further transcription.
1.5 CLINICAL USE OF PYROPHOSPHATE ANALOGUES
Phosphonoacetic acid, when used in animal models 
shows pronounced dermal toxicity (Boezi, 1979). PFA is 
less toxic, and is currently undergoing clinical trials 
after showing promise against cutaneous herpes 
infections when applied as a 3% Cw/w) cream (Oberg, 1983).
One of the problems which must be overcome 
before pyrophosphate analogues can be used generally in 
chemotherapy is their great affinity for calcified 
tissue. Although undesirable for an antiviral, this 
property has proved useful in other medical fields.
The pyrophosphate analogues ethylidenehydroxy- 
diphosphonate (EHDP) and dichloromethylenediphosphonate 
(C12MDP, Fig. 1.5) inhibit resorption of bone and the 
former also inhibits mineralisation of soft tissue.
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with improved efficacy in cell culture. The bulkyness of 
the lipophilic group may also render the compound 
incompatible with the hydroxyapatite matrix of calcified 
tissue for stereochemical reasons, reducing the tendency 
to accumulate in bones and teeth.
1.6 OUTLINE OF WORK UNDERTAKEN
The aim of the present work was to prepare some 
lipophilic pyrophosphate analogues, which for the reasons 
described above might be expected to be improved 
inhibitors of influenza virus replication in cells.
This required a thorough investigation of the 
synthetic methods available, preparation of monohalogenated 
methylenebisphosphonates and their subsequent alkylation 
via metallated intermediates. The compounds would then be 
assessed as inhibitors in enzyme assay and cell culture 
systems. It was hoped that the lipophilic analogues 
would show greater virus inhibition but with less cytotoxicity 
than has been observed for other halogenated analogues 
(Cload, 1983) in cell culture.
It was also proposed to use the methodology 
developed, to prepare an affinity label to identify which 
of the viral proteins the analogues interact most closely 
with in exerting their observed antiviral effect.
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CHAPTER 2
SYNTHESIS OF HALOGENATED METHYLENEBISPHOSPHONATES
2.1 EARLY WORK
The first reported preparation of a halogenated 
derivative of a methylenebisphosphonate ester, was the 
formation of tetraethyl dichloromethylenebisphosphonate 
as a byproduct of the reaction between bromotrichloro- 
methane and triethylphosphite (Bunyan and Cadogan, 1962). 
It was proposed that the reaction proceeded via a radical 
chain transfer mechanism (the major product being diethyl- 
trichloromethylphosphonate, Fig. 2.1(i)). If chloroform 
was used in place of bromotrichloromethane, small amounts 
of tetraethylmethylenebisphosphonate were isolable 
(Burn, et al., 1964) with tetraethylchloromethylenebis­
phosphonate postulated as an intermediate. This method 
proved difficult to adjust to give high yields of the 
halogenomethylenebisphosphonate esters (Nicholson and 
Vaughn, 1971), so other routes have been sought to these 
halogenated species.
Preparations of methylenebisphosphonate esters 
have been reported via an Arbusov reaction (Fig. 2.1(ii)), 
with near quantitative yields being claimed for the 
tetraisopropyl ester (Proctor and Gamble Co., 1966) and 
more modest yields for other esters (Schwarzenbach and 
Zurc, 1950). Halogenation of these esters has proven to 
be the most versatile and widely used route to tetra-
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Fig. 2.1(1) Formation o£ tetraethyldichloromethylenebiaphosphonate 
(Buny&n and Cadogan, 1962).
p<o r )3
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Fig. 2.1(ii) Preparation of methylenebisphosphonate by an 
Arbusov reaction.
alkyl halogenomethylenebisphosphonates . Fluorination 
to the mono- and difluoro-derivatives is possible with 
perchlorylfluoride (McKenna and Shen, 1981). A less 
hazardous route to the difluoro compound though, involves 
preparation first of dialkyl bromodifluoromethylphosphonate 
(Burton and Flynn, 1977) followed by a Michaelis-Becker 
reaction with a dialkyl phosphite to yield the difluorinated 
bisphosphonate (Blackburn, et al. , 1981, Burton, et al., 
1982, Fig. 2.1(iii)). However, several methods are known 
for the preparation of other halogenated derivatives which 
do proceed via tetraalkylmethylenebisphosphonates.
Excellent yields have been claimed for prepara­
tion of a variety of dihalogenated methylenebisphosphonates 
by reaction of the parent compound with alkaline hypohalite 
(Quimby, et al. , 1968), using an excess of either 
commercially available sodium hypochlorite for chlorination, 
or the appropriate hypohalite prepared in situ for 
bromination or iodination (Fig. 2.1(iv)) . It has been 
demonstrated (Curry, 1971) that whilst dihalogenation of 
tetraisopropyl methylenebisphosphonate proceeds smoothly, 
the analogous ethyl and methyl esters must be well buffered 
to prevent base-induced cleavage of the P-C bond. Indeed 
it has been found that for the ethyl ester, the cleavage 
reaction predominates in the absence of carbonate as a 
buffer, the product being diethyldichloromethylphosphonate 
(Seyferth and Marmor, 1973) . In this study it was observed 
that even with buffered mixtures, up to 15% (by 31P n.m.r.) 
of the products can result from this side reaction.
Despite this, good yields of all esters of dichloro- and
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Fig. 2.1(111) Two-step preparation of tetraalkyl difluoromethylene- 
bisphosphonate.
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Fig. 2.1(iv) Reaction af tetraalkyl methylenebisphosphonate with 
sodium hypohalite.
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dibromo methylenebisphosphonates can be prepared in this 
way.
2.1.1 Preparation of Monohalogenated Species
The method discussed above is not however, 
readily adapted for the preparation of the analogous 
monohalo derivatives. It has been shown that using a 
single equivalent of hypohalite, prepared in situ, 
mixtures of dihalo-, monohalo- and unhalogenated products 
were formed (Quiroby, et al. , 1968). Adjustment of the 
solvent system allowed a maximum yield of 60% (by 3lP n.m.r.) 
tetraisopropyl monobromomethylenebisphosphonate to be 
prepared, which was not readily separable from the other 
species present in the mixture.
Direct reaction of one equivalent of molecular 
halogen with the sodium salt of methylenebisphosphonate 
esters also does not simply yield the monohalo derivative, 
but rather mixtures similar to those described above. The 
monohalo species in this case was never observed as 
constituting more than 50% of the product mixture (Quimby, 
et al. , 1968) .
Hata has prepared monohalogenated derivatives of 
active methylene compounds (e.g., monobromomalonitrile) by 
extended heating of the corresponding dihalogenated and 
unhalogenated species (Hata, 1964) , but this method has been 
shown to be unsuccessful in the case of methylenebisphos­
phonates (Nicholson and Vaughn, 1971). In the same paper 
it was noted that the most appropriate method for the 
preparation of the monohalo derivative, given the difficulties
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inherent in other methods, would be to selectively remove 
a single halogen from the bridge carbon of the more 
accessible tetraalkyl dihalomethylenebisphosphonates.
It was reported that this could be achieved by reacting 
the dihalo compound with one equivalent of sodium hydro­
sulphide (Nicholson and Vaughn, 1971) . The mechanism 
for the reaction was unclear but was thought to involve both 
nucleophilic displacement and reduction. The method proved 
unreliable in this study, which led to the investigation of 
other methods by which dihalo species could be dehalogenated, 
and the mechanism involved in the process.
2.2 RESULTS AND DISCUSSION
2.2.1 Nucleophilic Displacements of Halogen
from Dlhalogenomethyleneblsphosphonates
In the present study, it was noticed that 
reaction of tetraisopropyldtchloromethylenebisphosphonate 
with an excess of potassium fluoride in acetonitrile, with 
[18,6]crown ether as catalyst, resulted in complete 
dehalogenation to yield primarily (> 60% by 3lP n.m.r.) 
the corresponding ester of methylenebisphosphonate. It was 
thought that the mechanism may be similar to the afore­
mentioned speculative mechanism of Nicholsonand if so 
the method may be adaptable to give good yields of the 
monochlorinated analogue.
It was found that reaction of a single equivalent 
of potassium fluoride under the same conditions yielded the 
desired tetraisopropyl chloromethylene bisphosphonate as 
70% of the phosphorus-containing material (55% isolated
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yield) after 7 days at elevated temperature. No fluorine- 
containing products could be detected at any stage either
spectrum, showing that no nucleophilic displacement had 
occurred at the central carbon, nor had any P-F bonds 
formed by direct attack at phosphorus. A byproduct of the
phosphonate resulting from P-C bond cleavage (Fig. 2.2(D). 
This type of cleavage was subsequently observed, also as 
a side reaction, when the anions [ (RO) 2P lO) ] 2CC1 (R « Me,
Et) were formed using a strong base. Hence it was thought 
that the reaction could proceed via a carbanion intermediate, 
produced by positive halogen abstraction from the bridge 
carbon by fluoride, which then becomes reprotonated under 
the reaction conditions (Fig. 2.2J(i) ) . Positive halogen
by *®F n.m.r. or by 3lP-l9F coupling in the ^1P n.m.r.
( iPrO)2P(0)CH2CI
H
[('Pr0)2P(0 )]2C^
Cl
Mechanism of the reaction between tetraisopropyl- 
dichloromethylenebisphosphonate and naked fluoride 
ion.
Fig. 2.2.1(i)
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abstraction has been reported previously as a mechanism 
in reactions of halogenated phosphonates (Burton and 
Flynn, 1980) and stable carbanions of the type proposed 
have been observed both by others (Seyferth and Marmor,
1973, Quimby, et al., 1968) and in this study.
Addition of one equivalent of cyclohexene, which 
might be expected to react with any chlorine monofluoride 
produced to accelerate the reaction, increased the reaction 
rate so that no starting material was present in the 
mixture after 2 days, but resulted in an increased proportion 
of side products.
The same reaction using a sodium fluoride/[18,61 crown 
system produced no chloromethylenebisphosphonate esters.
This is because the sodium ion does not make such good 
complexes with [18,6]crown ethers as potassium ion due to 
the cavity size of the ether. This is estimated at 
2.6-3.2 8 (Pederson and Frensdorff, 1972) and as such is 
more suitable for potassium ion (ionic diameter, 2.66 8) 
than sodium ion (ionic diameter, 1.90, Whaley, 1973).
Thus, "naked" fluoride ion is not available using sodium 
fluoride and so the displacement does not occur.
When potassium fluoride/[ 18,6] crown ether was 
reacted with tetraisopropyl dibromomethylenebisphosphonate 
under the conditions described, positive halogen abstraction 
was again observed and tetraisopropylbromomethylenebisphos- 
phonate was produced as 70% of the reaction mixture (by 
31P n.m.r., 50% isolated).
Fluoride ion as the naked anion in acetonitrile 
is the smallest and most nucleophilic of the halide ions
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(Liottov, et al., 1975). Furthermore, chlorine monofluoride 
has the highest bond energy of any of the interhalogen 
compounds containing chlorine (Downs and Adams, 1973a), which 
may explain why analogous reactions to those described, 
were not seen when naked chloride, bromide, iodide or 
cyanide ions were used in place of fluoride ion in the 
reaction mixture.
Other nucleophiles were shown to react in the 
same way as fluoride. Hydroxide ion gave tetraisopropyl- 
chloromethylenebisphosphonate as 40% of the product 
mixture from the dichloro analogue under similar conditions 
to those described, but this was also accompanied by partial 
de-esterification. Hydride ion reacted more slowly than 
fluoride and hydroxide to yield a mixture of the mono- 
chloro (30%) and the fully dehalogenated (10%) derivatives 
after 7 days.
Bulkier nucleophiles, such as 2-mercaptopyridine, 
triphenyl phosphine and dithlonite ion showed no reaction 
under similar conditions over a period of 3 days.
Thus, it seems that only small, highly nucleophilic 
species are capable of removing a chlorine from the bridge 
carbon by positive halogen abstraction due to the highly 
constrained nature of the reaction site. It appears 
likely that the reaction described by Nicholson proceeds 
via a similar route, with sodium ion stabilisation of the 
intermediate anion, followed by breakdown of the products 
into sodium chloride and elemental sulphur (Fig. 2.2.1(ii)).
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Fig. 2.2.1(11) Mechanism of the reaction between te tr a isopropyl- 
dichlorcmethylenebisphosphonate and sodium hydro­
sulphide .
2.2.2 Metal-Halogen Exchange
Metal-halogen exchange between organic halides 
and metal alkyls is well documented (e.g., Wardell, 1982) 
and the reaction has been shown to be well suited to the 
dichloromethylenebisphosphonate ethyl ester (Seyferth and 
Marmor, 1973) and can be adapted to give good yields of 
the monohalogenated analogue by aqueous quenching of the 
intermediate anion (Fig. 2.2.2). The reaction is cleaner 
than any of the nucleophilic displacements described in 
the previous section, which is due to the greatly 
increased stability of the intermediate anion when generated 
in the presence of an available metal counter-ion. This 
stabilising effect is so great that metal salts of the 
unhalogenated analogue have been observed as stable species
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Fig. 2.2.2 Preparation of tetraalkyl chloromethylenebisphos-
phonate by metal/halogen exchange.
in solution by 3lP and *H n.m.r. (Quimby, et al. , 1968) 
and air stable compounds prepared and analysed 
(Baldeschweiler, et al., 1962) . In this study such 
salts of esters of chlororoethylenebisphosphonate have 
been studied by 3lP and 13C n.m.r. spectroscopy. No 
analogous stable anions could be observed in the course 
of any of the experiments described in the previous 
section.
The increase in selectivity and speed of 
this method over the fluoride reaction, means it has 
proven to be the most efficient preparation of tetraalkyl- 
chloromethylenebisphosphonates in this study. The method 
described by Seyferth (Seyferth and Marmor, 1973) has 
proved widely applicable in this present work if the
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alkyl lithium is chosen so as to match the reactivity 
of the dichloromethylenebisphosphonate ester. The original 
reaction of 1 equivalent of n-butyl lithium with the tetra­
ethyl ester, was found to give a quantitative yield of the 
corresponding anion (Table 2.2.2 for 3lP n.m.r.) which when 
quenched with water and the product purified gave the 
desired tetraethylchloromethylenebisphosphonate in 75% 
isolated yield.
Reaction of a single equivalent of n-butyl 
lithium with the tetraisopropyl ester of dichloromethylene- 
bisphosphonate was found to only provide 80% conversion to 
the intermediate anion, and an excess of n-butyllithium 
was required to give quantitative conversion. Reaction of 
one equivalent of methyl lithium however, with the same 
dichloro species under identical conditions was observed 
to give 100% conversion to the anion. Quenching of this 
intermediate and work up gave tetraisopropylchloromethylene- 
bisphosphonate in 82% isolated yield.
Reaction of n-butyllithium with the tetramethyl 
ester of dichloromethylenebisphosphonate at -78°C resulted 
in formation of the corresponding intermediate lithium 
salt in only 24% yield by 3lP n.m.r. This salt was 
accompanied by several species which can be postulated 
as being dimethylhalomethylphosphonates due to base induced 
C-P bond cleavage (3lP n.m.r. 6 11.5, 10.9 and 1.3 p.p.m.). 
However, when the tetramethyl ester of the dichloro 
compound was reacted under the same conditions with 
tert-butyl lithium, no cleavage was observed and the only 
species seen by 3lP n.m.r. was the desired lithium salt.
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TABLE 2.2.2 31P N.m.r. Chemical Shifts (6, p.p.m.)
of Esters of Methylene Bisphosphonate 
and their Halogenated Derivatives
Compound R = Me R « Et R “ ‘pr
[(RO)2P(0)J2CH2 23.0 19.3 17.4
I(RO)2P(0)]2chci 15.5 13.2 11.5
[(RO)2P(0)J2CC12 10.2 8.3 6.5
[(RO)2P (0))2CH~Na+ «5.5* 41.5a 40.5a
((RO)2p (o)]2cci'li+ 36.8 34.7 32.3
[(RO)2P (0)]2CHBr - - 11.5
[(R0)2P(0)]2CBr2 “ “ 6.4
aQuimby, et al. , 1968
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Quenching and distillation yielded the corresponding raono- 
chloro species in 78% isolated yield.
Hence a clean, rapid method for preparation of 
several esters of chloromethylenebisphosphonate is now 
available by dichlorination of the parent methylenebisphos- 
phonate ester followed by metal-halogen exchange with a 
suitable alkyl lithium. The good yields available and the 
ease of purification of the products make this the route of 
choice to the monohalogenated compounds.
2.3 MATERIALS AND METHODS
2.3.1 Materials
(i) All compounds were commercially available and were 
used as received unless otherwise stated (Appendix I).
(ii) All reagents were of analytical grade or were 
purified prior to use.
2.3.2 General Chemical Procedures
(i) 1H N.m.r. spectra were recorded at 220 MHz
using a Perkin-Elmer R34 spectrometer. Chemical shifts 
are quoted with either tetramethylsilane (TMS) (in CDCl^, 
d4-methanol or dg-benzene) or sodium 3-(trimethylsilyl)-1- 
propane sulphonate (TSS) (in DjO) as internal* standards.
31P N.m.r. were recorded at either 36.44 MHz using a 
Bruker WH90 spectrometer or at 162.0 MHz using a Bruker 
WH400 spectrometer and were proton decoupled. 31P N.m.r. 
shifts are quoted relative to an external standard 
(85% HjPO^) with downfield shifts positive. 13C N.m.r.
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were recorded at 100.62 MHz on a Bruker WH400 instrument 
with TMS as internal standard.
(ii) Mass spectra were recorded using a Kratos MS80 
instrument, and the method of Cload and Hutchinson (1983b) 
for chemical ionisation spectra (Cl), or the method 
described in Appendix II for fast atom bombardment (FAB) 
spectra.
(iii) Flash column chromatography was carried out
according to the method of Still (1978) using the solvent 
systems described in the text.
(iv) Elemental analyses were carried out by Elemental
Micro-Analysis Ltd., Okehampton, Devon, U.K. or Butterworth 
Laboratories Ltd., Teddington, Middlesex, U.K.
2.4 EXPERIMENTAL
2.4.1 Preparation of Tetraisopropyl Methylene-
bisphosphonate
Triisopropyl phosphite and dibromomethane were 
combined in the molar ratio 3:1 and the mixture heated 
under vigorous reflux for 48 h. Tetraisopropyl methylene- 
bisphosphonate was isolated by vacuum distillation (b.p. 
118-120°C 0 0.08 mmHg). Yield 42* (3lP n.m.r. (CDClj)
6 17.4 p.p.m.(s); *H n.m.r. (CDC13) 6 1.35 (24 H, d,
J = 7.5 Hz), 2.38 (2H, t, J « 20 Hz), 4.7 (4H, m) p.p.m.;
13C n.m.r. (CgDg) 6 23.8, 24.0, 28.5 (t, J * 136.8 Hz),
70.6, 70.8 p.p.m.; Accurate Mass (M + H)+ Calc. 345.1596 Found 
345.1594]
2.4.2 Preparation of Tetraethyl methylene- 
bisphosphonate
Elemental sodium (10 g, 0.435 mol) was added
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in small pieces, with stirring and occasional cooling, 
to diethyl phosphite (125 g, 0.905 mol) at 40°C, under 
dry nitrogen, in a 500 ml 3-necked flask equipped with a 
thermometer and reflux condenser, over a period of 2 h. 
Dichloromethane (25 g, 0.294 mol) was then added and the 
mixture stirred at 40°C for 3 h. A further portion of 
CH2CI2 (15 g, 0.177 mol) was then added and stirring 
continued at 40°C overnight. After cooling to room 
temperature, toluene/petroleum ether b.p. 60-80°C,
1/1 (v/v) 150 ml) was added and the mixture stirred for 
a further  ^h. The precipitated sodium chloride was 
then removed by filtration, washed with petroleum ether 
b.p. 60-80°C (50 ml) and the combined filtrates dried 
over MgSOj and evaporated. The title compound was 
isolated by vacuum distillation (b.p. 120-122°C @ 0.1 mmHg). 
Yield = 35.8 g, 57%. [3lP n.m.r. (CDClj) 6 19.3 p.p.m.(s); 
*H n.m.r. (CDC13) & 1.35 (12H, t, J « 7 Hz), 2.45 (2H, t,
J * 19 Hz), 4.2 (8H, m) p.p.m.; 13C n.m.r. (CgDg) 6 16.3,
26.1 (t, J = 135.3 Hz), 62.2 p.p.m.; Accurate mass (M+’) 
calcd. 288.0892, Found 288.0886]
2.4.3 Preparation of Tetraisopropyl dichloro-
methylenebisphosphonate
Tetraisopropyl dichloromethylenebisphosphonate 
was prepared by the method of Quimby (Quixnby, et al. , 1968) 
in 91% yield after distillation (b.p. 120°C @ 0.05 mmHg)
(3lP n.m.r. (CDCl^) 6 6.4 p.p.m.(s); H n.m.r. (CDC13)
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6 1.4 (24H, d, J - 8 Hz) 4.9 (4H, m) p.p.m.).
2.4.4 Preparation of Tetraethyl dichloromethylene- 
bisphosphonate
Tetraethyl dichloromethylenebisphosphonate was 
prepared as described by Curry 11971) . 3lp N.m.r. analysis 
of the residue showed it to be a mixture of the title 
compound (88%) and CHCljP(O)(OEt)2 (12%) (6 10.6 p.p.m.). 
Distillation yielded the pure title compound (76%, b.p. 
118-120°C 9 0.05 mmHg) [3lP n.m.r. (CDClj) 6 8.3 p.p.m.(s);
*H n.m.r. (CDClj) « 1.42 (12H, t, J - 7 Hz) 4.48 (8H, ra) ; 
Accurate mass calc, (for 35C12) 356.0112, Found 356.0110].
2.4.5 Preparation of Tetramethyl dichloromethylene- 
bisphosphonate
Tetramethyl dichloromethylenebisphosphonate was 
prepared as described by Curry (1971) and the pure product 
isolated by distillation (60%, b.p. 92-94°C 9 0.04 mmHg)
I3lP n.m.r. (CDC13) 6 10.2 p.p.m.(s); *H n.m.r. (CDC13)
6 4.05 (d, J = 11 Hz) p.p.m.; Accurate mass calcd. (for 3^C12) 
299.9486, Found 299.9519].
2.4.6 Preparation of Tetralsopropyl chloromethy lene- 
bisphosphonate
Tetraisopropyl chloromethylenebisphosphonate was 
prepared by the method of Seyferth and Marmor (1973) using 
a solution of methyl lithium in place of n-butyllithium.
The product was isolated pure by distillation {82%, b.p.
110-112°C @ 0.05 mmHg) [3lP n.m.r. (CDC13) 6 11.4 p.p.m.(s) ;
*H n.m.r. (CDClj) 6 1.35 (24H, d, J - 8 Hz) 3.9 (1H, t,
J = 20 Hz), 4.9 (4H, m) p.p.m.; Analysis found: C, 40.9;
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H, 7.35; Cl, 9.7*; calc, for CjjHjgCIPjOg C, 41.2;
H, 7.72; Cl, 9.4*1.
2.4.7 Preparation of Tetraethyl chloromethylene-
bisphosphonate
Tetraethyl chloromethylenebisphosphonate was 
prepared as described by Seyferth and Marmor (1973) , the 
product being isolated by vacuum distillation (75%, b.p.
1 2 6 — 128°C § 0..38 mmHg) [3lP n . m . r .  (CDClj) 6 13.2 p . p . m . ( s ) ;
*H n.m.r. (CDClj) 6 1.4 (12H, t, J  » 7 H z ) , 4,.05 (1H, t.
J  -  18.5 Hz) , 4. 3 5  ( 8H, m) p . p . m . ;  A n a l y s i s found: C, 33.4;
H, 6.65; Cl, 11.5*; Calc, f o r  C gH 21C l P 2C>6 : C, 33.5;
H, 6.56; Cl, 1 1 . 0 « ] .
2.4.8 Preparation of Tetramethyl chloromethylenebis­
phosphonate
Tetramethyl chloromethylenebisphosphonate was 
prepared by the method of Seyferth and Marmor (1973), except 
that a solution of tert-butyllithium was used in place of 
n-butyllithium. The product was isolated by distillation 
(78*, b.p. 90-91°C @ 0.05 mmHg). [3lP n.m.r. (CDClj) 6
15.4 p.p.m.(s); *H n.m.r. 6 3.75 (12H, m), 4.0 (1H, t, 
j = 18 Hz) p.p.m.; Analysis found: C, 22.36; H, 5.29%; 
Calc, for C5H13C1P206; C, 22.53; H, 4.91%).
2.4.9 Preparation of Tetraisopropy 1 dibromo- 
methylenebisphosphonate
Tetraisopropy 1 dibromomethylenebisphosphonate 
was prepared by hypohalogénation of tetraisopropyl methylene- 
bisphosphonate. Tetraisopropyl methylenebisphosphonate 
(10 g, 0.029 mol) was stirred vigorously in a solution of
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K2C03 (55 g) in water (180 ml) at 40°C. Bromine (20 g,
0.125 mol) in heptane (20 ml) was added dropwise over 2 h 
with stirring. The reaction mixture was cooled to room 
temperature and extracted with chloroform (2 x 150 ml) .
The combined extracts were dried over MgS04, evaporated 
and the residue distilled in vacuo to yield the pure 
title compound (12.7 g, 87%, b.p. 124-125°C @ 0.08 mmHg)
[31P n.m.r. (CDCl-j) 6 6.4 p.p.m. (s) ; *H n.m.r. (CDC13)
6 1.35 (24H, d, J = 8 Hz), 4.8 (4H, m) p.p.m.; CIMS 
(M + H)+ 505, 503, 501 (1:2:1); Accurate mass (M + H),+", 
(^Br2) , calc.: 500.9805; Found: 500.9785].
2.4.10 Preparation of Tetraisopropyl bromomethylenebis-
phosphonate by Monohalogenation
Tetraisopropyl methylenebisphosphonate (11.5 g, 
0.037 mol) was reacted as described in Section 2.4.9 with 
one equivalent of bromine (0.85 ml, 0.019 mol) in heptane 
(4.5 ml). The product was isolated by flash column 
chromatography eluting with 10/1 (v/v) petroleum ether 
b.p. 40-60°C/acetone (3.24 g, 30*). [3lP n.m.r. (CDClj)
S 11.5 p.p.m. <s) ; 3H n.m.r. (CDClj) 4 1.35 (24H, d, J «
8 Hz), 3.75 (1H, t, J - 20 Hz), 4.9 4H, m) p.p.m.;
Analysis found; C, 36.83; H, 7.22»; calc, for C13H29BrP206 
C, 36.9; H, 6.91«).
2.4.11 Preparation of Tetraisopropyl bromomethylene-
bisphosphonate by Selective Dehalogenation
Tetraisopropyl dibromomethylenebisphosphonate 
was dehalogenated by metal/halogen exchange as described 
in Section 2.4.6. The product was isolated by flash
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column chromatography and distillation (58%, b.p. 118—120 C 
@ 0.08 mmHg).
2.4.12 Nucleophilic Displacements from Tetraisopropyl
dichloromethylenebisphosphonate
All reactions described in Section 2.2.1 were 
prepared similarly to the following.
118,6]Crown ether (0.1 g) was dissolved in 
acetonitrile (5 ml) with stirring and dry KF (0.17 g, 2.9 mmol) 
added slowly over 30 min. to ensure complete solvation. 
Tetraisopropyl dichloromethylenebisphosphonate (1.0 g,
2.4 mmol) was added and the mixture maintained at 55-60°C 
with stirring. The reaction was followed by extracting 
small aliquots, quenching them with water and recording 
the 3lP n.m.r. spectrum. This showed that there was no 
more starting material present after 7 days. The reaction 
was quenched by cooling to room temperature and addition 
of water (20 ml). The aqueous layer was extracted with 
chloroform (2 x 40 ml) , the extracts washed with water 
(3 x 25 ml) dried over MgS04 and the solvent removed 
in vacuo. The major product was tetraisopropyl chloro- 
methylenebisphosphonate which was isolated by flash 
column chromatography eluting with petroleum ether 
b.p. 40-60°C/chloroform 2/1 (v/v) CO.51 g, 55%).
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CHAPTER 3
ALKYLATIONS OE METHYLENEBISPHOSPHONATES
3.1 BACKGROUND
Alkylations of tetraalkyl roethylenebisphosphonates 
have been known for some time. Low yields have been 
reported for the monoalkylation of tetraethyl methylene- 
bisphosphonate via both the potassium (Kosolopoff, 1953) and 
sodium salts (Cotton and Schum, 1963) . In more extensive 
studies it was shown that alkylations of the tetraisopropyl 
ester in the same manner gives only moderately improved 
yields (Hays and Logan, 1966, Quimby, et al., 1968). In situ 
alkylation of the lithium salt of tetraethyl chloromethylene- 
bisphosphonate (generated as described in Section 2.2.2 by 
metal/halogen exchange between n-butyllithium and tetra­
ethyl dichloromethylenebisphosphonate) has also been reported 
(Seyferth and Marmor, 1973). In a limited study, good yields 
were only observed for méthylation with significantly 
reduced yields for alkylation with more complex groups.
In this study these methods have all been 
assessed with a view to finding the best method available 
for alkylation, particularly of monohalogenated methylene- 
bisphosphonates.
One of the major problems with the alkylation 
methods described above is one of selectivity. It was 
observed that for sodium salts of tetraisopropyl methylene- 
bisphosphonate, monohalogenation did not occur exclusively
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(Quimby, et at., 1968). 3lP N.m.r. analysis confirmed 
that mixtures of mono- and dialkylated products were 
obtained along with unalkylated starting material. The 
monoalkylated product predominated to a varying degree 
depending on the compound, but isolated yields suffered for 
each due to the difficulty of separating these mixtures 
as a result of the very similar properties of the species. 
The formation of the dialkyl derivative has been attributed 
to an exchange reaction between the monoalkylated species 
and the metal salt (Quimby, et at. , 1968).
3.2 RESULTS AND DISCUSSION
3.2.1 Alkylations of Tetraisopropyl chloro-
methylenebisphosphonate
3.2.1.1 __Sodium and Lithium Salt Intermediates
Preparation of the sodium salt of tetraiso­
propyl chloromethylenebisphosphonate, by treatment of the 
species with sodium hydride, and alkylating in situ with 
primary alkyl iodides resulted in the yields listed in 
Table 3.2.1.1.
As can be seen, a good yield of the methylated 
derivative can be obtained but for alkylation with larger 
groups, yields deteriorate rapidly with increasing chain 
length and for reaction of the salt with hexyl iodide, 
the monoalkylated species is no longer the predominant 
species.
On alkylation of the lithium salt of tetraiso­
propyl chloromethylenebisphosphonate good yields were again 
only observed for reaction with iodomethane. As previously
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Table 3.2.1.1 Yields and chemical shifts of the products from the 
alkylation of tetraisopropyl sodiochloromethylene- 
bisphosphonate.
observed (Seyferth and Marmor, 1973) this method could 
not readily be used to obtain good yields for reaction 
with larger primary alkyl iodides. For reactions via 
both the sodium and lithium salts, several side products 
were observed which can be rationalised in terms of a 
metal/halogen exchange process (Fig. 3.2.1.1). The mono- 
alkylated product and the unreacted metal salt can undergo 
exchange to furnish directly the dihalogenated derivative 
observed in product mixtures. This also results in a new 
anion which on subsequent reaction yields the dialkylated 
derivative. Other side products can be seen which are 
assignable to cleavage processes via the intermediate 
salt. Thus, slower quenching of the intermediate anion by
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cleaved products
[('PrOljPOlJjCCIH ■asE*-[(lPrO)2P<0)]2Ca-M--Bl— [('Pr0)2P(0))2CCIR
[('Pr0)2P(0)]2CR2
3.2.1.1 Metal/halogen exchange between the initial product 
and intermediate during alkylation of lithio- or 
sodio cMoromethylenebisphosphonate, to give all observed products.
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an alkyl iodide, due to its increased bulkyness, can result 
in all these side reactions becoming more significant.
3.2.1.2 Thallium Salt Intermediates
Similar side reactions to those described above 
are known to accompany the alkylation of sodium or 
potassium enolates of 6-diketones (i.e., dialkylation, 
6-diketone cleavage as well as O-alkylation, Claisen con­
densation, etc.). These competitive reactions have been 
shown to be avoidable if the crystalline thallium(I) salt 
of the requisite enolate is prepared and then reacted with 
an alkyl iodide (Taylor, et al., 1968). Due to the 
similarity of the 6-diketone and methylenebisphosphonate 
systems, it was thought that the same approach may prove 
similarly successful for monoalkylation of the latter.
Treatment of tetraisopropylchloromethylene- 
bisphosphonate with one equivalent of thallium(I) ethoxide 
in tetrahydrofuran at room temperature immediately resulted 
in formation of a cloudy white solution. Reaction of this 
thallium(I) salt intermediate with primary alkyl iodides 
produced excellent yields of the monoalkylated products 
(Table 3.2.1.2). The thallium intermediate was found to 
be more versatile than either the sodium or lithium salts 
in that side product formation was not important, even 
with alkyl iodides of up to six carbon atoms in length.
Reaction of the thallium(I) salt with secondary 
alkyl iodides (2-iodopropane and 2-iodobutane) was seen 
to be far less selective. No reaction was observed using 
the standard procedure developed, and only under forcing 
conditions (elevated temperature and prolonged reaction 
times) could the monoalkylated product be observed by

31P n.m.r. as constituting about 15% of a complex product 
mixture. The main compound identified in this mixture 
was the unalkylated (i.e., reprotonated) species, but 
several other peaks could be seen which were attributed 
to P-C bond cleavage reactions. In this case the 
competing reactions occur because of the reluctance of 
the secondary alkyl iodide to react, presumably due to the 
effect of steric hindrance. As expected, primary alkyl 
bromides reacted more slowly than their corresponding 
iodide. Primary alkyl iodides of six or more carbons 
in length also react rather sluggishly under the conditions 
described so that slightly reduced yields are isolable for 
hexylation and even smaller yields are seen for longer or 
more complex iodides. For example, reaction of the 
thallium(I) salt of tetraisopropyl chloromethylenebisphosphonate 
with 1-iodohexadecane results in 72% monoalkylation by 3lP 
n.m.r. Reaction of the same salt with 1-(2-chloro—4—methoxy- 
phenoxy)-6-iodohexane overnight, resulted in an isolated 
yield of 62% of the bisphosphonate ester analogue of 
arildone (Diana, et al. , 1977). These decreased yields 
can be attributed to the reduced mobility of the larger 
iodides under the reaction conditions, causing the desired 
reaction to proceed more slowly and allowing competing 
reactions to occur.
3.2.2 Alkylation of Tetraisopropyl bromomethylene-
bisphosphonate
The method described above was also extended 
to provide modest isolated yields of monoalkylated 
derivatives of tetraisopropyl bromomethylenebisphosphonate.
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It was found though, that the competing reactions were more 
predominant than for the chloro-analogue. The side products 
could be minimised by forming the thallium salt intermediate 
at low temperature, followed by a short period of low 
temperature alkylation and then proceeding in the usual 
manner. Again such side reactions become more important 
with increasing size of the alkylating group, although 
reasonable yields could be isolated for primary alkyl 
groups of up to four carbon atoms in length (Table 3.2.1.2).
3.2.3 Alkylation of Tetraisopropyl methyleneblsphosphonate
Tetraisopropyl methylenebisphosphonate was less 
reactive towards thallium ethoxide than its halogenated 
derivatives. Reaction of the ester with one equivalent of 
the base, followed by alkylation with ethyl iodide yielded 
only 51% of the monoalkylated derivative by 3lP n.m.r. For 
optimum yields of the monoalkylated product, 1.4 equivalents 
of base were required to form the anion and in this way up 
to 75% of the product mixture comprised the monoalkylated 
derivative (Table 3.2.1.2).
Some exchange occurred to give the dialkylated 
compound and hence it was concluded that this method held 
no advantage over the method of Quimby, et al. (1968) for 
alkylation of tetraisopropyl methylenebisphosphonate, 
despite being superior for monoalkylation of the halogenated 
derivatives. Improved isolated yields were obtainable by 
separating the products by flash column chromatography 
(Still, et al. , 1978) rather than by fractional distillation.
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3.2.4 Relative Reactivities of Derivatives of
Tetraisopropyl methy lenebisphosphonate
The differences in the reactions of the three 
methylenebisphosphonate tetraisopropyl ester species can 
be rationalised in terms of their reactivity towards 
thallium(I)ethoxide and the stability of their thallium 
salts once formed. The salt of tetraisopropyl methy lene­
bisphosphonate is the least easily formed of the three.
This is probably because there is no electron withdrawing 
group on the bridge which would give extra stability to 
the intermediate anion, as is the case for the two halogenated 
analogues. Since 1.4 equivalents of thallous ethoxide 
are required to give the best yields of monoalkylated 
product, the opportunity exists for dialkylation by both 
exchange between the monoalkylated species and the 
intermediate, or reaction between the monoalkylated species 
and a second molecule of base, each followed by a second 
alkylation.
For the chloro- and bromo-derivatives, quantitative 
yields of the anion intermediate appear to be formed with 
a single equivalent of thallium(I)ethoxide. Hence, the 
only opportunities for competing reactions are through 
metal/halogen exchange or P-C bond cleavage reactions.
The bromo-compound is much more prone to metal/halogen 
exchange, and this property can be equated with the fact 
that the first ionisation potential of bromine is less 
than that of chlorine (Downs and Adams, 1973b), since 
the halogen must be abstracted as a positively charged 
entity.
59
P-C bond cleavage is not important for the 
reaction of the chloro-species, but is mere prevalent 
for the bromo-analogue, which may mean that the heavier 
halogen fails to stabilise the intermediate anion to 
the same extent as chlorine, rendering the thallium salt 
of the bromo-analogue more susceptible to cleavage.
3.2.5 Differing reactivities of Different Esters
of Methylenebisphosphonate and Derivatives 
to Alkylation
It was anticipated that alkylation of the
tetraethyl or tetramethyl esters of all the compounds
examined, by the same route, would produce similar or
even improved yields in cases, due to the reduction in
steric hindrance around the carbanion reaction centre.
These primary esters would also be more rapidly hydrolysed,
via the tetra (trimethylsilyl) ester (McKenna and Schmid-
hauser, 1979), than the isopropyl ester, which could prove
invaluable for preparation of more sensitive species.
However, reduced yields for the alkylation of tetraethyl
esters were observed and for the vetraroethyl esters the
P-C bond cleavage reaction was the predominant reaction,
making them useless for the preparation of monoalkylated
products. These observations required further investigation.
3.2.5.1____ 3lP N.m.r. Examination of the Relative Rates
of Reaction of Esters of Chloromethylene- 
bisphosphonate
The relative rates of alkylation of the 
tetraisopropyl and tetraethyl esters of chlorome thy lene­
bisphosphonate were examined qualitatively by 3lP n.m.r.
A sample of the lithium salt of each ester was prepared
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and its 3lP n.m.r. spectrum recorded, a primary alkyl 
iodide was added and further spectra recorded at suitable 
intervals. The relative rates of alkylation can be seen 
from the proportions of the peaks due to the anion (6 32.3 
(iPr) and 34.7 (Et) p.p.m.) and the monoalkylated product 
(6 14.7 (*Pr) and 16.4 (Et) p.p.m.) (Fig. 3.2.5.1). It 
can be estimated that the alkylation of the lithium salt 
is nearly twice as fast (at room temperature) for the tetra- 
isopropyl ester than for the tetraethyl ester. Side 
reactions however, proceed at a comparable rate for both 
esters so that the slower production of a monoalkylated 
product with the tetraethyl ester, means that it accounts 
for a smaller proportion of the final product distribution.
These observations rationalise the behaviour 
seen both in this study and with previous work, in that 
alkylations of tetraisopropyl methylenebisphosphonate 
(Quimby, et al. , 1968) give better isolated yields than 
the corresponding reaction with the tetraethyl ester 
(Kosolopoff, 1953).
Similar relative rates of reaction were seen 
for the alkylation of thallium salts, the tetraisopropyl 
esters again reacting more rapidly. However, this 
reaction was less satisfactorily followed by n.m.r., since 
the anion intermediate is only very sparingly soluble 
in organic solvents. Quenching of aliquots of the 
reaction mixture with water at intervals and equating the 
proportion of the reformed chloromethylenebisphosphonate 
ester with that of the anion in solution, was the method 
used to follow these reactions. This method assumes
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Fig. 3.2.5.1 Time—course of the alkylation of tetr a isopropyl 
and tetraethyl lithiochloromethylenebisphosphonate.
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that the chloromethylenebisphosphonate esters do not 
exist in the reaction mixture, which is almost certainly 
not the case.
The observation that the alkylation of the 
tetraisopropyl ester proceeds more rapidly than that of 
the tetraethyl ester was the opposite of what might 
be expected on purely steric grounds. Thus, the anion 
intermediates must differ either electronically or 
energetically to account for the behaviour described.
3.2.5.2____13C N.m.r. Study of Methylenebisphosphonate
Esters and their Anions
The electronic nature of the central carbon 
atom in the methylene bisphosphonate esters and their 
anions were investigated by 13C n.m.r. (Table 3.2.5.2).
The first feature of the results to be noticed is that 
there is an increase in the 3lP-13C one bond coupling 
constants for all the phosphorus containing species, on 
moving from the parent compound to the anion. This is 
consistent with a change in hybridisation of the central 
carbon atom, on removal of the bridge proton, from sp3 
to sp2 (Stothers, 1972). The 13C chemical shifts, 
however, would seem to indicate that this can only be 
the case if the anions are not appreciably delocalised.
The signals for the anions are shifted 12-17 p.p.m. upfield 
from those of the corresponding parent species. These 
changes in chemical shift can be compared with those 
seen for the carbonyl analogues where the negative charge 
would be epxected to be delocalised to a greater extent.
Formation of the anion of triethylphosphono- 
acetate, results in a downfield shift of 5.6 p.p.m. for
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TABLE 3.2.5.2 13C N.m.r. data for the central carbon
atom in methylenebisphosphonates, 
triethylphosphonacetate, pentane-2,4- 
dione and their anions
Compound 6(p.p.m.) J13c .31p "**»
[(MeO)2P(O)]2CHC1 42.1 141.9
I (MeO) 2P (O) ) 2CC1 <_l Na 1 + 1 30.2 236.9
l (EtO)2P(O)]2CHC1 43.9 141.9
[(EtO)2P(O)12C1(_)Na < + > 31.1 236.4
[(i-Pro)2P(0)]2CHC1 45.5 143.4
[ (i-PrO) 2P (0) ] 2CC1<'1 Na 1+1 33.8 234.3
[ (MeO) 2P (O) ] 2CH2 24.0 135.3
[ (MeO) 2P (0) 12CH(_) Ha(+) 7.3 217.5
[(Et0)2P(0)]2CH2 26.1 135.3
[(EtO)2P (0)]2CH *“1N a 1 8.6 217.7
I (i-PrO) 2P(0) 12CH2 28.5 136.8
t (1-Pro) 2P (0) ] 2CH (_)Na(+1 11.1 214.7
(EtO)2P(O)CHjCOOEt 34.7 133.8
(EtO) 2P (O) CH *~1 COOEtNa *+l 40.3 219.1
kMeCOCH2COMe 52.8
1 MeCOCH(“)COMeNa(+) 96.9
•Wilkie and Haworth, 1978
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the signal due to the central carbon atom, relative to the 
protonated parent species, and it has been reported for 
pentane-2,4-dione that the analagous transformation results 
in a downfield shift of 44 p.p.m. in the 13C n.m.r. for 
the central carbon (Wilkie and Haworth, 1978) . So the 
species with the greatest delocalisation have the greatest 
downfield shift on removal of a proton by sodium hydride.
A similar pattern for the relative amounts of 
delocalisation for these species has been suggested from 
infrared evidence (Cotton and Schunn, 1963), so it can be 
concluded that there is negligible delocalisation of 
negative charge through the phosphate bonds in methylene- 
bisphosphonates, and furthermore that there is little 
difference in the electronic properties of the anions 
regardless of which ester is being examined.
Thus the difference in reactivity of the different 
esters can be ascribed to the differing stabilities of their 
anions. It can be seen that the anions of tetraisopropyl 
ester species would be the most subject to steric 
destabilisation, on account of the bulkyness of the isopropyl 
groups, and as the least stable anion it might be expected 
to react most rapidly. The more stable anions, those of 
the ethyl and methyl ester species react more sluggishly 
with alkyl iodides and so become susceptible £0 side 
reactions, rendering them less useful for the preparation 
of roonoalkylated methylenebisphosphonates.
3.2.6 Hydrolysis of Methylenebisphosphonates 
Hydrolysis of esters of methylenebisphosphonates
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by treatment with refluxing hydrochloric acid is the 
traditional method of preparation of the corresponding 
free acid (Kosolopoff, 1950). Yields are not high, 
however, (Hays and Logan, 1966), and so alternative 
procedures have been sought to facilitate deesterification 
under milder conditions.
It has been demonstrated that halogenotrialkyl- 
silanes interact with alkyl-phosphates and phosphinates 
to give the corresponding trialkylsilyl derivatives 
(Schwartz and Schoeller, 1958). This observation has 
become the basis of the roost commonly used hydrolysis 
procedure, as these silylesters are readily hydrolysed 
under neutral conditions. Several reagents have been used 
to effect this transformation reaction which have a 
range of reactivities so that selectivity is possible 
between, for example, primary and secondary esters or 
alkyl and aryl esters.
Chlorotrimethylsilane is the least reactive of 
the species used. If used in combination with sodium 
iodide, efficient dealkylation is claimed (Morita, et al. , 
1979) but formation of halogenated side products has been 
observed (McKenna and Schmidhauser, 1979). Use of 
iodotrimethy1silane greatly reduces the amounts of these 
side products (Blackburn and Ingleson, 1980) /  and this 
reagent rapidly and selectively transesterifies phosphate 
ester functions.
A slightly less reactive homologous reagent, 
bromotrimethylsilane, has also been shown to effect 
selective transesterifications of phosphate esters (e.g..
ee
[(RO)2PÎO)]2Cr ' r 2 --------- BdMS------------------  [(Me3S i0 )2P (0))2C R 'R 2
[(H O JjP iO jjjCR 'R 2
Mechanism
Fig. 3.2.6 Hydrolysis of phosphonate esters using broisotrimethyl- 
silane.
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Hata, et al.. 1979, McKenna, et al., 1977). This reagent 
proved in this study to be sufficiently reactive to be 
used for clean, quantitative hydrolysis of tetraisopropyl 
esters (Fig. 3.2.6) at room temperature under nitrogen.
This was considered more convenient than using iodotrimethyl 
silane, which although more reactive, had to be used at 
low temperature in the dark to prevent discolouration of 
reaction mixtures.
3.2.7 Conclusions on the Synthesis of C-Alkyl
Halogenomethylene bisphosphonates
The most efficient preparation of C-alkyl 
halogenomethylene bisphosphonic acids is by dihalogenation 
of the isopropyl ester, selective monodehalogenation, 
alkylation via the thallium(I) salt and finally deesterifica­
tion via the tetra *-( trime thy lsilyl) ester.
It has been demonstrated that yields for the 
halogénation and alkylation reactions are smaller if 
tetraethyl or tetramethyl esters are used. Reduced yields 
are also obtained if any other of the metals examined 
is used as the counterion for the alkylation intermediate. 
Finally, the most efficient hydrolysis if affected by 
treatment with bromotrimethylsilane followed by hydrolysis 
of the silylated intermediate with aqueous methanol.
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3.3 EXPERIMENTAL
3.3.1 Alkylation of Tetraisopropyl sodiochloro- 
methyleneblsphosphonate
Alkylation of the sodium salt of tetraisopropyl
chloroxnethylenebisphosphonate was carried out essentially 
as described for the unhalogenated analogue (Quimby, et al. , 
1968). Yields are listed in Table 3.2.1.1.
bisphosphonate was prepared as described in Section 2.4.6. 
The salt was alkylated by addition of an alkyl iodide and 
the mixture heated under reflux for 2 h. The products 
were isolated as described by Seyferth and Marmor (1973)
showed for the méthylation reaction, the tetraisopropyl 
esters of methylchloromethylenebisphosphonate (65%), 
chloromethylenebisphosphonate (20%) and dichloromethylene- 
bisphosphonate (15%) . For the ethylation reaction, the 
tetraisopropyl esters of ethylchloromethylenebisphosphonate 
(36%), chloromethylenebisphosphonate (12%) and dichloro­
methy lenebisphosphonate (25%) as well as traces of four 
other products.
bisphosphonate esters was effected using the same general
3.3.2 Alkylation of Tetraisopropyl lithiochloro-
The lithium salt of tetraisopropylchloromethylene
as oils. 31P N.m.r. analysis of the product mixtures
3.3.3 Preparation of Tetraisopropyl C-Alkylchloro- 
methylenebisphosphonates via Thallium(I)
Salt Intermediates
Preparation of all the alkylated chloromethylene-
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procedure. A typical example is given below.
Tetraisopropyl chloromethylenebisphosphonate 
(0.5 g, 1.3 mmol) was dissolved in dry, freshly distilled 
THF (10 ml) and the mixture stirred at room temperature 
under an atmosphere of dry nitrogen. Thallium(I)ethoxide 
(95 yl, 1.3 mmol) was added all at once and stirring 
continued at room temperature for 40 min. during which time 
the mixture was seen to turn cloudy. Iodoethane (5 ml) was 
added and the mixture heated under reflux for 2 h. The 
solution was then cooled and the orange thallium iodide 
precipitate removed by percolation through a short florisil 
column, eluting with petroleum ether b.p. 40-60°C/acetone, 
1/1 (v/v, 120 ml). The residue was concentrated in vacuo 
to an oil, which was shown by 3lP n.m.r. analysis to 
contain the monoethylated product as 97% of the product 
mixture. This was purified by flash column chromatography, 
eluting with petroleum ether b.p. 40-60°C/acetone, 6/1 
(v/v), to give the pure product (yield 0.44 g, 81%).
During the preparations of the n-propylated 
and n-butylated analogues, the reaction vessel was kept 
dark, since the respective alkyl iodides are light 
sensitive.
For the preparation of the benzylated compound, 
the thallium intermediate was alkylated by treatment with 
an excess of a mixture of benzyl bromide and benzyl iodide 
prepared, in an efficient fume hood, as follows. Benzyl 
bromide (5 g, 0.029 mol) was added to a solution of sodium 
iodide (4.4 g, 0.03 mol) in acetone (25 ml). The mixture 
was stirred at room temperature for 10 min., filtered and
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then concentrated in vacuo. This mixture (1H n.m.r 
(CCl^JPhCHjBr 6 4.41 p.p.m.; PhCHjI 4 4.48 p.p.m.; 
ratio 1:4) was used immediately in the alkylation step.
All data for the compounds prepared are listed 
in Table 3.2.1.2.
3.3.4 Preparation of Tetraisopropyl C-Alkylbromo- 
methylenebisphosphonates
Alkylation of tetraisopropyl bromomethylenebisphos- 
phonate was by the same general procedure described above 
for the chloro analogue, except that formation of the anion 
intermediate was carried out at -20°C and the subsequent 
alkylation was performed by stirring with the alkylating 
agent, initially at -20°C for 1 h and then under reflux 
for 1^ h. The data for the compounds prepared are listed 
in Table 3.2.1.2.
3.3.5 Preparation of Tetraisopropyl C-Alkylmethylene- 
bisphosphonate
Preparation of tetraisopropyl C-alkylmethylene- 
bisphosphonate was effected as described above, except 
that 1.4 equivalents of thallous ethoxide were used to 
form the anion intermediate, which was then alkylated 
as normal. Purification of the product mixtures was by 
flash column chromatography eluting with petroleum ether 
b.p. 40-60°/acetone, 5/2 (v/v). The data for the compounds 
prepared in this way is given in Table 3.2.1.2.
73.3.6 Analysis of the Time-Course of Reactions 
bv ¿IP N.M.R.
The required methylenebisphosphonate ester 
(100 mg) was dissolved in C6Dg (2 ml) and the anion formed 
by addition of a single equivalent of the requisite 
lithium alkyl. The 3lP n.m.r. spectrum (36.4 MHz) was 
recorded. The alkylating agent was added and the 
subsequent reaction followed by recording the31P n.m.r. 
at suitable intervals.
3.3.7 Analysis of Anions and Parent Species by
13ç n .m I~r I
The anion was formed as described above in 
CgDg by addition of one equivalent of sodium hydride.
The 13C n.m.r. spectrum (22.62 MHz or 100.62 MHz) was 
recorded and compared to that of the starting material. 
Formation of the anion of the methyl ester was accompanied 
by some cleavage of the P-C bridge bond.
3.3.8 Hydrolysis of Tetraisopropyl Esters of 
Methylenebisphosphonates
Hydrolyses were performed using a standard 
procedure. A typical example is described below. 
Tetraisopropyl(ethylchloromethylene)bisphosphonate 
(400 mg, 0.96 mmol) was dissolved in CC14 (1 ml) under 
an atmosphere of dry nitrogen. Bromotrimethylsilane 
(1.3 ml, 10 mmol, 2.5 fold excess) was added and the 
mixture stirred at room temperature for 20 h. The solution 
was then lyophilised (3H n.m.r. analysis showed there to be 
no isopropyl groups present) and hydrolysed by repeated 
addition of aqueous methanol and lyophilisation. The
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residue was dissolved in a little water and isolated as
the tetrasodium salt by ion exchange on Dowex 50
(Na+ form) (Yield, 0.29 g, 92*). Analytical data for all
the compounds isolated in this way is listed in Table 3.2.1.2.
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CHAPTER 4
ACTIVITY OF METHYLENEBISPHOSPHONATES 
AGAINST INFLUENZA VIRUSES
4.1 METHODS
4.1.1 Preparation of Virus Stocks
The influenza A/X49 strain (a cross between 
A/England/864/75 and A/Puerto Rico/8/34 with the H3N2 
surface antigens of the A/England strain) was used for 
preparation of the influenza RNA transcriptase enzyme 
assay stocks, and was grown in the allantoic sacs of 
fertile hens eggs essentially as described by Kelly and 
Dinunock (1974).
Eleven day old embryonated hen's eggs were 
innoculated with infected allantoic fluid (0.1 ml of a 
10“4 dilution in PBS). The eggs were incubated (33°C/48 h) 
and then chilled (-20°C/2 h). The allantoic fluid was 
collected and clarified by centrifugation (3000 r.p.m./20 min.); 
from this point onwards all procedures were carried out 
at 0-4°C. The supernatant was collected and the virus 
pelletted by centrifugation (21,000 r.p.m./90 min., 6 x 
300 ml rotor). The supernatant w&s discarded^and the virus 
pellet allowed to soak overnight in PBS. The virus pellet 
was resuspended in PBS (10 ml) and clarified (2500 r.p.m./
10 min.) before application onto a velocity gradient of 
15-45% (w/v) sucrose in buffer (60 ml, 10 mM fcrts-HCl,
150 mM NaCl, pH 7.4) and centrifuged (22,000 r.p.m./l h.
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3 x 65 ml swing-out rotor). The diffuse virus band was 
collected by bottom puncture and the sucrose diluted with 
PBS and layered onto an equilibrium gradient of 30-70% (w/v) 
sucrose in buffer (50 ml, 10 mM tris-HCl, 150 mM NaCl, pH 
7.4) and centrifuged (20,000 r.p.m./overnight, 3 x 65 ml 
swing-out rotor). The virus band was collected as before, 
diluted with PBS and the virus pelleted by centrifugation 
(30,000 r.p.m., 2 h, 8 x 50 ml rotor). The supernatant 
was discarded and the pellet allowed to soak overnight 
in PBS before resuspending the virus in buffer (0.5 ml,
400 yM tris-HCl, pH 8.0) and frozen in aliquots at 
-70°c, thawing once prior to use.
4.1.2 Influenza RNA Transcriptase Assay
RNA dependent RNA polymerase (transcriptase) 
activity was assayed in a 200 yl reaction mixture 
containing 50 mM tris-HCl, pH 8.0, 5 mM Mg(CH3C02)2'
150 mM KC1, 5 mM dithiothreitol, 0.4 mM adenylyl-(3*-5’)- 
guanosine(ApG), 0.25% (v/v) Nonidet P-40, 0.4 mM ATP,
0.4 mM CTP, 0.4 mM GTP, (3H]-UTP (5 yCi) and purified 
virus 10 pi. Mixtures were kept at 4°C until addition of 
virus and then incubated for 1 h at 30°C. Reactions 
were terminated by addition of 200 yl of ice cold 
saturated sodium pyrophosphate followed by cold TCA 
(2 ml, 10% w/v) and the mixtures kept on ice for 2 h 
after agitation. Precipitated material was collected on 
Whatman GF/C discs which were wetted with cold 10% (w/v)
TCA, washed with 2 x 10 ml cold 10% (w/v) TCA, 10 ml 
ethanol and 5 ml ether, then oven dried before
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counting in a toluene based scintillant. Each concentration 
of inhibitor was tested in duplicate and semi-logarithmic 
dose-response curves drawn for each compound, from which 
the concentration required to inhibit the enzyme by 50% 
was determined (ID^q ).
4.1.3 Plaque Reduction Assay
Madin-Darby canine kidney (MDCK) cells were 
seeded onto 5 cm plastic culture dishes (in duplicate) at
3 x 106 cells/plate. Cells were grown at 37°C in a 
humidified atmosphere of 5% C02 in air until confluent 
in maintenance medium (DMEM supplemented with 10% NCS,
4 mM L-glutamine and penicillin/streptomycin, 50 units/ml). 
The confluent monolayers were washed with PBS and 
aspirated to dryness. Virus suspension 100 yl, 60 p.f.u.) 
was added to the cell sheets and left for 15 min. at
room temperature, the inhibitor added in PBS (300 yl) and 
the cell sheets left for a further 45 min. at room 
temperature. Cells were then overlaid with an agar 
medium (3.6 ml) containing 0.1% BSA, 2.5 yg/ml crystalline 
trypsin and 0.1% DEAE Dextran. The plates were incubated 
at 33°C for 4-6 days, stained with neutral red and the 
plaques counted. The percentage of plaque inhibition 
relative to the infected control, was determined for each 
inhibitor at a concentration of 500 yM.
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4.2 EXPERIMENTAL AND RESULTS
4.2.1 Effect of Haloqenated and Alkylated 
Methylenebisphosphonates on Influenza 
RNA Transcriptase Activity
Table 4.2 shows the ID50 values of the compounds 
tested and their zinc stability constants (Section 4.2.3). 
All the alkylated analogues showed similar inhibition 
against the enzyme, regardless of the length of the 
alkyl group involved. A typical dose-response curve is 
shown in Fig. 4.2.1).
4.2.2 Effect of Alkylchloromethylenebisphos­
phonates on Influenza A/X49 Replication 
in MDCK Cells
Several alkylchlororoethylenebisphosphonates 
were evaluated for anti-influenza activity in MDCK cells 
by a simple plaque reduction assay, the results of which 
are shown in Table 4.2. All alkylated analogues were 
superior inhibitors of the virus in cell culture than 
PAA or the parent chloromethylenebisphosphonic acid.
An increase in activity was seen with increasing 
lipophilicity of the alkyl side chain. No cell damage 
could be observed at concentrations of up to eight times 
those required for activity.
4.2.3 Determination of Zinc Binding Ability
Zinc binding was assessed by determination of 
the metal complex stability constant, pKdt, by the gel 
filtration method of Hummel and Dreyer (1962) . The 
details of the technique have been described by Yoza (1977).
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Fig. 4.2.1 A typical dose-response curve, showing the activity 
of C-benzylchloromethylenebisphosphonate on 
influenza A/X49 transcriptase at various concentra­
tions .
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Table 4.2 Biological Activity of Methylenebisphosphonates, 
[(HO)2P(O)]2CR1R2, and PAA
R1 R2 pK(j • (Zn2+) ID50 <WM) PR 500%
H H 5.3 > 500 n.d.
H Cl > 6 85 22
Cl Cl > 6 75 n.d.
Me Cl > 6 200 n.d.
Et Cl n.d. 190 n.d.
n-Pr Cl n.d. 195 34
n-Bu Cl > 6 190 37
n-Hex Cl > 6 230 83
CHjPh Cl > 6 130 60
H Br > 6 80 n.d.
Br Br > 6 40 n.d.
Me Br n.d. 160 n.d.
Et Br > 6 180 n.d.
(PAA) (5.5) (275) (0)
PR500 - %reduction of p.f.u. caused by analogue at
(virus control = 
a concentration
7.7 x 108) 
of 500 uM.
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4.2.4 Assessment of C-Benzylchloromethy lenebis-
phosphonate as a Bone Imaging Agent
C-Benzylchloromethylenebisphosphonic acid was 
bound to Tc-99m in the presence of SnCl2 as a reducing 
agent (pH ^ 6). The material chromatographed as one 
species and when injected intravenously into 3 mice with 
sacrifice 1 hour later, distribution was similar to other 
good Tc-99m bone imaging agents. That is, uptake in the 
femur was quite high, while the blood "background" was 
slightly higher than with some other agents.
4.3 DISCUSSION
Detergent-disrupted virus preparations, as 
used in this study, make available an RNA transcriptase 
activity which can be assayed in the presence of ApG as primer 
(Plotch and Krug, 1977) and using endogenous RNA as template. 
In this study the ID^q values refer to the inhibition of 
the whole of the transcriptase activity by 50%, since 
specific stages of the polymerisation process have not 
been fully characterised and the transcriptase enzyme 
kinetics have been found to be complex (Cload, 1983).
Dibromomethylenebisphosphonic acid was the 
most effective inhibitor of influenza A/X49 tested. The 
concentration required to inhibit the transcriptase activity 
by 50% was found to be 40 uM as compared to the 
published value of 10 yM (Cload and Hutchinson, 1983a).
All of the halo- and dihalo-derivatives were found to be 
effective inhibitors of the enzyme as in other studies 
(e.g., Cload, 1983) but on substitution with an alkyl
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group the concentration required to produce 50% enzyme 
inhibition increased roughly two-fold (Table 4.2). Within 
the limits of error of the enzyme assay procedure, it 
can only be concluded that in cell-free systems the length 
of the alkyl chain attached to the bridge does not 
significantly alter the ID5Q. This is perhaps slightly 
surprising as it means that the enzyme active site can 
accommodate a large range of sizes of inhibitor. There 
would, however, be very little difference in the effect 
of the various alkyl groups on the acid properties of the 
compounds and this appears to be the important factor in 
cell-free systems.
Magnesium ions are essential for the transcriptase 
activity and one possibility is that pyrophosphate analogues 
complex with magnesium ions to remove them from solution 
and hence disrupt viral processes. However, this seems 
unlikely as magnesium is present in the polymerase 
reactions at 5 mM whereas the compounds studied here are 
active at about one twenty-fifth of this concentration.
All of the alkylated analogues assessed for 
zinc binding ability were found to have pK<j' values 
of greater than 6 (Table 4.2). It has been shown 
previously that compounds which bind zinc this 
effectively, make good inhibitors of influenza RNA 
transcriptase (Cload, 1983; Naylor, 1985). This lends 
credence to the proposal that analogues of inorganic 
pyrophosphate owe their activity to binding tightly 
at an essential zinc ion at or adjacent to the 
transcriptase active site.
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In the plaque reduction assay the lipophilicity 
of the side chain has a significant effect. It can be seen 
from Table 4.2 that all the alkylated analogues tested in 
cell culture are superior inhibitors to the parent chloro- 
methylenebisphosphonic acid, and that all of the compounds 
examined were more active than PAA. Furthermore, the 
compounds with the largest, and hence most lipophilic, 
side chains are the most effective against influenza in 
cells. This can only be due to the increased lipophilicity 
enabling the compounds to cross the cell wall more readily 
to reach the active site, since all the inhibitors are of 
comparable efficacy in enzyme assays. Even a small alkyl 
group such as n-propyl is sufficiently lipophilic to 
enhance the activity of halógenated methylenebisphosphonates 
in cell culture. Of the compounds screened, only PAA 
showed any significant cellular cytotoxicity at a 
concentration of 8 mM, much greater than that required 
for activity.
In an attempt to qualitatively assess whether the 
compounds shown to be improved inhibitors of influenza in 
cell culture would show any reduced affinity for calcified 
tissue, C-benzylchloromethylenebisphosphonic acid was 
examined as a potential bone imaging agent. As described 
in Section 4.2.4, distribution of the radioactively tagged 
compound in mice was similar to that observed for other 
good bone imaging agents. Thus, it could not be said 
that the benzyl side chain group significantly affected 
the affinity of halogenated methylenebisphosphonates for 
calcified tissue. Perhaps a much larger and more bulky
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group is needed to make such compounds incompatible with 
the hydroxyapatite matrix of bones and teeth.
It can be concluded that lipophilic side chains 
increase the anti-influenza activity of halogenated pyro­
phosphate analogues in cell culture but not in cell-free 
systems, and that the small alkyl groups used in this 
study have little effect on the affinity of such species 
for calcified tissue.
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CHAPTER 5
PREPARATION AND TESTING OF AN AFFINITY LABEL 
FOR INFLUENZA RNA TRANSCRIPTASE
5.1 INTRODUCTION
As described in Section 1.2.2.2, synthesis 
of virally-coded mRNA can be divided into three distinct 
phases. Initiation begins by cleavage of a capped 
oligonucleotide from cellular RNA and then incorporation 
of the first residue. Secondly, elongation occurs for 
12-14 bases at which time the transcriptase complex begins 
to move down the nascent chain. Finally, a complex 
termination mechanism comes into effect.
Phosphonoformic acid has been shown to prevent 
elongation beyond 12—13 bases (Stridh and Datema, 1984) 
and thus its activity appears to coincide with the point at 
which the transcriptase complex begins to move. The question 
still remains unanswered, however, as to which of the viral 
proteins which make up the complex, pyrophosphate analogues 
interact with to exert their observed antiviral activity.
It is claimed that pyrophosphate analogues bind at the 
pyrophosphate/nucleotidetriphosphate binding^site of DNA 
polymerases (Leinbach, et al. , 1976) , and such a site in 
the RNA transcriptase complex of fowl plague virus (FPV) 
has recently been shown to be located in the PB^ protein 
(Romanos and Hay, 1984). This would imply that 
pyrophosphate analogues interact with this protein.
Alternatively, the experiments with PFA indicate that 
they could interact with PB2, to prevent its dissociation 
from the cap of the growing nucleotide chain.
It was decided to attempt to resolve this 
problem by preparation of an affinity label for the 
transcriptase.
5.1.1 Design of an Affinity Label
The affinity label chosen, was based on the 
alkylated derivatives already shown to be inhibitors of 
the enzyme, and which must interact with it. The molecule 
shown in Fig. 5.1.1 has the two phosphonate groups to bind 
with the metal ion proposed to be at the active site, and 
the halogen on the bridge to give the correct acid properties 
necessary for good antiviral activity. The long chain 
terminates in an aldehyde group which might be expected
Fig. 5.1.1 Structure of the affinity label.
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to react with any amino acid residues with nucleophilic 
side chain functions, close to the active site. A 
shorter chain may result in the aldehyde group being too 
far removed from potential sites of reaction and hence 
being unable to interact with them. The molecule would 
thus become irreversibly bound to the protein containing the 
active site. Radioactive reduction of the complex formed 
would enable identification of this protein by gel 
electrophoresis and fluorography.
5.2 SYNTHESIS OF THE AFFINITY LABEL
The synthetic strategy adopted for the preparation 
of the affinity label described above, was to utilise the 
methods already developed for chlorination and alkylation 
of tetraisopropyl methylenebisphosphonate. This then, 
required the preparation of a straight chain iodide, with 
a group at the opposite end of the molecule which could 
be developed into an aldehyde functionality, with which 
to alkylate tetraisopropyl chloromethylenebisphosphonate.
It was assumed that the alkylation reaction would affect 
an aldehyde group if it were already present in the 
alkylating species.
Two of the most widely used methods of masking 
a carbonyl group, involve the disguise of the reactive 
functionality as either a 1,3-dithiane (Seebach and 
Corey, 1975) or as an oxazine (Meyers, et at. , 1969a) 
which are then developed into a later stage. However, 
preparation of species with these groups at one end of an 
alkyl chain and a halogen at the other is not possible
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as cyclisation reactions occur in each case (Seebach and 
Corey, 1965; Meyers, et al., 1969b) (Fig. 5.2(i)).
Fig. 5.2(i) Cyclised structure* of (a) bromoalkyldithianes and
(b) bromoalkyloxazines.
Preparation of aldehydes is also possible by 
hydridic reduction of nitriles and quenching with acid 
(Brown and Garg, 1964), but reaction of iodopropionitrile 
with the thallium salt of tetraisopropylchloromethylene- 
bisphosphonate under the standard conditions developed 
previously (Chapter 3), failed to result in any alkylation 
of the type required, precluding this as a possible route to 
the affinity label.
It was decided to approach the aldehyde by 
way of the corresponding alcohol, and subsequent oxidation. 
Hence a straight chain iodo-alcohol was the first 
synthetic objective.
Halo-alcohols can be prepared by cleavage of 
cyclic ethers by Lewis acids in the presence of halide 
ion. Several methods are known for cleavage of tetrahydro-
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furan using various boron compounds. 4-Iodobutan-l-ol 
is produced by cleaving THF with borohydride in the presence 
of molecular iodine (Long and Freeguard, 1965) or boron 
trifluoride etherate in the presence of iodide ion 
(Mandal, et al. , 1985). Each of these methods was 
investigated but it was found that they were restricted 
to the five-membered cyclic ether, and larger ethers 
were not cleaved. A third method in which diborane 
is used for cleavage in the presence of molecular 
iodine (Long and Freeguard, 1964) proved more versatile 
in that five-, six- and seven-membered cyclic ethers 
were all cleaved to their respective iodo-alcohols. 
6-Iodohexan-l-ol (2) was prepared in this way from 
oxepane (1) in good yield (Fig. 5.2 (ii)), and was reacted 
with the thallium(I) salt of tetraisopropylchloromethylene 
bisphosphonate under the standard conditions described 
(Section 3.3.3). This, however, failed to give the 
desired derivative, which was thought to be due to the 
alcohol function interfering with the alkylation reaction. 
Hence it was decided that protection of the hydroxyl 
function of 6-iodohexan-l-ol was required to permit a 
clean alkylation. Protection of the alcohol as an ester 
was discounted as the electrophilic carbonyl group would 
probably react with the thallium salt intermediate, so 
an ether protecting group appeared to be the best option. 
Thus 6-iodohexan-l-ol was protected as its tetrahydro- 
pyranyl ether (3) by reaction with dihydropyran and 
pyridinium para-toluene sulphonate (PPTS), a mild
acid catalyst (Miyashita, et al., 1977) (Fig. 5.2(ii)),
Q  W i  - h m c ^ v  ^ ■ p p t s  -  0 - 0 ( C H 2»6 .
N r
(1) (2 ) (3 )
Fig. 5.2(ii) Synthesis of 6-iodohexyltetrahydropyranyl ether.
U)
f iPrO )2P<0)] 2C C I(C H 2 ) 6 O T H P  
(5 )
P P TS.
E10H
[ ( '  Pr0)2 P (0 )] 2 CCt(CH2)gC HO -
(7 )
[(¡P rO ^ P tO )] 2C C l(C H 2) 6OH 
( 6 )
Fig. 5.2(iii) Synthesis of 7-chloro-7,7-bis(diisopropylphosphonato) 
heptanal.
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and an overall yield of 70% for the cleavage and
protection steps was realised. When a large excess of
this iodo-ether was used to alkylate the thallium salt
of tetraisopropylchloromethylenebisphosphonate in the
usual manner, the mono alkylation product (5) was observed by
31P n.m.r., to account for 78% of the phosphorus containing
material.
The alkylated material was separated from the 
unreacted 6-iodohexyltetrahydropyranyl ether by column 
chromatography. Complete purification was not effected 
at this stage, but rather the partially purified product 
was first hydrolysed by mild acid catalysed transesterifi­
cation (Fig. 5.2(111)1 Mlyashita, et al., 1977). The new 
product (6) was more readily purified since the free hydroxyl 
group ensured that the affinity of this molecule for silica 
was very different to the unreacted tetraisopropylchloro- 
methylenebisphosphonate (4) and the ether (5), allowing 
good separation by flash column chromatography.
Having achieved the preparation of 7-chloro-7,7- 
bis(diisopropylphosphonato)heptan-l-ol in 40% yield for 
the two step process, the next steps required were the 
oxidation of the alcohol to an aldehyde 
and the removal of the phosphate ester groups.
A number of reagents are known for the trans­
formation of alcohols to the aldehyde level of oxidation 
which use chromium(VI) as the oxidising species, with 
pyridinium chlorochromate (PCC) (Corey and Suggs, 1975) 
perhaps the most widely used. This reagent was used to 
oxidise the phosphonate alcohol (6) to the corresponding 
aldehyde (7) in 42% (Fig. 5.2(iii)). This disappointing
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return was ascribed to the bisphosphonate moiety forming 
chelate complexes with a chromium metal ion species 
(Cotton and Schunn, 1963) and hence being removed from 
the mixture in the work up. Thus, a non-metallic 
oxidising agent was sought which would not exhibit such 
undesirable properties and consequently give improved 
yields. 1,1,l-Triacetoxy-2,l-benzoxiodol-3(3H)one
(Dess-Martin Periodinane; DMP) is a novel reagent which 
satisfies these conditions (Fig. 5.2 (iv)); Dess and Martin, 
1983). It has several advantages over some chromium 
based reagents in that oxidation stops at the aldehyde 
level, it is soluble in a variety of organic solvents 
and the work up procedure is clean and rapid. When this 
reagent was used to oxidise the alcohol (6), the 
corresponding aldehyde was isolated in 93% yield (Fig.
5.2 (ill)).
Fig. 5.2(iv) Structure of Dess-Martin periodinane.
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The aldehyde (7) was then treated with bromo- 
trimethylsilane (BrTMS) in an attempt to remove the 
isopropyl phosphonate ester groups. A clean reaction was 
not observed. Several phosphorus containing species 
were seen by n.m.r. and more than one brominated
phosphonate seen by fast atom bombardment mass spectrometry 
(Appendix II). This suggests that several side reactions 
are taking place at the aldehyde group. It is known that 
iodotrimethyl silane (ITMS) reacts with aldehydes to give 
a-iodotrimethylsilyl ethers which in the presence of excess 
ITMS generally give further reaction such as diiodination 
(Jung, et al., 1978). It seems that similar side reactions 
are occurring in this case and so some method had to be 
found to avoid the use of trimethylsilyl reagents in the 
presence of the aldehyde function.
One solution to avoid side reactions would be 
to protect the aldehyde group prior to removal of the 
phosphonate ester groups. However, most of the widely 
used cyclic acetal or thioacetal groups can be adversely 
affected by trimethylsilyl iodide or bromide (e.g.,
Bryant, et al. , 1979) resulting in cleavage and halogéna­
tion. Aldehydes can be protected as imidazolidines 
(Wanzlick and Ldchel, 1953) which might be expected to 
be less reactive than acetals and thioacetals to 
trimethylsilyl reagents, but no reaction of the aldehyde 
(7) could be observed with N ,N '—diphenylethylenediamine 
to form such a species.
Thus it was decided to carry out the deesterifica­
tion of the phosphonate ester groups on the alcohol (6) and
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then oxidise the resultant phosphonic acid - alcohol to 
the desired aldehyde. Alcohols are known, however, to 
react slowly with bromotrimethylsilane to give the 
corresponding bromide (Jung and Hartfield, 1978), so 
direct reaction is not possible in this case, but if the 
alcohol is converted to its trimethylsilyl ether, no 
such reaction occurs (Jung and Hartfield, 1978). Thus, 
when the alcohol (6) was converted to its trimethylsilyl 
ether with chlorotrimethylsilane (C1TMS) , hexamethyldisila- 
zane (HMDS) and pyridine (Sweeley, et al., 1963), followed 
by treatment with BrTMS and hydrolysis in the usual way, 
the pure free phosphonic acid-alcohol (8) was obtained in 
93% yield (Fig. 5.2(v)). The intermediate trimethylsilyl-
(['PrO)2 P(0^  2 C C4( CH2)6OH 
( 6 ) (i) CITMS/HMDS /  Pyridine 
\ .  (¡¡) BrTMS 
\ ( i i i )  H20
[(H O )2P (0 )] 2c c k c h 2) 6 o h  
/ (8)
£h 0 )2 P (0 )] 2c c k c h 2) 5c h o
(9 )
Fig. 5.2(v) Synthesis of 7-chloro-7 ,7-bisphosphonatoheptanal.
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ether was observed by lH n.m.r. spectroscopy and mass 
spectrometry as the only species present.
Oxidation of the alcohol (8) presented a 
problem, in that the compound was insoluble in organic 
solvents and so none of the conventional methods could be 
used to perform the transformation. One alternative was 
to use the Swern technique of DMSO oxidation (Mancuso 
and Swern, 1981), but this requires the use of anhydrides 
to activate the DMSO which would probably also catalyse 
coupling of the phosphonates. The periodinane oxidant 
used previously is so versatile it was decided to develop 
a system so that it could be employed in this case to perform 
the desired oxidation. The periodinane is soluble in 
acetonitrile and oxidation reactions are unaffected by 
the presence of pyridine (Dess and Martin, 1983) . The 
alcohol (8) was partially dissolved in a mixture of these 
two solvents and oxidised with the periodinane reagent. 
Purification of the product by ion exchange chromatography 
gave the pure aldehyde (9) in 40% yield (Fig. 5.2(v)) and 
so the target molecule was isolated in 16% yield overall.
5.3 ASSESSMENT OF THE BIOLOGICAL ACTIVITY
OF 7-CHLORO-7,7-BISPHOSPHONATOHEPTANAL
The aldehyde (9) was tested as an inhibitor of 
influenza RNA transcriptase in the manner described in 
Section 4.2.1 and was found to cause 50% inhibition of 
transcription when present at a concentration of 
260 mM. This is about the same as was found for
1 - chloroheptylidene-l.t-bisphosphonic acid. So as expected.
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the aldehyde function has no effect on the inhibitory 
power of the compound, and thus the species prepared is 
suitable for use as an affinity label.
5.4 AFFINITY LABELLING OF INFLUENZA RNA
TRANSCRIPTASE
Influenza A/X49 virus was incubated with the 
affinity label and thé complex reduced with tritiated 
sodium borohydride, essentially as described by Romanos 
and Hay (1984) . The proteins were separated by polyacrylamide 
gel electrophoresis and fluorographed to see which protein 
contained the radioactive label. It can be seen from 
Fig. 5.4 that no single protein has been labelled specifically 
but that the majority of the radioactivity has become 
incorporated into the three P proteins, two of which run 
virtually together under the conditions used. No other 
proteins such as HA or NA are labelled in this experiment.
It can not be said, however, which of the P proteins 
contains the site of activity for pyrophosphate analogues 
from this experiment. The fact that the affinity label 
becomes associated with the proteins making up the 
transcriptase complex though, supports the proposal that 
such analogues exert their antiviral activity^ by acting 
directly on the transcriptase.
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5.5 EXPERIMENTAL
5.5.1 Preparation of 6-Iodohexyltetrahydropyranyl
Ether
Oxepane (14 ml, 0.125 mol) was mixed with iodine 
(12.65 g, 0.05 mol) in a three-necked flask fitted with 
a gas inlet, a condenser and a thermometer. The mixture 
was reacted with diborane by bubbling a large excess of 
the gas through the reaction vessel maintained at 45°C.
The diborane was formed in a gas generator flask by the 
action of NaBH4 (7 g, 0.185 mol) on a vigorously stirred 
solution of BF3.Et20 (37 ml, 0.226 mol) in diglyme (150 ml) 
over 3 h (Zweifel and Brown, 1963). During the reaction 
the dark iodine colour was seen to fade to leave a pale 
amber solution. This borate ester was then hydrolysed 
by addition of saturated NaCl solution (30 ml) and 
stirring for 10 min. The mixture was then extracted 
with ether (2 x 75 ml) and the organic extracts washed 
with saturated NaCl solution (50 ml) and water (2 x 50 ml). 
The organic solution was dried over MgS04 and the solvent 
removed in vacuo below 45°C to yield a thick yellow oil 
(18.2 g) which was 6-iodohexan-l-ol [1H n.m.r. (CDCl^) 6 
1.35-1.55 (6H, m), 1.85 (2H, m) , 3.15 (2H, t, J - 8 Hz)
3.38 (1H,*), 3.52 (2H, t, J - 8 Hz) p.p.m.l. This was 
converted immediately to the tetrahydropyranyl ether by 
dissolving the residue in CH2C12 (40 ml), adding dihydro- 
pyran (14 ml, 0.18 mol) and PPTS (2.5 g, 0.01 mol, prepared 
as described by Miyashita, et al. (1977)) and stirring 
at room temperature for 3 hours. Diethyl ether (100 ml) 
was then added and the mixture washed with saturated
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NaCl soln. (100 ml) and water (2 x 75 ml) . The organic 
portion was dried over MgSO^ and the solvents removed 
in vacuo, to leave an amber oil. This was purified by 
flash column chromatography (eluting with petroleum 
ether b.p. 40-60°C/acetone, 15/1, v/v) to yield a 
colourless oil (Distillation results in decomposition)
(21.7 g, 70*). *H n.m.r. (CC14) 6 1.35-1.7 (10H, m), 1.75- 
1.95 (4H, m), 3.18 (2H, t, J - 8 Hz), 3.25-3.5 (2H, m) ,
3.6-3.8 (2H, m), 4.5 (1H, t, J - 2 Hz) p.p.im.; l3C
(CDClj) 6 6.4, 19.3, 24.9, 25.2 , 29.2, 30.0 , 30.4,
33.1, 61.8, 66.9, 98..4 p.p.m.; Analysis C, 42.0; H
I, 40.1%; cn H2iI02 requires C , 42.32; H, 6.78;
I, 40.65.
5.5.2 Preparation of 7-Chloro-7,7-bls(diisopropyl-
phosphonato)heptyltetrahydropyranyl Ether
Tetraisopropyl chloromethylenebisphosphonate (5 g,
0.0132 mol) was dissolved in dry THF (15 ml) under nitrogen.
Alkylation with 6-iodohexyltetrahydropyranyl ether
(25 g, excess) was carried out as described in Section 3.3.3.
After the usual work-up the product was partially purified by
column chromatography (elution, petroleum ether b.p.
40-60°/acetone, 12/1, v/v). This returned the unreacted
iodide, and a mixture of the iodide and the title
compound (ratio about 1:12) as an oil (3.85 g). A small
sample was rechromatographed for n.m.r. analysis, but
the bulk of the product was reacted in the next stage
without further purification. (1H N.m.r. (CDClj) 6 1.32
(24H, m) , 1.45-1.7 (14H, m) , 1.7-1.9 (2H, m) , 2.0-2.15
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(2H, m) 3.35-3.55 (1H, m) , 3.95-4.15 <2H, m), 4.85 (4H, m) 
p.p.m.l
5.5.3 Preparation of 7-Chloro-7,7-bls(diisopropyl- 
phosphonato)heptan-l-ol
The residue from above was dissolved in ethanol 
(120 ml) and transesterified using PPTS at elevated 
temperature as described (Miyashita, et al. , 1977) . 
Purification of the product by flash column chromatography 
(eluting first with petroleum ether b.p. 40-60°/acetone, 
10/1, v/v changing to 3/1, v/v after removal of the starting 
materials) yielded the pure title compound (2.55 g, 40.3% 
from tetraisopropyl chloromethylenebisphosphonate). 
llH N.m.r. (CDClj) 6 1.2-1.8 (32H, m), 2.0-2.2 (2H, m),
3.62 (2H, t, J • 1 HI, 4.75-4.9 (4H, m) p.p.m.; 3lP n.m.r. 
(CDClj) « 14.75(b ); l3C n.m.r. (CDClj) i 23.0, 24.0, 24.1 
(t, J - 6 Hz), 25.1, 29.3, 34.2, 35.6, 61.9, 62.5 (t.
J = 145 Hz), 72.9, 73.1 p.p.m.; mass spec (Cl) m/z 
479, 481 (3:1)]
5.5.4 Preparation of 7-Chloro-7,7-bis(diiso- 
propylphosphonato)heptanal
The alcohol prepared above (480 mg, 1 mmol) was 
oxidised with DMP as described (Dess and Martin, 1983) to 
yield the pure title compound (445 mg, 93%). [1H N.m.r.
(CDC13) 6 1.3-1.45 (26H, m), 1.55-1.75 (4H, m), 2.0-2.2 
(2H, m), 2.4 (2H, t, J - 8 Hz), 4.8-4.95 (4H, m), 9.75 
(1H, t, J = 1.5 Hz) p.p.m.; 3lP n.m.r. (CDCI3) 6 14.75(s); 
13C n.m.r. (CDClj) 6 21.6, 23.4, 24.1 (t, J - 6 Hz), 24.3, 
29.2, 35.7 (t, J - 6 Hz), 43.5, 62.5 (t, J - 14.5 Hz) 72.8,
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73.0, 202.3 p.p.m.; mass spec. (Cl) m/z 477, 479 (3:1)].
5.5.5 Preparation of 7-Chloro-7,7-bisphosphonato-
heptan-l-ol
The alcohol prepared in Section 5.5.3 (1.5 g, 3.13 mmol) 
was dissolved in pyridine (9 ml) and HMDS (1.3 ml, 6.2 mmol) 
and CITMS (0.55 ml, 4.3 mmol) added in a dry nitrogen 
atmosphere. The mixture was stirred at room temperature for 
15 min., and the resultant white precipitate removed by 
filtration. The filtrate was lyophilised to leave the 
trimethylsilyl ether l1H n.m.r. (CDCl^) -CH2OSiMe3 6 3.54 
(t, J = 8 Hz) p.p.m.; mass spec. (Cl) m/z 551, 553 (3:1)].
The ether was redissolved in CCl4 (2 ml) , BrTMS (6 ml,
45 mmol) added and the mixture stirred at room temperature 
for 20 h. The usual work up (Section 3.3.8) provided the 
fully hydrolysed alcohol (0.905 g, 93%) l*H n.m.r. (D20) 6 
1.2-1.4 (4H, m) , 1.4-1.6 (4H, ft»), 2.0-2.2 (2H, m) , 3.55 
(2H, t, J «= 8 Hz) p.p.m.; 3lP n.m.r. (DjO) 17.3 p.p.m. (s)].
5.5.6 Preparation of 7-Chloro-7,7-bisphosphonato-
heptanal
The fully hydrolysed alcohol from above (800 mg,
2.58 mmol) was suspended in pyridine (6 ml) and acetonitrile 
(12 ml). DMP (1.3 g, 3.06 mmol) was added and the mixture 
stirred at room temperature under nitrogen for 18 h. The 
solvents were removed in vacuo and water (5 ml) added 
to the dried mixture, and the insoluble matter removed by 
filtration. Trie thy 1 ammonium bicarbonate (1 M, 10 ml) was 
added to the filtrate and the mixture lyophilised. The 
residue was purified by ion exchange chromatography on a 
DEAE Sephadex-A25 column (50 g, dry support, eluting with
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EtjNH^HCOj”r pH 8.4, 0-1 M gradient) to yield the pure 
aldehyde as the bis(triethylammonium) salt (622 mg, 40%).
(1H N.m.r. (D20) 6 1.2 (;20H, m) ,r 1.4-1..7 (4H, m),
1.95-2.15 (4H, ra), 3.12 (12H r q<, J « 8 Hz) , 9.65 (1H, t
J - 1.5 Hz) p.p.m.;, 3*p n.m .r. (d2o ) <5 15.0 p.p.m. (s);
Analysis C, 44.75; H, 9.37; N,, 6.0%; C19H44CIN2°7P2
requires C, 44.75; H, 8.8; N, 5.5%) .
5.5.7 Affinity Labelling of Influenza Virus
Influenza A/X49 virus, prepared as described 
in Section 4.1.1, was incubated at 30°C with the affinity 
label (2 mM) as described by Romanos and Hay (1984). The 
complex formed was reduced with I^HlNaBH^ (3 mCi), and 
the proteins isolated by sedimentation through a 10% 
sucrose cushion (w/v in 10 mM trie-HCl, pH 7.4) (40,000 r.p.m., 
6 x 20 angle rotor). The proteins were separated by 
polyacrylamide gel electrophoresis on a 17% discontinuous 
gel, and the gel fluorographed by soaking in commercially 
available fluor (Amplify) for 30 min., drying and exposing 
to Fuji X-ray film for 11 days at -70°C.
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CHAPTER 6
POLIO AND OTHER PICORNAVIRUSES
6.1 INTRODUCTION
Poliomyelitis has been all but eradicated 
throughout most of the developed world by the introduction 
of effective vaccines (e.g., Sabin, 1959) as a result of 
intensive research since the 1930's. Despite this the 
virus is still widely investigated in molecular biology, 
as the simplicity of its structure makes it an attractive 
species through which to study complex molecular 
processes, many of which are common to both viruses and 
animal cells. There are also several other related 
viruses which are not under the same control.
Polioviruses are members of the family of 
picornaviridae (a compound word made up of Pico/RNA/ 
viridae, i.e., small RNA viruses) and the genus entero­
viruses. Other genera in the family include rhinoviruses 
(responsible for the common cold), cardioviruses (causing 
infections often localised in the heart muscle) and foot 
and mouth disease viruses (affecting livestock) (Newman, 
et al. , 1973). All would appear to be evolved from a 
common ancestor, since their biology is remarkably 
similar, with mutations occurring due to external 
influences (such as pH) allowing growth of the viruses 
in a greater variety of cells.
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6.2 STRUCTURE OF POLIOVIRUS
Picornavlruses are probably the simplest known 
animal viruses. The polio virion consists of a non- 
enveloped icosahedral protein nucleocapsid of about 22 run 
in diameter, containing one molecule of positive single 
stranded RNA. The virion has a weight of about 6.2 x 10®, 
of which around 30% is the weight of the RNA. The protein 
coat is formed from 60 molecules of each of four proteins 
(Rueckert, 1971) known as virion proteins (VP) 1, 2, 3 and 
4, of molecular weights 37,000, 31,000, 26,000 and 8,000 
respectively. Because the virion has no lipid envelope, 
it is able to withstand attack from both water-immiscible 
solvents, and anionic detergents such as sodium dodecyl 
sulphate (SDS). Indeed treatment with SDS forms the 
basis of the purification of virions and their isolation 
from cell debris.
Polio virion RNA has been shown to be infectious 
(Baltimore, 1969) and has a molecular weight of about 
2.6 x 10®, corresponding to a length of around 7,500 bases. 
The 3'-terminus consist of polyadenylic acid (Yugo and 
Wimmer, 1972) with an estimated length of 75 nucleotides 
(Spector and Baltimore, 1975). Removal of this poly (A) 
results in greatly reduced infectivity of the remaining 
RNA (Spector and Baltimore, 1974).
The 5'-terminus of vRNA has received much 
attention in recent years and although it was first 
suggested that it terminated with pAp (Wimmer, 1972) 
it has since been shown that the 5'-terminus is pUp,
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covalently linked through its phosphate to the tyrosine 
hydroxyl of a short peptide called VPg (Lee, et al., 1977). 
This 5'-terminal is not required for infectivity and is 
cleaved from the vRNA prior to protein synthesis, so 
that most of the intracellular RNA lacks VPg (Lee, et al. , 
1977).
6.3 REPLICATION OF POLIOVIRUS
6.3.1 Initial Stages of Infection
Polioviruses only infect human or simian cells, 
but the isolated vRNA can be used to infect non-susceptible 
cells (Baltimore, 1969), probably because it can bypass 
the specific cell receptors responsible for binding the 
intact virion. For other picornaviruses it has been 
demonstrated that the protein VP4 is involved in the 
adsorption process, and that if the virion lacks VP4 
it is not adsorbed (Crowell and Phillipson, 1971) .
The ensuing events are not fully understood, 
but the attached virus somehow becomes uncoated at the 
membrane receptor and the vRNA enters the cytoplasm.
Between three and four hours after infection host cell 
protein and RNA synthesis is completely inhibited 
(Baltimore, 1969) and it has been suggested that virally 
coded proteins may be responsible (Wright and Cooper,
1974; Baltimore, 1969). It has been shown by pulse 
labelling experiments that viral synthesis occurs only in 
the cytoplasm (Baltimore, 1969) and enucleated cells 
are capable of carrying out the entire virus life cycle 
(Pollack and Goldman, 1973).
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6.3.2 Translation of Virus mRNA
Translation of infecting RNA must begin prior 
to viral RNA synthesis since virus specific proteins
are required for the latter. Many virally coded proteins
• rhave been isolated from infected cells and the sum of 
their molecular weights greatly exceeds the coding 
capacity of the mRNA, resulting in the proposal that 
extensive secondary processing occurs, i.e., the final 
gene products are derived from larger initial translation 
products (Summers and Maizel, 1968).
The degradation pathway has been partially eluci­
dated (Fig. 6.3.2) by the use of pulse-chase labelling
*ot-Tyf-0-A-U
H,N
IA»o
XOH
* t
Fig. 6.3.2 Processing of poliovirus proteins.
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experiments, as well as tryptic digest fingerprinting 
with amino acid analogue inhibitors of protolytic cleavage 
(Baltimore, 1971).
The polyprotein N00 is the primary translation 
product if all proteolytic activity is inhibited. It has 
a molecular weight of > 200,000 and as such represents the 
total translatable information carried by the poliovirus 
RNA (Jacobson, et al. , 1970) . In the normal course of 
events, this polyprotein is subject to nascent cleavage 
to give the primary digestion products Nla and Nib. A 
premature termination mechanism for formation of these 
proteins can be discounted since they are formed at the 
same stage (along with NX) and only a single initiation 
site has been identified (Jacobson and Baltimore, 1968) .
Such nascent cleavages have been shown to occur in cell free 
systems, but subsequent protein processing does not occur 
(Villa-Komoroff, et al., 1975) showing that further 
cleavages take place in the cytoplasm. It is here that 
Nib is processed in two further steps to produce the 
protein N4 and the virally coded protease of molecular 
weight 22,000. It is uncertain whether this protease 
is responsible for the nascent cleavages (i.e., that it 
is enzymically active whilst still part of the polyprotein) 
or whether host cell enzymes exact this primary step, 
but the viral protease is known to perform all the secondary 
cleavages to produce the final gene products (Fraenkel- 
Conrat, et al. , 1982).
The N4 protein is a component of the RNA 
polymerase. In combination with a host cell protein, it 
has been shown to be capable of performing both steps
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of the RNA replication cycle (Baltimore, 1984).
Protein Nla is processed into the structural 
proteins of the procapsid-VPO, 1 and 3 - and VPO is 
further cleaved into VP2 and VP4 during virion morpho­
genesis (Jacobson and Baltimore, 1968a). Other transitory 
products shown (Fig. 6.3.2) may be responsible for the 
previously mentioned supression of host cell processes, 
or in a viral release mechanism.
6.3.3 Transcription of Viral RNA
Kinetic studies have revealed that RNA 
replication begins within half an hour of infection and 
increases exponentially until a maximum is reached after 
about four hours, after which it is linear until ceasing 
about eight hours post-infection (Baltimore, 1969) . Three 
types of intracellular RNA have been identified and 
implicated in poliovirus replication. The first, intra­
cellular single stranded mRNA, differs from vRNA only in 
that it lacks the 5'-terminal protein VPg (Lee, et al., 
1977), while their nucleotide sequences are identical 
(Baltimore, 1984) . A double stranded RNA containing the 
plus strand and a complete complementary minus strand 
of RNA has also been isolated and is thought to be a 
byproduct of the replication process (Baltimore, 1984).
The third type of RNA is the replicative intermediate (RI) 
RNA which also contains a minus strand which serves as 
the template for plus strand synthesis (the opposite sense 
RI has never been detected but is presumed to exist). 
Because both minus and plus strands are synthesised, two
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initiation processes are required and one model has the 
same initiator involved in both cases.
The location of poly(A) at the 3'-end of viral 
RNA and the fact that it is not involved in translation 
(Spector, et at. , 1975) led to speculation that it might 
be implicated in initiation of minus strand synthesis 
(which must commence at the 3'-terminus). This was 
reinforced when it was shown that infected cells 
contain a poly(A) dependent poly(U) polymerase activity 
(Flanegan and Baltimore, 1977). This enzyme was used to 
copy viral RNA (Dasgupta, et al. , 1979) and in combination 
with a host cell enzyme forms the poliovirus RNA replicase 
(Baron and Baltimore, 1982).
Use of anti-protein antibodies on the replicase 
reactions has indicated that the virally coded protein,
VPg, must be involved in the initiation reaction and this, 
along with the discovery of VPgpUpU in infected cells 
(Crawford and Baltimore, 1983) suggested the replication 
model shown in Fig. 6.3.3(i).
It is thought that VPg or a precursor of VPg 
is a substrate for enzymatic uridylation at the tyrosine 
hydroxyl. The resultant molecule then binds to the 
replicase and plus strand RNA by hybridisation to the 
3'-poly(A) and is then elongated to give the minus strand. 
The minus strand is then copied by hybridisation of VPgpUpU 
to the two 5'-As of the minus strand followed by elongation 
by the replicase (Baltimore, 1984).
A recent extension to this mechanism has been 
proposed that has the plus and minus strands synthesised
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Synthesis o f m inus strand: ____________
VPg-pUUA«CAG----- ’ aoi -------AAAA„AAA
Copying m inus strand:
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Fig. 6.3.3(1) Model of poliovirus replication in which VPgpUpU is 
involved in initiation of synthesis of both plus and 
minus strands.
by different means (Fig. 6.3.3. (ID). It is suggested 
that synthesis of minus strands on a plus strand template 
is actually initiated by terminal uridyl transferase 
which adds a short chain of uridyl residues onto the 
poly (A) end of the poliovirion RNA molecule. This oligo(U) 
chain soon hydrogen bonds to the poly (A) , and further 
elongation gives a double stranded RNA structure which, 
it is hypothesised, is cut by a pre-VPg on a cellular
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5' UTP
* *
--------------------- -AAAAAAUUUU
Fig. 6.3.3(11) Model for the role of terminal uridyl transferase in 
replication of poliovirus RNA.
membrane, liberating two strands (Andrews, et al. , 1985).
It is possible that VPg-pUpU is involved in 
initiation of plus strand synthesis by this mechanism, 
but there is no direct evidence of this from labelling 
studies (Andrews, et al. , 1985).
6.3.4 Assembly and Release
Assembly of polioviruses has been widely
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studied and there is good evidence for the model shown 
in Fig. 6.3.4. Five Nla protein molecules appear to
VP2 ♦
Virion
RNA/IVP2. VP4. 
VPI. VP3)«j
RNA/IVPO. VPI. 
VP3lœ
RNA
Procapsid 
|(VP0. VPI. 
V P 3 U I«
Aggregate 
(VPO. VPI. VP3)S
(1a)s
Fig. 6.3.4 Assembly of the poliovirion.
aggregate and then cleave to the constituent proteins 
VPO, 1 and 3, which further aggregate to form the 
procapsid (Jacobson and Baltimore, 1968a). The next 
stage is association with vRNA to form the provirion 
(Fernandez-Thomas and Baltimore, 1973). The vRNA of the 
provirion is insensitive to RNAase digestion implying 
that it is inside the particle (Rekosh, 1977). The 
final stage is proteolysis of VPO to VP2 and VP4, 
resulting in the formation of the virion particle 
(Jacobson and Baltimore, 1968a) although some*'VPO 
remains uncleaved. Virus release is much less well 
studied and the control mechanism is not understood, 
although complete virions leave the cytoplasm after 
cell rupture and some virus-specific protein may be 
involved (Rekosh, 1977).
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6.4 TARGETS FOR INHIBITION OF REPLICATION
Despite the highly successful vaccines for 
poliovirus cases still occur, and other picornaviruses, 
which have very similar biological properties, are 
widespread amongst humans and livestock. Thus, with the 
current advanced state of knowledge of picornavirus 
replicative processes in vivo, potential targets for 
antiviral chemotherapy can be proposed and examined 
more closely.
Since many of the infections caused by 
picornaviruses are relatively mild, it is especially 
important in their case to ensure that uninfected cells 
are not disrupted by chemotherapy. Thus, only virus 
specific events or proteins must be selected as targets 
for inhibition. Clearly from the preceding discussion, 
there are several poliovirus specific processes which 
represent potential candidates for the inhibition of viral 
replication.
6.4.1 Inhibition of Initial Stages of Infection
Since the viral protein VP4 is required for 
attachment and penetration (Crowell and Phillipson, 1971), 
it represents a possible line of attack. MySfoviruses have 
been inhibited by oligopeptides of similar sequence to 
the virus fusion protein (F protein) (Choppin, et al. , 
1983) which is thought to perform a similar function to 
VP4. However, a greater understanding of the attachment 
and penetration phases of the infection is required
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before an inhibitor of these processes can be designed 
rationally.
6.4.2 Inhibition of Intracellular Events
As mentioned in Section 6.3.3, poliovirus 
has a virally induced RNA dependent RNA polymerase 
activity, and such virus specific enzymes provide good 
targets for antiviral agents since they are absent 
from uninfected cells. This enzyme may be the site of 
action of the poliovirus inhibitor, guanidine hydrochloride 
(Baltimore, 1969).
Another essential virus specific protein is the 
virally coded protease CSection 6.3.2), and a specific 
inhibitor of this enzyme would shut down the virus 
secondary protein processing and prevent formation of 
the structural proteins. This protease is probably 
responsible for the proteolytic cleavage of VPg from 
the vRNA to form the intracellular mRNA (Fig. 6.4.2) 
since it can be seen from comparison of the nucleotide 
sequences that an RNAase cannot be responsible for the 
cleavage (Lee, et at., 1977). Thus, inhibition of the 
protease may also interfere with formation of primary 
gene products by preventing release of mRNA.
The unmasking of vRNA to mRNA could also be 
prevented by modification of groups around the nucleo- 
peptide linkage so as to make the bonds chemically inert 
to hydrolysis. If any method of blocking the removal of 
VPg were found, the modified 5'-terminus could be 
incorporated into the vRNA by using a suitable precursor as
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( i )  V P g -O -p -U U A A A C A G
(¡¡) p -U U A A A C A G
(iii) G A YT G LP N K K P N V P T 1R T A K V Q  
IO---
Fig. 6.4.2 Poliovirus RNAs (i) mRNA, (ii) vRNA, (iii) sequence of 
VPg (one letter amino acid codes).
a primer for vRNA synthesis according to the model 
described (Section 6.3.3).
For this preliminary study it was decided 
to focus on synthetic procedures for the preparation of 
simple nucleopeptide model compounds of the poliovirus
vR N A .
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CHAPTER 7
SYNTHESIS OF NUCLEOPEPTIDE FRAGMENTS
7.1 INTRODUCTION
Several routes to simple nucleopeptides can be 
envisaged. Phosphorylation of one fragment followed by 
reaction with the second fragment, is one conceivable method. 
Phosphorylations of both tyrosine (Alewood, et al., 1983) 
and tyrosine containing peptides (Ferrell, et al., 1948) 
are known and uridine 5'-monophosphate is commercially 
available. Many reagents are known for coupling of such 
species to alcohols via mixed anhydrides (e.g., Reese,1978) . 
Such a stepwise method would be wasteful, since low yields 
are observed for phosphorylation and coupling, and time 
consuming as several steps are required. Hence the 
most attractive route would be a 'one-pot' synthesis of the 
type used for coupling of nucleotides through a 3'-►5' 
phosphate linkage.
The synthetic strategy adopted then, was to 
prepare small protected peptides, corresponding to portions 
of the sequence of VPg. The free hydroxyl of the tyrosyl 
residue would then be coupled to a protected uridine using 
one of the so-called 'bifunctional' phosphorylating agents 
in analogy to the phosphotriester approach to nucleotide 
synthesis (Reese, 1978). The resulting fully blocked 
nucleopeptide would then be deprotected to give the 
desired peptidyluridylphosphodiester.
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7.2 RESULTS AND DISCUSSION
7.2.1 Protection and Coupling of Amino Acids
The first phase of the synthetic route was the 
preparation of the protected building blocks.
Amino acids were protected using well established 
methods. The benzyloxycarbonyl group introduced by 
Bergmann and Zervas (1932) was used to block the amino 
group of the N-terminal amino acid. The next amino acid 
in the sequence was protected as its ethyl ester 
hydrochloride by the method of Curtius (Greenstein and 
Winitz, 1961) before being coupled to the protected 
N-terminal residue.
Two methods were used for the coupling reactions. 
The first involved use of phosphorus oxychloride (Wieland 
and Heinke, 1956) which activates the carboxylic acid 
reagent by formation of a mixed carboxylic-dichlorophosphoric 
acid anhydride which then reacts with the amine reactant 
(Fig. 7.2.1(D) leading to the desired product. The 
simple isolation of the pure product from the reaction 
was the major advantage of this method, however a serious 
disadvantage was found in that the t-butyl ether group 
used to protect the hydroxyl side chain of threonine was 
labile in the presence of phosphorus oxychloride. Thus 
a second coupling method was required to which this 
protecting group would be stable. Dicyclohexylcarbodiimide 
(DCC) was selected as a non-acidic, well established 
coupling reagent (Khorana, 1952). The mechanism of 
formation of the peptide again involves intermediacy of
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R> R2
Fig. 7.2.1 (1) Mechanism of POCl3 activated amino acid coupling.
^ ^ N H C  NH^ ^ J
Fig. 7.2.1 (ii) Mechanism of DCC activated amino acid coupling.
TABLE 7.2.1 Preparations of Protected Peptides
Protected Peptide Method Yield 1H n.m.r., p.p.m. (Solvent)
Z-Ala-Tyr-OEt p o c i 3 72 1.1-1.3 (6H, m) , 3.0 (2H, m ) , 4.15 (3H, m) 4.6 (1H, t, 
J - 7 Hz), 5.1 (2H, s), 6.7 (2H, d, J - 8 Hz), 7.0 
(2H, d, J - 8 Hz), 7.35 (5H, m ) . (CD3OD)
Z-GlyAla-OEt p o c i 3 69 1.3 (3H, t, J - 8 Hz), 1.42 (3H, d, J - 7 Hz), 3.9 (2H, br.nO,4.2 (2H, q, J - 8 Hz), 4.6 (1H, m), 5.18 (2H, s), 7.38 (5H, m). (CDjCD)
Z-Tyr-Thr(OtBu)OEt DCC 80 1.1 (12H, m), 1.3 (3H, t, J - 8 H z ) , 3.05 (2H, m ) ,
4.0-4.3 (5H, m), 4.5 (2H, m ) , 5.15 (2H, s ) , 6.7 (2H, d, 
J - 8 Hz), 7.05 (2H, m ) , 7.35 (5H, m ) . (CDC13 )
Z-Thr(OtBu)GlyOEt DCC 76 1.1-1.3 (15H, m), 4.0 (2H, m ) , 4.15 (3H, m ) , 4.35 (1H, 
in), 5.12 (2H, s), 7.35 (5H, m) . (CDCI3 )
Z-Tyr-Thr(OtBu)GlyOEt DCC/POCl3 22 1.1-1.3 (15H, m) , 3.0-3.1 (2H, m ) , 4.0 (2H, m ) , 4.1-4.4 
(5H, m), 5.1 (2H, s), 6.7 (2H, d, J - 8 H z ) , 7.1 (2H, m ) , 
7.35 (5H, m). (CD3OD)
Z-GlyAlaTyr-OEt POCl 3 34 1.0 (3H, t, J - 8 Hz), 1.4 (3H, d, J - 7 H z ) , 3.15 (2H, 
m), 3.95-4.25 (4H, m ) , 5.0 (4H, m ) , 7.0-7.3 (9H, m ) . 
(d->-pyridine)
Z-AlaTyrThr(OtBu)OEt DCC 49 1.1 (12H, m), 1.28 (6H, m ) , 2.9-3.25 (2H, m ) , 4.1-4.3 
3H, m), 4.5 (1H, d, J - 3 H z ) , 4.65-4.8 (2H, m ) , 5.15 
(2H, s), 6.7 (2H, m), 7.1 (2H, m ) , 7.35 (5H, n ) . 
(c d 3o d )
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an activated species, this time formed initially between 
the carboxylic acid reagent and the diimide, followed by 
reaction of the active anhydride with the amine reagent 
(Fig. 7.2.1(ii)). Under these conditions the t-butyl 
ether remained intact, but the work-up procedures were 
more laborious due to the dicyclohexyl urea residue 
present in the product and the reluctance of the 
t-butyl ether compounds to recrystallise.
If a tripeptide were to be prepared, the C-terminal 
ethyl ester protecting group of the dipeptide was removed by 
saponification and the product coupled with a further 
carboxy-protected amino acid (Fig. 7.2.1(iii)) to give 
the desired sequence tripeptide (Table 7.2.1).
7.2.2 Protection of Uridine
The uridine, to which the fully blocked peptides 
would be coupled, was protected as the well known 
2' ,3'-isopropylidene ketal, by reaction with acetone and 
an acid catalyst (Fig. 7.2.2), in good yield (Tipson, 1968).
7.2.3 Coupling of Uridine to Peptides through a
Phosphate
A method was required for coupling of the two 
protected fragments, each with a single free hydroxyl, 
through a phosphate linkage. In the field of nucleotide 
synthesis, 3'-►5' phosphate linkages can be introduced by 
sequential addition of a single equivalent of each of 
the properly protected nucleotides to a phosphodichlori- 
date modified by reaction with a triazole (Broka, et al. , 
1980) or hydroxyoenzotriazole (van der Marel, et al., 1981).
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ZNH L h  ? N H C 0 2E. ZNH 2 n H C 0 2H
l r z  r 2 h # *
Fig. 7.2.1 (iii) Synthesis of protected peptides.
Fig. 7.2.2 Preparation of 2 ', 3 •-0-isopropylidene uridine.
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Such an approach has been used to prepare nucleopeptides of 
uridine by reaction of the hydroxybenztriazole derivative 
of 2-chloro phenylphosphodichloridate first with a protected 
uridine and then with a tyrosine containing peptide deriva­
tive (Fig. 7.2.3(1,); Schattenkerk, et at., 1984). However, 
in this study this work was not reproducible. Although 
the uridine residue reacted smoothly under the conditions 
described, no aryl species could be induced to react 
with the intermediate to form the triester directly.
This failure to react was assumed to be due to the lack 
of nucleophilicity of the aryl hydroxyl, and efforts to 
improve the reactivity by addition of tertiary bases 
such as pyridine and 1-methylimidazole were also unsuccess­
ful. Hence, another coupling method was required if 
this route was to prove fruitful. Again, a method widely 
used in nucleotide synthesis was explored. Letsinger, 
et al. (1975) introduced the phosphite method for preparation 
of 3'■*■5' nucleotide phosphate linkages, in which the two 
nucleotides are added stepwise to a dichlorophosphite and 
the P(III) product oxidised to the P(V) species with 
iodine and water.
The phosphite species used is considerably more 
reactive than the phosphate employed in the previous method, 
and the reaction is complete in one hour even at -78°C.
In this study, methyl dichlorophosphite proved sufficiently 
reactive to allow reaction, firstly with the hydroxy group 
of a tyrosine containing protected peptide, and secondly 
with a protected uridine, at low temperature. Subsequent 
room temperature oxidation to the P(V) product and
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Fig. 7.2.3d) Preparation of protected nucleopeptides by the 
phosphate route.
C \  in i)(Tvr):-78*C
(Tyr)Ov Ij .Hj O
(T y r) O
c /  i O ( U )  ;-78*C ( U ) 0 /
R.T.
( U ) 0
Fig. 7.2.3(ii) Preparation of protected nucleopeptides by the 
phosphite route.
work-up gave the fully protected nucleopeptide as a 
fluffy white solid (Fig. 7.2.3(11)). Modest yields 
were obtained in this manner (Table 7.2.3) but sufficient 
material was isolated to proceed with the deprotection 
phase. Improved yields may be obtainable by modification 
of the dichlorophosphite with triazole or tetrazole, 
which it is claimed can give a more selective 'bifunctional' 
species for nucleotide synthesis (Fourrey and Shire,
1981).
Subsequent to this work, dialkyl phosphochloridites 
have been used to phosphorylate N-protected hydroxy 
containing amino acids in good yield (Perich, et al., 1986) 
again showing the increased reactivity of the P(III) 
species.
7.2.4 Deprotection of nucleopeptides
Having prepared the fully blocked species, 
deprotection to the free acid nucleopeptide was required.
The major advantage of the protecting groups used 
was their compatibility, that is they could be removed 
selectively if desired. Benzyloxycarbonyl groups can be 
readily removed by hydrogen donor hydrogenation (Anantharamaiah, 
et al., 1977), ethyl esters of peptides by saponification 
(Bodansky and Bodansky, 1984) and t-butyl ethers by 
treatment with cold trifluoroacetic acid (Beyerman and 
Bontekoe, 1961). The 2 ' ,3'-isopropylidene ketal of 
uridine is readily hydrolysed under mild acid conditions, 
and the phosphate methyl ester can be selectively removed by 
treatment with thiophenol and triethylamine (Daub and
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T a b l e  7 . 2 . 3  P r o t e c t e d  u r i d i n e  nucleopeptides
p r e p a r e d  b y  the ph o s p h i t e  route
P r o t e c t e d  Peptide Y i e l d  («) 3lP n.m.r. (p.p.m.)
N - A c - T y r - O E t 57 -5.10
Z - A l a - T y r - O E t 40 -4.85, -4.97
Z - T y r - T h r ( O t Bu)OEt 45 -4.79, -4.91
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van Tamelen, 1977) .
Initially, however, a single step procedure for 
removal of all protecting groups was sought for brevity.
Boron tribromide is known to remove all the amino acid 
protecting gorups used in this study but does not affect 
peptide bonds (Felix, 1974). When the fully protected 
nucleopeptide was treated with this reagent, it was found 
that the isopropylidene group was easily hydrolysed 
(which might be expected in view of the highly acidic 
nature of the reagent) and the phosphate methyl ester group 
was also removed to the extent of about 60% (by 1H n.m.r.) 
during the reaction time, along with the expected 
deblocking of all the amino acid functional groups. Thus, 
purification of the product mixture by ion exchange on 
DEAE Sephadex and Dowex 50, afforded the pure products as 
a white fluffy solid in yields of between 10 and 15%. The 
low yield was due primarily to the incomplete hydrolysis 
of the methyl ester group, which could, if improved yields 
were required, be completed by a brief treatment with 
thiophenol and triethylamine, and secondly to a side 
reaction of cleavage of the base-sugar bond of the uridine 
to give uracil. This could be observed as occurring in 
8-10% of the product by 1H n.m.r. Boron tribromide has been 
used to cleave benzyl groups from dibenzyl uracil at 
elevated temperature and prolonged reaction times 
(Kundu, et at. , 1980) and clearly the more fragile 
sugar-base bond is susceptible to such vigorous acid hydrolysis 
even under the much milder conditions employed here.
Thus, it has been demonstrated that nucleopeptide
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fragments of the type found in poliovirus vRNA can be 
readily synthesised. The next stage would be to examine 
the hydrolysis of such species by the poliovirus coded 
protease and to design an inhibitor of that protease based 
on the observations made.
7.3 EXPERIMENTAL
7.3.1 Preparation of Amino Acid Ethyl Ester 
Hydrochlorides
The required amino acid (20 g) was suspended in 
ethanol (300 ml) and dry HC1 gas bubbled through until 
the amino acid had dissolved. The mixture was then 
heated under reflux for 3 h during which time the stream 
of gas was maintained. The mixture was cooled and 
evaporated to dryness twice from ethanol. The resultant 
solid was dried in vacuo over NaOH and recrystallised 
from ethyl acetate [TyrOEt.HCl, yield 19.53 g, 72%; 1H 
n.m.r. (DjO) 6 1.25 (3H, t, J - 7 Hz), 3.2 (2H, m),
4.2-4.4 (3H, m), 6.8-7.2 (4H, ABm) p.p.m.; AlaOEt.HCl, yield
29.3 g, 85%; *H n.ra.r. (DjO) 4 1.25 (3H, t, J - 7 Hz) , 1.5
(2H, d, J - 8 Hz), 4.1-4.3 (3H, m) p.p.m.; GlyOEt.HCl yield 29.0 g, 
78%; lH n.m.r. (DjO) 4 1.25 (3H, t, J = 7 HI), 3.95 (2H, s),
4.3 (2H, quart., J = 7 Hz)p.p.m.] -*
7.3.2 Preparation of Amino Acid Benzyl Carbamates 
Benzyloxycarbonylalanine, benzyloxycarbonyl-
tyrosine and benzyloxycarbonyl glycine were purchased from 
Lancaster Synthesis Ltd. (Morecombe, Lancs.). Benzyloxy­
carbonyl threonine was prepared as described (Bodansky
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and Bodansky, 1984) in 66% yield.
7.3.3 Preparation of O-t-Butylthreonine Ethyl Ester
Benzyloxycarbonyl threonine (10 g, 39.5 mmol)
was reacted with ethyl iodide as described by Bocchi, 
at al. , (1979) to give the corresponding ethyl ester which 
,was purified by column chromatography (elution, petroleum 
ether b.p. 40-60°/acetone, 6/1, v/v). [Yield, 9.92 g,
34.8 mmol, 88»; lH n.m.r. (CDClj) 4 1.2 (6H, m), 2.4 
(1H, br.s), 4.1-4.3 (4H, m), 5.1 (2H, s) 5.65 (1H, m)
7.3 (5H, m) p.p.m.]
Benzyloxycarbonylthreonine ethyl ester (3.9 g,
13.67 mmol) was dissolved in CHjClj (30 ml) and cooled to 
0°C. 2-Methylpropene (36 ml) and cone. HjSO^ (0.4 ml) 
were added and the mixture stoppered and left at 
room temperature for 4 days. The mixture was then cooled to 
0°C and washed with cold 5* (w/v) NaHCC>3 (3 X 40 ml) . The 
washings were re-extracted with (2 x 40 ml) and
the combined organic portions washed with water (50 ml), 
dried over MgS04 and the solvent removed in vacuo. The 
product was purified by column chromatography (elution, 
petroleum ether b.p. 40-60°/acetone, 20/1, v/v). [Yield 
3.40 g, 73%; *H n.m.r. (CDC13) 6 1.1 (9H, s), 1.2-1.3 (6H, m), 
4.0-4.25 (4H, m), 5.1 (2H, s) 5.5 (1H, m), 7.*5 (5H, m) 
p.p.m.]
The benzyl carbamate was then removed by hydro- 
genolysis as described (Anantharamaiah, et al., 1977) in 
78% yield [1H n.m.r. (CDClj) 6 1.1 (9H, s), 1.25-1.4 (6H, m),
- 2 Hz) 4.0-4.4 (4H, m) p.p.m.)3.3 (1H, d, J
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7.3.4 Preparation of Peptides
7.3.4.1 Phosphorus Oxychloride Method
The appropriately protected amino acids or 
peptides were reacted as described by Greenstein and 
Winitz (1961) and the resultant protected peptides 
recrystallised from methanol/water (yields and analytical 
data in Table 7.2.1).
7.3.4.2 Dicyclohexylcarbodilmlde (DCC) Method
The protected amino acids or peptides containing 
a t-butyl ether group were coupled using DCC as described 
by Bodansky and Bodansky (1984) and the resultant 
protected peptides purified by column chromatography 
(yields and analytical data in Table 7.2.1).
7.3.5 Saponification of Dipeptide Ethyl Esters 
Saponification of dipeptide ethyl esters was
carried out as described (Bodansky and Bodansky» 1.984) 
(yields and analytical data in Table 7.2.1).
7.3.6 Preparation of 2',3'-O-Isopropylidene Uridine 
Uridine (10 g, 0.041 mol) was reacted with
acetone as described (Tipson, 1968) and the product 
(8.73 g, 75%) recrystallised from methanol [ 1H N.m.r. (DjO) 
6 1.4 (3H» s ) ,  1.6 (3H, s) , 3.8 (2H» m) , 4.35 (1H» m),
4.9 (1H, m), 5.1 (1H, m), 5.85 (2H, m) , 7.75 (1H, d,
J = 8 Hz) p.p.m.]
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7.3.7 Preparation of Methyl dichlorophosphite
Methyl dichlorophosphite was prepared from PC13 
and methanol as described (Martin and Pizzolato, 1950) 
and the product distilled twice prior to use (b.p. 92-93°C).
7.3.8 Preparation of Protected Uridyl-Peptidy1-Phosphates 
Methyl dichlorophosphite (100 ul, 1.1 mmol) in
THF/pyridine (4/1, v/v, 8 ml) was cooled to -78°C. The 
protected peptide (1 mmol) was dried by coevaporation 
with pyridine and added as a solution in THF (1 ml) and 
the mixture stirred for 15 min. at -78°C. Isopropylidene 
uridine (225 mg, 0.8 mmol) was dried by coevaporation with 
pyridine and added to the mixture as a solution in THF 
(1 ml) and stirring continued at -78°C for a further 
30 min. The temperature was then allowed to rise to -30°C, 
when a mixture of iodine (500 mg) in water/THF (1/2, v/v 
6 ml) was added and stirring continued for 10 min. 
at room temperature. The mixture was then evaporated to 
dryness and dissolved in CHCl^ (30 ml). The organic 
solution was washed with 5% (w/v) NaSjOj (10 ml) and 
water (10 ml), dried over MgS04 and evaporated to leave 
a white solid. The product was purified by column 
chromatography (elution, petroleum ether b.p. 40-60°C/ 
acetone, 1/1, v/v). Yields and analytical data are 
shown in Table 7.2.3).
7.3.9 Preparation of N-Acetyltyrosyluridylphosphate 
The fully protected tyrosyluridylphosphate
prepared as described above (270 mg, 0.44 mmol) was
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dissolved in methanol (2 ml) and treated with 2 M 
NaOH (0.25 ml, 0.5 mmol) and stirred at room temperature 
for 1% h. The mixture was neutralised by dropwise 
addition of cone. HC1. The residue was treated with 
Dowex 50 (H+ form, 2 ml beads) at 70°C for 2 min. and 
passed down a short Dowex column. The resulting product 
was dissolved in a mixture of dioxan (7 ml) , triethyl-»- 
amine (3 ml) and thiophenol (2.5 ml) and the mixture 
stirred at room temperature for 4 h. After this time, 
the solvents were removed in vacuo and the residue 
partitioned between water and ethyl acetate. The water 
layer was lyophilised and the product isolated by ion 
exchange chromatography on DEAE Sephadex A-25, eluting 
with a 0-0.5 M gradient of HNEt3+HCC>3", pH 8.3. The 
product was converted to the free acid by ion exchange 
on Dowex 50 (H+ form) (30 mg, 13%). llH N.m.r. (400 MHz, 
D20) 6 1.83 (3H, s) 2.85-3.1 (2H, m) , 4.05-4.1 (1H, m),
4.15 (3H, m) , 4.5 (1H, dd, Jx - 5.5 Hz, J2 - 4 5 Hz) ,
5.6 (1H, d, J - 8 Hz) , 5.82 (1H, d, J = 4.5 Hz) , 7.0-7.1
(4H, m) , 7.6 (1H, d, J = 8 Hz) p.p.m.; 3lP n.m.r. (162 MHz
d2o ) 6 - 4.1 p.p.m.(s) ; Analysis C, 43.94; H, 4..55%;
Calc . for C18H22N3°11P- C, 44.26; 4.51%.)
7.3.10 Preparation of Other Peptidyluridylphosphates
The protected nucleopeptide prepared as described 
above (250 mg) was dissolved in CH2C12 (25 ml) under 
nitrogen at -10°C. Boron tribromide (5 ml of 1 M solution 
in CH2C12) was added dropwise with stirring at -10°C. 
Stirring was continued for 2 h at 0°C and then for 1 h
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at room temperature. Water (40 ml) was then added and the 
organic layer separated and extracted with water (3 x 30 ml) . 
The combined aqueous portions were evaporated to dryness 
and the product isolated by ion exchange chromatography 
on DEAE Sephadex A-25 (HNEt3+HC03”f pH 8.3, 0-0.5 H 
gradient) followed by conversion to the free acid by ion 
exchange on Dowex 50 (H+ form).
[AlaTyr-p-Urd: Yield, 24.8 mg, 14.3*; *H n.m.r. (400 MHz, 
DjO) 1.4 (3H, dd, J3 - 7 Hz, Jj - 3.5 Hz), 2.8-3.2 (2H, m) ,
4.1 (1H, m) , 4.15-4.2 (7H,r m) 5.6 (1H, d, J - 8 Hz), 5.85 (1H, d
J - 4.5 Hz) , 7.0-7.1 (4H, m) , 7.6 (1H, d, J = 8 Hz) p.p.m.;
31P n.m.r. (162 MHz, D20) 6 -4..1 p..p.m. (s) ; Urd--p-TyrThr:
yield, 27.5 mg, 16.1»; 1H n.m.r. (400 MHz, DjO) i 1.0 
(3H, d, J = 6.5 Hz), 2.95-3.05 (2H, ml, 4.0 (1H, m) , 
4.05-4.15 (4H, m), 4.18 (1H, t, J = 7 Hz). 4.26 (1H, d,
J = 4 Hz), 5.5 (1H, d, J - 8 Hz), 5.75 (1H, d, J = 4 Hz) , 
6.95-7.1 (4H, m) 7.55 (1H, d, J = 8 Hz) p.p.m.; 3lP n.m.r. 
(162 MHz, D20) 6 -4.1 p.p.m.(s).l
APPENDIX I
SOURCES OF MATERIALS
Adenosine-(3'-5')guanosine
Sigma (London) Chemical Co., 
Poole, Dorset, U.K.
Amplify
Amersham International PLC, 
Amersham, Bucks., U.K.
BromotrimethyIsilane
Aldrich Chemical Co. Ltd., 
Gillingham, Dorset, U.K.
I18,6)-Crown ether
Aldrich Chemical Co. Ltd., 
Gillingham, Dorset, U.K.
DEAE Sephadex A-25
Pharmacia Fine Chemicals, 
Uppsala, Sweden
Deuterated Solvents
Aldrich Chemical Co. Ltd., 
Gillingham, Dorset, U.K.
D.M.E.M. (X 10)
Flow Laboratories Ltd., 
Irvine, Ayrshire, U.K.
D.M.P.
Aldrich Chemical Co. Ltd., 
Gillingham, Dorset, U.K.
Dowex 50 (H+>
B.D.H. Chemicals Ltd., 
Poole, Dorset, U.K.
GF/C Discs
Whatman Ltd. , 
Maidstone, Kent, U.K.
1-Hydroxyethanebisphosphonic Acid
Albright and Wilson Ltd., 
Warley. West Midlands, U.K.
Iodotrimethylsilane
Aldrich Chemical Co. Ltd., 
Gillingham, Dorset, U.K.
Lithium Alkyls
Aldrich Chemical Co. Ltd., 
Gillingham, Dorset, U.K.
MDCK Cells
Flow Laboratories Ltd., 
Irvine, Ayrshire, U.K.
[3H|NaBH4
Amersham International PLC, 
Amersham, Bucks., U.K.
NEAA
Flow Laboratories Ltd., 
Irvine, Ayrshire, U.K.
Nucleotide triphosphates
Sigma (London) Chemical Co. 
Poole, Dorset, U.K.
Oxepane
Aldrich Chemical Co., 
Gillingham, Dorset, U.K.
Penicillin/Streptomycin
Flow Laboratories Ltd., 
Irvine, Ayrshire, U.K.
PAA
Sigma (London) Chemical Co. 
Poole, Dorset, U.K.
PFA
Sigma (London) Chemical Co. 
Poole, Dorset, U.K.
3-Phosphonopropionic Acid
Fluorochem Ltd.,
Glossop, Derbyshire, U.K.
Pharmacia Fine Chemicals, 
Uppsala, Sweden
Silica Gel 60 (230-400 Mesh)
E. Merck, G.F.R.
Thallium(I)ethoxide
B.D.H. Chemical Ltd.,
Poole, Dorset, U.K.
[5-H3]Uridine Triphosphate
Amersham International PLC, 
Amersham, Bucks., U.K.
Zinc Chloride (Spectrosol)
B.D.H. Chemicals Ltd., 
Poole, Dorset, U.K.
Sephadex G-10
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APPENDIX II
FAST ATOM BOMBARDMENT MASS SPECTROMETRY 
OF SALTS OF PYROPHOSPHATE ANALOGUES
All.I INTRODUCTION
Esters of pyrophosphate analogues are readily 
analysed by chemical ionisation mass spectrometry (CIMS) 
with ammonia as the reagent gas of choice (Cload and 
Hutchinson, 1983b). However, the active antiviral 
species, the free acids and salts, are not sufficiently 
volatile for analysis by this technique or by conventional 
electron impact mass spectrometry (EIMS).
Several methods of ionisation have appeared 
in recent years aimed at overcoming these types of 
volatility problems, such as field desorption (FD) 
(Bubzikiewicz and Linschied, 1977) and secondary 
ion mass spectrometry (SIMS) (Liu, et at., 1981), but 
perhaps the most versatile of these newer methods is 
fast atom bombardment mass spectrometry (FABMS) (Barber, 
et at. , 1981).
As the name suggests this technique involves 
bombarding a solvated sample with an energetic beam 
of either xenon or argon atoms (accelerated to 4-8 k eV 
as ions and then charge exchanged without significant 
loss of momentum) . Particles are sputtered from the 
sample surface, some of which are charged and 
consequently can be detected in a conventional mass 
spectrometer.
The majority of FABMS has been carried out on 
samples suspended in matrices of low vapour pressure, 
viscous solvents, such as glycerol. This means that 
the surfactant properties of the compound and its 
solubility are important factors in the quality of the 
spectra obtained, since replenishment of the sample 
at the surface is necessary so that it can be 
continuously ejected from that surface. It is this fact 
that makes highly polar and charged species the most amenable 
to study by FABMS, since they are most likely to have 
the required properties. Thus, FABMS is a complementary 
technique to CIMS and EIMS in that different and 
previously inaccessible information is obtained.
The ionic species observed by FABMS also differ 
from those seen conventionally. No radical ions are 
obtained, instead ionisation is by addition or loss of 
a proton to give the species (M + H)+ and (M - H) 
respectively. Ionisation can also occur by addition or 
loss of metal ions if any are present. The ions produced 
are of much lower energy than those made by EIMS or 
CIMS, which means that very little fragmentation occurs.
Glycerol can interfere with the spectra 
produced in that it forms ionised oligomers of the type
lGlyn + H,+' uith itsel£ and <M ♦ Glyn * H > *"• wlth the 
sample. The abundance of these oligomeric species
decreases with increasing n, and are barely detectable 
at higher mass.
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All.2 EXPERIMENTAL
FABMS analysis of all species was carried out 
by mixing an aqueous solution of the free acids (15 pi,
0.3 M) with 2 M sodium or potassium hydroxide (10 ul).
This mixture was suspended in glycerol (35 pi) , giving 
an overall conventration of 0.075 M pyrophosphate 
analogue in 60% glycerol containing 4 equivalents of 
counterion. Alternatively, FABMS spectra were obtained 
from samples of the requisite salt or free acid dissolved 
in 60% glycerol.
Mass spectra were obtained on an MS80 mass spec­
trometer fitted with a standard FAB gun (Kratos Analytical 
Instruments Ltd., Manchester, U.K.) and data analysed 
using a DS55 data system. The primary argon beam energy 
was 4 k eV with a gun current of 300 pA. Spectra were 
recorded with the sample probe at room temperature using a 
resolution of 1000. Spectra of the free acids were 
recorded on a Finnigan model 3300 mass spectrometer 
fitted with an Ion Tech Bll NF saddle field gun as 
described (Caprioli, et al., 1983) and using xenon as 
the bombarding gas at 8 k eV and 40 pA gun current.
All.3 RESULTS AND DISCUSSION
All. 3.1 Spectra of Free Acids of Pyrophosphate Analogues
FABMS spectra of the free acids of these 
species were recorded in the positive mode, the general 
species ovserved being (M + H ♦ Glyn)+ (where n = 0, 1, 2, 3)
137
138
(Table All.3.1) which decrease in intensity with
increasing n. The majority of pyrophosphate analogues 
would appear in the region in which glycerol oligomers 
occur as intense peaks (i.e. 93,185,277 a.m.u.) (e.g..
Fig. All.3.1). Thus, the spectra could be improved 
by use of metal counterions to shift the region of 
interest to higher mass, away from the glycerol 
dominated area.
Fig. All.3.1 FAB spectrum of PA A
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Table All.3.1 Principal ions and Relative
Abundance (%) in FABMS Spectra of 
Free Acids of Pyrophosphate 
Analogues
Compound Spectrum
(2) 93 (100),, 141 (34), 185 (38) , 233 (12)
(3) 93 (100),, 155 (38), 185 (51) , 247 (12)
277 (3) , 329 (4)
(4) 93 (100)r 185 (11) 207 (10), 277 (0.5)
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All.3.2 Spectra of Alkali Metal Salts of Pyrophosphate
Analogues
In all cases, positive FABMS of pyrophosphate 
analogues (TablesAII.3.2(i) and AII.3.2(ii)) results in 
species which contain as many as five alkali metal 
counterions so that spectra are elongated over a much 
greater mass range.
Fig. All.3.2 shows two spectra of dimethylamino­
methylene bisphosphonic acid as its sodium and potassium 
salts, showing that the heavier potassium ions make for 
the clearest FAB mass spectra, in that the peaks of 
interest are well removed from interfering peaks. Little 
noise was discernible in any of the spectra recorded.
Negative FABMS was less useful since smaller 
total ion currents were obtained and sample peaks were 
barely discernible from baseline noise. The types of 
species observed were (M - H) , (M - H2 + Na) ,
(M - H3 + Na2)" etc.
No advantage was gained by using triethanolamine, 
trigol or thioglycerol as matrix or by interchanging the 
bombarding gases.
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Fig. All.3.2 Comparison of FABMS spectra of (i) sodium 
and (ii) potassium salts of dimethylamino- 
methylene bisphosphonic acid.
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Table All.3.2(1) Sample Ions and Relative Abundance (%) 
in the FABMS Spectra of Sodium Salts of 
Pyrophosphate Analogues
Compound Spectrum
(1) 233 (13) , 245
(2) 141 (12) , 163
(3) 155 (16) , 177
243 (19)
(4) 207 (100) , 229
295 (38) , 317
(5) 264 (26) , 286
(6) 213 (18) , 235
301 (10)
(7) 267 (39) , 269
291 (65) , 293
315 (9) , 333 (
(8) 355 (24) , 357
379 (100) , 381
403 (37)
(9) 211 (45) , 213
255 (19) , 257
299 (100) , 301
(10) 255 (20) , 257
299 (100) , 301
(11) 225 (12) , 227269 (84) , 271
313 (72) , 315
(12) 301 (100) , 303
345 (45) , 347
289 (80) , 391
(61) , 267 (100),, 289 (55)
(58) , 207 (27) , 229 (100)
(36) , 199 (100),r 221 (67)
(56)
(34)
, 251 (43) , 273 (20)
(88) , 308 (100),, 330 (45)
(98) , 257 (100),, 279 (20)
(20), 271 (4), 289 (100), 
(13), 311 (85) , 313 (52), 
17), 335 (12), 337 (3)
(49) , 359 (28) , 377 (50) , 
(48), 399 (32), 401 (76)
(15), 233 (12), 235 (7),
(8), 277 (76), 279 (27), 
(30), 321 (34) , 323 (12)
(23), 277 (60), 279 (62), 
(99) , 321 (80) , 323 (78)
(5) , 247 (62) , 249 (20) , 
(29), 291 (100) , 293 (34),
(26) , 335 (20), 337 (8)
(33), 323 (20) , 325 (8) , 
(15), 367 (75), 369 (25),
(27) , 411 (12), 413 (5)
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Table All.3.2(11) Sample Ions and Relative Abundances
(*) in the FABMS Spectra of Potassium 
Salts of Pyrophosphate Analogues
Compound Spectrum
(1) 255 (34) , 293 (64) , 331 (100) , 369 (22)
(2) 155 (23) , 193 (12) , 231 (99) , 269 (100)
307 (36)
(3) 179 (8) , 217 (42) , 255 (100) , 293 (74)
(4) 207 (28), 283 (5) , 321 (53) , 359 (100),
397 (46)
(5) 258 (4) , 296 (16) , 334 (80) , 372 (100),
410 (29)
(6) 191 (14) , 229 (18) , 267 (95) , 305 (100)
343 (24)
(7) 283 (26) , 285 (19) , 287 (4) , 321 (100) ,
323 (71) , 325 (39) , 359 (76) , 361 (66),
363 (24) , 397 (6) , 399 (4), 401 (3)
(8) 371 (52) , 373 (100) , 375 (56) , 409 (48)
411 (94) , 413 (54) , 447 (34) , 449 (68) ,
451 (40)
(9) 211 (20) , 213 (8) , 249 (48) , 251 (15),
287 (98) , 289 (32) , 325 (100) , 327 (32)
363 (75) , 365 (28)
(10) 293 (60) , 295 (58) , 331 (100) , 333 (95)
369 (76) , 371 (77) , 407 (30) , 409 (30)
Ul) 263 (70) , 265 (25) , 301 (100) , 303 (33)
339 (70) , 341 (22) , 377 (40) , 379 (14),
415 (15) , 417 (5)
(12) 301 (10) , 303 (4) , 339 (32) , 341 (10) ,
377 (100) , 379 (34) , 415 (42) , 417 (14)
453 (36) , 455 (12) , 491 (25) , 493 (10)
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SYNTHESIS OF ALKYLATED M ETHYLENE BISPHOSPHONATES VIA 
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Thallium« I) derivatives of esterified methylene bisphosphonates can be readily 
obtained by treating the latter with thallium«I) ethoxide under anhydrous conditions. 
Alkylation of the thallium«I) derivatives by a range of primary alkyl iodides takes 
place smoothly, and significantly higher yields are obtained than for the correspond­
ing reactions with lithio or sodio derivatives.
Introduction
Halogenated methylene bisphosphonic acids, c.g.. 1 where (R* 1— Cl or Br. R2 — H) 
or «R1 — R: - Cl or Br) are inhibitors of the RNA transcriptase of influenza virus A 
and this inhibitory activity has been correlated with the effectiveness of these 
compounds as chelators of zinc ions [1|. Highly polar compounds such as 1 are not 
taken up readily by cells and hence we have turned our attention to the synthesis of 
C-alkylated monohalogenomethylene bisphosphonic acids 1 where R1 = alkyl. R2 - 
Cl or Br as these compounds should cross lipid membranes more readily than the 
unalkylated analogues.
(HO^P^CR' R2 P(0)(0H)j
(1)
There are two methods available for the synthesis of 1 (R1 = alkyl. R2 — Cl or Br). 
The first involves the alkylation of the tetraisopropyl ester of methylene bis­
phosphonic acid la followed by halogenation and removal of the esterifying groups. 
This route has been reported previously, the sodio derivative of tetraisopropyl la 
was alkylated and the product then halogenated with a sodium hypohalite. However, 
yields were poor as < 25% alkylation [2] and 45% halogenation (3) occurred. Our 
studies have shown that it is more efficient to invert the two steps as the yields are 
much higher and the products are more readily purified «Scheme 1). Monohalogena- 
tion of tetraisopropyl la cannot be accomplished in a single step in good yield [2)
0022-328X/85/S03.30 C 198$ Elsevier Sequoia S.A
R M*. El, Pf. "-Bu. CH,Ph
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hul the monodehalogenation of 1 (R1 = R - Cl or Br» can readily he achieved using 
either fluoride ion [4| or n-hutyllithium [5|. We find that alkylation of the tetraiso- 
propyl esters of monochloromethylene It and monohromomethvlene Im bis- 
phosphonic acids occurs in high yield when thallium!I» ethoxide is used as base to 
generate the mono-anion followed by treatment of the latter with a primary alkyl 
iodide. Alkylation of tetraisopropyl la can be carried out in a similar manner when 
an excess of thalliumfl) ethoxide is used as base. Hydrolysis of the tetraisopropyl 
esters of the C-alkylated products is most efficiently carried out on a small scale via 
the formation of the tetraftrimethylsilyl) esters with bromotrimethylsilane. The 
C-alkylated monochloromethylene bisphosphonic acids are inhibitors of the RNA 
transcriptase of influenza virus A. a full report of their biological activities will be 
published elsew here.
Results and discussion
The alkylation of organophosphorus compounds by means of their thallium 
derivatives has not previously been reported although quantitative C-alkylation of 
/f-diketones has been achieved via stable organothallium intermediates [6j. We have 
obtained isolated yields of more than 80% of the closely analogous tetra esters of 
C-alkylated monochloromethylene bisphosphonales by means of organothallium 
intermediates ( fable 1). Such high yields could not be obtained when butyllithium. 
sodium hydride or sodium metal were used to form the reactive intermediates. For 
example, when tetraisopropyl le was treated with either sodium metal or sodium 
hydnde followed by iodomethane. 3,P NMR analysis of the reaction showed the 
presence of tetraisopropyl C-methyl monochloromethylene (If) and tetraisopropyl 
C-dimethyl methylene 1 (R1 « R2 * Me) bisphosphonates in the ratio 9/1. When 
lodoethane or iodobutanc were reacted with the sodio derivative of tetraisopropyl le 
complex mixtures of products were obtained. 31P NMR analysis showed the pres­
ence of < 45% tetraisopropyl (1; R1 « Cl. R2 - Et or Bu) and ca. 30% of C-dial-
TABLE 1
CHARACTERISATION OF ALKYLATED METHYLENE BISPHOSPHONATES
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Teiraisopropyl euer*_____________________  Tetri sodium salts
No. R' R2 Alkylation 
by "PNM R
<*>
Yield
isolated
(9)
Parent ion(s) 
<A#f HlinCIMS
Analyses
C
(Found (calcd.H?))
H P
U H H - 345 4M "<4.55)
0.81
(0.76) (23.5)
lb H Me 72 47 359 8.67
(8.63)
1.27
(1.44)
20.8
(22.3)
Ic H El 68 45 373 13.96
(12.33)
3.74
(2.05)
22.15
(21.23)
M H n-Bu 74 49 401 18.64
(18.75)
2.70
(2.50)
19.52
(19.38)
Ic a H - 379. 381 3.84
(4.02)
1.76
(0.34)
19.30
(20.77)
If a Me 98 80 393. 395 7.75
(7.70)
2.22
(0.96)
20.40
(19.84)
■g a El 97 81 407.409 11.5
(1103)
2.19
(1.53)
18.07
(18.99)
lb a n-Pr 97 78 421.423 14.37
(14.10)
2.66
(2.06)
19.61
(18.21)
II a n-Bu 96 78 435. 437 14.81
(16.93)
2.90
(2.54)
16.70
(17.5)
•j a n-Hex 96 79 463. 465 21.40
(21.96)
3.89
(3.40)
16.37
(16.21)
Ik a CH2Ph 99 82 469. 471 23.11
(24.70)
2.39
(180)
16.75
(15.96)
Cl i-Pr IS - 421.423 - - -
Im Br H - 423. 425 3.80(3.50) 1.95(0.30)
17.60
(18.10)
la Br Me 93 70 437. 438 6.09
(6.70)
1.72
(0.84)
lo Br El 87 63 451.453 9.70
(9-70)
LSI
(1.35)
18.01
(16.70)
kylated products (Table 2). These results confirm the observation of Quimby et al. 
(3) who found that monoalkylation of tetraisopropyl la did not occur in high yield 
by this route. We obtained a good yield of tetraisopropyl If when butyllithium was 
used to generate the mono-anion of tetraisopropyl le before alkylation of the latter 
with iodomethane. However, poor yields of C-monoalkylated products were ob­
tained with other iodoalkanes. Thus, the thallium(I) intermediate is unique in giving 
high yields of C-monoalkylated products with a range of iodoalkanes.
Treatment of the thallium salt of tetraisopropyl le with bromohexane gave a 36% 
yield (by 31P NMR) of tetraisopropyl C-n-hexyl monobromomethylene bis­
phosphonate lj compared with a 96% yield with iodohexane. This is in accordance 
with observations by Taylor et al. on the C-alkylation of /3-diketones (6). Although 
these authors reported that the alkylfction of thallium(I) salts of /8-diketones took 
place in high yield with 2-iodopropane, we have found that the equivalent reaction 
with esterified methylene bisphosphonates is very sluggish and we could only obtain 
15% of tetraisopropyl C-isopropyl monochloromethylene bisphosphonate II at 
elevated temperatures with prolonged reaction times. Presumably steric hindrance by
14«
TABLE 2
ALKYLATIONS OF TETRAISOPROPYL SODIOCHLOROMETHYLENE BISPHOSPHONATE
Alkylating Agent
M d Etl M
Yield by " P  Yield by "P  Yield by
*'P NMR Chemical "PNM R Chemical **P NMR 
(? ) shift ( 6 ) (9 ) shift <4) (T|
Starting material 2
Monoalky lated 
product 8V
Diaikylated 
product 9
Others
19
39
26
16
Chemical 
shift <« > 
11.4 
14.7 
23.3
the bulky groups around the central carbon atom in our compounds is an important 
factor in this reaction with secondary iodoalkancs.
Alkylation o f  the monobromo derivative 1m proceeded less cleanly than for the 
monochloro analogue. Fair yields o f  C-monoalkylated compounds could be isolated 
when the formation o f  the thallium salt was performed at low temperature ( — 20°C). 
When the salt was prepared at room temperatuie. up to 23% (by ’ ’ P N M R ) o f  side 
products were formed presumably due to positive halogen abstraction as has been 
observed in our earlier experiments |4) and by others [7], The increased tendency o f 
the monobromo derivative to undergo positive halogen abstraction can be correlated 
with the ionisation potentials o f  the two halogens [8] and presumably a monoiodo 
derivative would undergo dehalogenation even more rapidly. Best yields for mono­
alkylation o f  tetraisopropyl la  occurred at 30°C with an excess (1.4 equiv.) o f 
thallous cthoxide. Presumably the formation o f the monoanion is comparatively 
difficult in the absence o f  a chlorine atom on the central carbon atom.
A ll tetra esters were analysed by ammonia chemical ionisation mass spectrometry 
(C1MS) with ammonia as reagent gas (9). In every case an intense ion corresponding 
to ( M  + H )*  was observed, together with peaks corresponding to the successive loss 
o f  propcnc residues (Table 1). In the case o f  tetraisopropyl esters o f longer chain 
C-alkylated monohalogenated methylene bisphosphonates Ih j  and Ip  a second 
decomposition pathway o f  the parent (M  + H)* ions was possible involving elimina­
tion o f hydrogen halide from the bridge carbon atom.
The 'H  and 11P N M R  spectra o f  the acids are listed in Table 3. The tetraisopro­
pyl esters had very similar 'H  N M R  spectra with the addition o f peaks in the regions 
S 4.8-5.0 (m. methine protons. 4 H ) and 1.3S-1.3 ppm (d . methyl protons. 24H. J  7 
Hz). In the 'H  N M R  spectrum o f  tetraisopropyl C-benzyl monochloromethylene 
bisphosphonate Ik. four separate doublets were observed in the region 5 1.17-1.33 
ppm. The extremely bulky substituents around the bridge carbon atom have re­
stricted rotation and the separation o f  the doublets due to the methyl groups are 
presumably due to  diastereotopic effects as there are several prochiral centres in the 
molecule.
The hydrolysis o f  the tetraisopropyl esters in concentrated hydrochloric acid [10) 
does not give high yields o f the corresponding free acids. Treatment o f  the esters 
with an excess o f bromotrimethylsilane followed by aqueous methanol gave quanti-
TABLE J
NMR DATA OF ALKYLATED METHYLENE BISPHOSPHONANTES
" P Chemical shift (8(ppm>) 
(i-Pr)4-ester Na4-salt 
(CDCI,) (D.O)
'l l  chemical shifts(i(ppm)lof Na4-salls in DjO 
spin-spin coupling constants (J ) in Hr
la 17.2 18.0 2 40 0. 2H. J 21»
lb 22.0 23.2 1.44 (t. 3H «1). J 18. 8 <dh 2.25 (l. IH (q>. J 23. 
7.5 <q>
Ir 21.9 22.7 1.10(1. 3H. J 8). 1.7 2.0(m. 3H)Id 22.0 22.7 0.90 (c. 3H. J  7). 1.35 <2H seat. J 7). 1.55 (2H. quint. 
J 7». 1.75-2.0 (m. 2H). 2.25 (t. 1H (l). J, 23. J2 
7.5)
le 114 13.2 3 90(t. 1H. J 20)If 14.8 17.8 1 85(5. 3H, J 15)
14.75 17.2 1.17 (t. 3H. J 7.5). 2.25 (m. 2H)
Ih 14.8 17.3 0.87 (t. 3H. J 7.5). 1.65 (2H. seat.. J 7.5). 2.10 (m. 2H)
li 14.7 17.3 0.86 (t. 3H. J 7.5). 1.32 (2H. seat.. J 7). 1.62 (2H. quint.. 
J 7.5). 2.15 (m.2H)
U 14.75 17.3 0.86(1. 3H. J 7.5). 1.30(m.6H). 1.75 (2H. quint.. J 7.5). 
2.15 (m. 2H)
Ik 13.7 16.9 3.40 (s. 2H. J 13). 7.25 (m. 3H(. 7.40 (m.2H)
II 14.8 17.2Im 114 12.9 3.75(1. 1H. J 20)
In 14.9 17.8 2.02(1. 3H. J 15)
lo 14.7 17.5 1.14 (t. 3H. J 8). 2.18 (m. 2H. J 8)
lative yields o f  the free acids [11.12]. T h is  reaction is much cleaner than when 
iodotrimethylsilane [ 13] is used in place o f  the bromo derivative. Thus, the combina­
tion o f the use o f thallium(I) ethoxide to  form the monoanions o f esterified 
methylene bisphosphonates with the use o f  bromotrimethylsilane to remove the 
esterifying groups from the alkylated products results in significantly increased 
yields o f C-alkylated methylene bisphosphonic acids compared with previously 
reported procedures.
Experimental
Instrumentation
'H  N M R  spectra o f sodium salts o f  the free acids were recorded at 220 M H z 
(Table 3) on a Perkin-Elmer R34 spectrometer using deuterium oxide as solvent and 
3-<trimethylsilyl)-l-propane sulphonic acid  as internal standard. MP N M R  spectra 
were recorded to an accuracy o f  ±0 .5  ppm  (downfield shifts positive) at 36.44 M H z 
on a Bruker WH90 spectrometer using H ,P 0 4 as external standard. Chemical 
ionisation mass spectra with ammonia as reagent gas were obtained with an MS80 
mass spectrometer with a DS55 data system (Kratos Analytical Instruments). 
Analyses were carried out by Elemental Micro-Analysis Ltd. (Beaworthy. Devon. 
U.K.).
Preparation o f methylene bisphosphonates
fi) Tetraisopropyl dichloromethylene bisphosphonate. Tetraisopropyl methylene 
bisphosphonate (30 g. 0.09 mol: Lancaster Synthesis Ltd.. Morecambe. Lancs..
U .K .) was treated with excess sodium hypochlorite as previously described (3). Flash 
column chromatography o f the product on silica with 40 60 petroleum ether/acetone 
(2/1. v/ v ) as eluant gave a white solid (29.7 g. 829!). “ P N M R  analysis indicated 
that the only phosphorus-containing species present was the title compound (5  6.86 
ppm in C D C I,). The structure was confirmed by C IM S  when the principal ions were 
( M  + H ) ’ 413. 415. 417 in the ratio 9/6/1 due to the compounds with ’ ’ Cl and '7CI 
isotopes.
( i i )  Teiraisopropyl dihromomelhylene bisphosphonaie. Tetraisopropvl methylene 
bisphosphonate (10 g. 0.029 mol) was treated with an excess o f potassium hypo- 
bromite prepared in situ as described |4j. Flash column chromatography o f the 
product on silica using 40 60 petroleum ether/acetone (8/1. v / v ) as eluant gave a 
pale brown oil (11.4 g. 78$). *’ P N M R  analysis indicated that the only phosphorus- 
containing species present was the title compound (6  6.74 ppm in C D C I,). The 
structure was confirmed by C‘ lM S  when the principal ions were ( M  + H ) * 500. 502. 
504. in the ratio 1/2/1.
(H i) Teiraisopropyl esters o f  monochloromethylene ( le ) and monobromomelhylene 
d m ) hisphosphonic acids. Tetraisopropyl dichloromethylene bisphosphonale (5 g. 
0.012 mol) was treated with n-butvllithium (1 equiv.) as described (6) to give 
tetraisopropyl monochloromethylene bisphosphonate acid ( le )  (3.25 g. 71$ ) after 
chromatography on silica with elution with 40-60 petroleum ether/acetone (7/1. 
v/v). In a similar reaction, tetraisopropyl dibromomethylene bisphosphonate (5 g. 
0.01 mol) gave the tetraisopropyl ester o f monobromomethylene hisphosphonic acid 
Ini (2.7 g. 64$).
(iv ) Teiraisopropyl C-alkvl monochloromethylene bisphosphonales. A  standard 
procedure was used to prepare the tetraisopropyl C-alkyl monochloromethylene 
bisphosphonates listed in Table 1 and the preparation o f tetraisopropyl ester o f 
C-ethyl monochloromethylene bisphosphonic acid 1« given below is a typical 
example. Analytical data ( ” P N M R  spectra and ammonia C IM S ) are also given in 
Table 1.
Tetraisopropyl le  (0.5 g. 0.0013 mol) was dissolved in dry. freshly distilled 
tetrahydrofuran (10 ml) and the solution stirred for 40 min under nitrogen at room 
temperature in a 100 ml 3-necked flask fitted with a drying tube and a rubber 
septum. Thallium (I) ethoxide (95 pi. 0.0013 m ol) was added and the stirring 
continued for 40 min during which time the solution became cloudy. lodoethane (5 
ml. 0.032 mol) was added by syringe via the septum and the mixture heated under 
reflux for 2 h. The solution was then cooled and the orange thallium(l) iodide 
removed by passing the reaction mixture through a short column o f  Florisil and 
eluting with 40-60 petroleum ether/acetone (1/1. v / v ) (120 ml). The eluant was 
concentrated in vacuo to an oil which ” P N M R  analysis showed contained »  97$ 
tetraisopropyl Ig. The latter was purified by flash chromatography on silica with 
elution with 40-60 petroleum ether/acetone (6/1. v / v ) to give the pure tetraisopro­
pyl Ig  (0.44 g. 81$). During the preparations o f tetraisopropyl lh and l i  the reaction 
vessel was kept dark as the alkyl iodides are light sensitive. In the preparation o f 
tetraisopropyl lk . the thallium intermediate was treated with a mixture o f  benzyl 
iodide and bromide prepared, in an efficient fume hood, as follows. Benzyl bromide 
(5 g. 0.029 mol) was added to a solution o f sodium iodide (4.4 g. 0.03 mol) in acetone 
(25 ml). The mixture was stirred at room temperature fo 10 min. filtered and then 
concentrated in vacuo. This mixture (which was shown by 'H  N M R  to be a 4/1
mixture o f  benzyl iodide and benzyl bromide) was used immediately in the alkyla­
tion reaction.
(v ) Teiraisopropyl C-alkyl monobromomethylene bisphosphonates. The above pro­
cedure was used for the C-alkylation o f tetraisopropyl monobromomethylene bis­
phosphonate. In the case o f the C-ethyl derivative. MP N M R  analysis o f  the reaction 
showed that the tetraisopropyl esters o f lo  (8 7 ? . S 14.7 ppm), dibromomethylene 
(8 ? . S 17.2 ppm) and C-diethyl methylene (4 ? .  S 25.3 ppm) bisphosphonic acids 
were present. Column chromatography o f  the mixture on silica eluting with 40-60 
petroleum ether/acetone (5/2. v/ v ) gave pure tetraisopropyl lo  in 61? as a 
colourless oil.
(v i) Alkylation o f teiraisopropyl sodio-chloromethylene bisphosphonate was carried 
out as described |3J. ” P N M R  Analyses o f  the product mixtures arc shown in Table
2.
Ivii)  Alkylation o f  teiraisopropyl lithio-chloromethylene bisphosphonate. The lithium 
salt o f tetraisopropyl monochloromethylene bisphosphonate was prepared as de­
scribed above, an excess o f either iodomethane o r bromomethane was added and 
after the mixture had been heated under reflux for a short time, excess saturated 
sodium bicarbonate was added. The alkylated products were obtained from this 
reaction in the usual manner as oils. ’ ’ P  N M R  analysis revealed the presence o f  the 
following products: (a ) méthylation reaction: tetraisopropyl esters o f I f  65?. le  20?. 
and dichloromethylene ( 15?) ethylation reaction: tetraisopropyl esters o f  lg  36?. le  
12?. and dichloromethylene 25? bisphosphonic acids together with trace amounts 
o f four unidentified compounds.
( viii)  Hydrolysis o f tetraisopropyl esters o f  methylene bisphosphonic acids. 
Bromotrimethylsilane (2.5 fold excess) was added to each o f the esters under dry 
nitrogen and the mixture stirred at room temperature for >  20 h. the mixture was 
then lyophilised and excess aqueous methanol added. The aqueous methanol was 
removed in vacuo, further aqueous methanol was added and the solution evaporated 
again. This procedure was repeated 4 times. T h e  residues were dissolved in a little 
water and isolated as the tetrasodium salt by ion exchange chromatography on 
Dowex 50 (2  x  15 cm). In all cases isolated yields were in excess o f 90?.
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Preliminari et
R E LA T IV E  R E A C TIV IT IE S  O F  T E T R A A L K Y L  ESTERS O F  M E T H Y L E N E  
B IS P H O S PH O N IC  AC ID
DAVID W. HUTCHINSON* and GRAEME SEMPLE
Department of Chemistry. University of Warwick. Coventry CV4 7AL. West Midlands IGreat Britain) 
(Received March 26th. 1986)
The synthesis in high yield o f  tetraisopropyl esters o f C-alkylated methylene 
bisphosphonic acids can be achieved by the alkylation o f  the thallium salts of 
tetraisopropyl esters o f  the parent methylene bisphosphonic acids. Y ie ld s  o f  C-al- 
kylated products are markedly reduced when the tetraethyl or tetramethyl esters are 
used in this reaction. From a study o f the ,3C  and 31P  N M R  spectra o f  the 
methylene bisphosphonates and their anions, this difference in reactivity is ascribed 
to  steric factors. *1
Almost quantitative yields o f  C-alkylated esters (2 ) are formed from thallio 
derivatives o f  ( I .  R  =  i-Pr) or its bromo analogue and primary alkyl iodides (Scheme
1) [1]. However, under the same conditions, alkylation o f the lithio, sod io  or thallio 
derivatives o f  1. (R  =  Me or E t) gives very low ( <  20%) yields o f  C-alkylated 
products. Furthermore, the rate o f alkylation o f  the lithio derivative o f  I (R  — i-Pr) 
is faster than the rate o f  alkylation o f  the lithio derivative o f  I  (R  =  E t) and more 
side products are formed during the alkylation o f  the tetraethyl ester (F ig . 1). We
(R 0^P(0)CH CIP(0X 0R )3 **li *' TIOEy  ( RO)jP(0)C*~* CIPtOJtOR)2 
<1>
"  C>sl---------- « -  (RO)^ P{0)CCKCHfR*)P (0)(0R )j
(2)
SCHEME 1. The alkylation of anions of tetra-esters of monochlorotnethylene bisphosphonate. 
* To whom correspondence should be addressed.
0022-328X/86/S03.50 C 1986 Elsevier Sequoia S.A.
c*
I
i A — 1
Fig. 1. The lime course of alkylation of |(R0)2P(0)]2CC1 L i ' by n-butyl iodide in Ct D, at room 
temperature as studied by *' P NMR spectroscopy. Spectra were recorded on a Bruker WH90 spectrome­
ter at 36.4 MHz and were proton decoupled. The chemical shifts were recorded to an accuracy of ±0.5 
ppm (downfield shifts positive) relative to H ,P04 as external standard.
have also observed by 3,P  N M R  spectroscopy that a number o f products are formed 
when 1 (R  — M e) is treated with n-butyllithium [2]. Cleavage o f the C -P  bond 
occurs and this can be avoided if t-butyllithium is used in place o f n-butyllithium. 
While the rapid conversion o f  1 (R  — i-Pr) to  its anion can be achieved at — 78°C  
with one equivalent o f methyllithium. the esters 1 (R  -  M e or Et) undergo extensive 
side reactions with methyllithium under these conditions.
(R 0 )2P (0 )C H 2P ( 0 ) ( 0 R ) 2 (E t0 )2P (0 )C H 2C 0 0 E t RCO CH R 'CO R
(3) (4) (3)
»C  AND 51P N MR DATA FOR THE CENTRAL CARBON ATOM IN METHYLENE BIS­
PHOSPHONATES (I AND 3 k THE1R ANTONS. TR1ETHYL PHOSPHONOACETATE (4) AND 
PENTANE-2.4-DIONE (5)
(,5C NMR spectra wert recorded in C.D, al 22-63 MHz on a Broker WH90 spectrotneter and were
TABLE 1
equivalent of sodium hydride (50» dispersion in oil) to a solution n te of the protonated
Compound »C
«(ppm)
J i"C -
(Hz) «(ppm)
|(MeO),P(0)ljCHCl * 42.1 141.9 36.8
|(MeO)jPtO)ljCa N »- - 30.2
I(EiO).P(0)1jCHCT 43.9
|(EtO);PtO)):a  N«- 31.1 236.4
[(¡-Pro)j PtO») .CHC1 45.5
|0-PrO).P(OHjCa Na* 33.8
|(McO)jPtO)l2CH2 24.0
KMeOljPtOlljCH-Na* 7J 217.5
|(EtO)jPtO))jCHj 26.1
|(EtO)jP(0)l:C H -Na" 8.6
[(i-PiO).PtO>],CH. 28.5 136.8
|(i-Pro);PtO»;CH " Na* 11.1
(EtO).PtO|CH3COOEt 34.7 133.8 -
(EtO).PlO(CH COOEtNa- 40.3 -
MeCOCH .COMe * 52.8 -
MeCOCH" COMeNa* * 96.9
“ Recorded on a Broker WH400 spectrometer
The lithio and sodio derivatives o f tetra-esters o f methylene bisphosphonic acid 
(e  g. 1 or 3) were studied by ,5C  and 3,P  N M R  spectroscopy as these derivatives are 
considerably more soluble in organic solvents than their thallium analogues. The 
esters were dissolved in deuterobenzene at room temperature, the anions were 
formed by the addition o f base and then N M R  spectra were also recorded (Table 1). 
During the alkylation experiments (Fig. 1). an excess o f  butyl iodide was added in 
the N M R  tube to the preformed anions and the reactions were monitored by 31P 
N M R . The tetra-esters o f methylene bisphosphonic acid were commercially availa­
ble (Lancaster Synthesis). The tetra-esters o f  dichloromethylene bisphosphonic acid 
were prepared as previously described [1.3]. Treatment o f  these esters with methyl, 
n-butyl- or t-butyl-lithium (1.6 M  in hexane. 1 equivalent) gave the corresponding 
esters o f 1 [2]. The yield o f 1 (R  -  i-Pr) was 75%. 'H  N M R  (CDC13): S 1.35 (24H. d. 
J  8 Hz). 3.9 (1H. t, J  20 Hz), 4.9 (4H. m ) ppm. Analysis: Found: C. 40.92; H . 7.35; 
Cl. 9.74 C 15H „ a O jP j  ealed.: C. 41.2; H . 7.72; Cl. 9.36%. The yield o f 1 (R  -  Et) 
was 57%. 'H  N M R  (CDC13): S 1.4 (12H. t. J  7.4 H z). 4.05 (1H. t. J  18.5 Hz). 4.35 
(8H. m.) ppm. Analysis: Found: C. 33.4; H . 6.65; C l. 11.5. C9H 21C102P2 ealed.: C. 
33.5; H. 6.56; Cl. 11.0%. The yield o f 1 (R  =  M e) was 47%. 'H  N M R  (C D C 1 ,): S 
3.7 (12H. m,). 4.0 (1H. L J  18 H z) ppm. Analysis: Found: C. 22.36; H . 5.29. 
C ,H 1,C I02P: ealed : C . 22.52; H . 4.91%
The one-bond ,3C - 3,P  coupling constants between the phosphorus atoms and 
the central carbon atom in the anions o f 1 and 3 are much larger than those found
for the corresponding protonated compounds 1 and 3 (Table 1) suggesting that there 
is a change in hybridisation o f  the central atom from sp3 to  sp2 when the anions are 
formed (4). The ,JC  chemical shifts indicate that the anions derived from 1 and 3 are 
not appreciably delocalised as the signals due to the central carbon atom shift 
upfield approximately 12-17 ppm on formation o f the anions. These values may be 
compared with those obtained from the anion o f inethyl phosphonoacctate (4) 
where the negative charge might be expected to be delocalised to some extent over 
the carbcthoxy group. In this case, there is a downfield shift o f 3.6 ppm o f  the signal 
due to the central carbon atom on formation o f the anion. It has been reported for 
pentane-2.4-dione (5. R  -  Me; R' -  H ) in solution in DM SO-d„ that there is a large 
(44 ppm) downfield shift o f the signal due to  the central carbon atom on formation 
o f  the anion [$]. Presumably in this case there is considerable delocalisation o f the 
negative charge, and it has been suggested from infrared evidence (6) that this anion 
is appreciably more delocalised than the anions o f triethyl phosphonacetate or 3.
One explanation for the difference in reactivities between the isopropyl esters o f 
1 or 3 and their ethyl and methyl analogues is that the bulky isopropyl groups 
distort the anion and prevent the two phosphoryl groups and the central carbon 
atom from achieving coplanarity. ,JC  N M R  evidence indicates that there is minimal 
delocalisation o f charge in the anions o f  1 o r 3 and this distortion may result in the 
exposure o f  the negative charge on the central carbon atom to attack by electro­
philes. Arguments invoking differences in coplanarity o f  anions o f  /3-diketones have 
been used to explain differences in reactivities o f these compounds [7]
Thus, in the synthesis o f  C-alkylated methylene bisphosphonate esters, we find 
that while excellent yields can be obtained when the thallio derivatives o f  tetraiso- 
propyl esters are treated with primary alkyl iodides. Steric factors influence this 
reaction and considerably lower yields are obtained when either secondary alkyl 
iodides are used in this reaction or when the ethyl or methyl esters are employed.
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Stress proteins are induced by hyperosmoiarity in chick embryo fibroblasts
P IE R  GIORGIO PETRONIN1, MARIAROSAR1A 
TRAMACERE. GIUSEPPE PIEDIMONTE and 
ANGELO F. BORGHETTI
Isritu to  di Patologia Generale, University d i Parma. 43100 
Parma. Italy
A  wide range o f  environmental stimuli including heat, 
oxygen deprivation, teratogens, heavy metals, ethyl alcohol, 
amino acid analogues etc., is known to induce the synthesis 
o f  a family o f stress proteins in prokaryotic and eukaryotic 
cells (Ashbumer & Bonner. 1979). The functions o f  these 
inducible stress proteins are poorly understood. Schlesinger 
e t al. (1982) have hypothesized that the induction o f  these 
proteins could defend the cell exposed to an environmental 
insult from further damage by modifying the nuclear and 
the cytoplasmic cytoskeleton so to protect the metabolic 
apparatus from the stimulus persistance and to adapt 
consequently. In addition, the process o f  cell adaptation to 
adverse environmental factors is known to  involve the cell’ s 
ability to modify the chemical complexion o f  the membrane 
and to alter the activity o f  membrane-associated enzymes 
including transport processes (Quinn, 1983).
We have recently shown that the exposure o f  chick 
embryo fibroblasts to  a hyperosmolar medium results in an 
increase o f amino acid-transport activity. This change 
appears to be restricted to the A system o f  mediation for 
neutral amino acids, to be dependent on both active tran­
scription and translation, and to require a continuous 
exposure o f the cells to the hyperosmolar stimulus 
(Tramacer eetal., 1984<z,ft).
In pursuing a correlation between the probable increase 
in the number o f  transport molecules and the alteration o f 
gene expression in cells exposed to a hyperosmolar environ­
ment. we studied the pattern o f  polypeptides synthesized 
during the adaptation process to a hyperosmolar stress.
Secondary cultures o f  chick embryo fibroblasts were 
exposed to 0.5 osM in complete culture medium. Labelling 
was performed between 0.5 and 3 or 18.5 and 21 h o f  the 
hyperosmolar treatment. Cells were then solubilized in 
SDS/sample buffer and the labelled proteins were separated 
on 10% (w/v) SDS/polyacrylamide slab gel (Laemmli, 
1970) and detected by fluorography as described by Bonner 
&  Laskey (1974).
The effect o f cell exposure for 3 or 21 h to  a 0.5 osm 
medium on the pattern o f  protein synthesis was examined. 
When the pattern o f  polypeptides synthesized during the 
treatment was compared with those synthesized by un­
treated cells, the synthesis o f  certain proteins appeared 
reduced whereas for others there was a clear enhancement. 
As shown in Fig. 1. after 3 h o f hyperosmolar treatment 
four proteins with apparent M x o f  76000, 59 000, 51000 
and 38000 were synthesized in smaller amounts than in 
control cells, meanwhile others (M , 63 000 and 36 000) 
were synthesized in greater amounts. When cells were 
labelled between 18.5 and 21 h o f  hyperosmolar treatment, 
the synthesis o f those polypeptides that at 3 h o f  hyper­
osmolar exposure appeared reduced or increased, returned
Abbreviation used: SDS, sodium dodccyl sulphate.
lO^ X/W,
*** a s
(a) (6) (c) (d)
Fig. 1. Pattern o f  proteins synthesized in hyperosmolarity- 
treated chick embryo fibroblasts 
Cells were exposed to 0.5 osm in complete culture medium. 
The labelling procedure was performed with lOpCi of 
| ,4Clglycine/ml between 0.5 and 3 or 18.5 and 21 h o f the 
hyperosmolar treatment. Shown is a fluorograph o f the gel. 
Unes (a ) and (ft): controls at 3 or 21 h o f incubation, 
respectively. Lanes (c ) and (d ): cells exposed to 0.5 osm for 
3 or 21 h, respectively.
to control values. Moreover, the synthesis o f  M t 57 000 
polypeptide was markedly increased. These preliminary 
data suggest that the expression o f  some specific proteins 
changes at specific times during the cell adaptation to 
hyperosmoiarity. At early times there is a change in the
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synthesis of several polypeptides, whereas at later times the 
protein pattern appears to be sim ilar to control.
Our unpublished observations on the benaviour of such 
parameters as polyribosome profile, cation content and 
amino acid transport have shown a strong perturbation of 
these parameters in the first few hours of hyperosmolar 
treatment followed by a slow but persistent return to the 
values of the control. These results are an indication of the 
capacity of the cells to cope with an osmotically altered 
environment and are compatible with the above described 
modulation of protein synthesis. O f  course, the possibility 
that the change in the expression o f  specific proteins might 
be referred to the alteration o f some functions in hyper- 
osmolant> - treated cells deserves further study.
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Pyrophosphate analogues as inhibitors o f viral polymerases
D A V ID  W HUTCH IN SON . M A T T H EW  N A Y LO R . 
G R A EM E SEM PLE and P A U L A. C L O A D
Department o f  Chemistry. University o f  Warwick. Coventry 
CV4 7AL. U  K.
Analogues of pyrophotphoric acid. e.g. phosphonoacetic 
(I). phosphonoformic (II) and G-substituted methylene 
bisphosphanic acids ( III)  and the related tetrazole ( IV ) 
can act as product inhibitors o f viral polymerases. For 
example, the replication of herpes viruses can be inhibited 
by (I) (Boezi. 1979) or (Il)(O berg, 1983). both compounds 
inhibiting the DNA polymerases induced by these viruses. 
In addition. (I). (II), ( I I I.  X  =  Y  =  C l)  and ( IV ) can inhibit 
the RN A transcriptase activity o f influenza vims A  (Cload 
& Hutchinson. 1983; Stridh &  Datema, 1984).
(H O z P f O C H jC O jH  (H O ) jP (0 )C O jH
0 ) (II)
(H O )jP (0)CX YP (O X O H )J --------N
( III)  ¿ N j^ x l^ C H tP fO X O H ^
H
( IV )
(HO ),P(S)OP(OXO H), (H O )2P(S)OP(SXOH)]
(V ) (V I)
The inhibition o f the R N A  transcriptase activity of 
influenza vims by these compounds appears to be related 
to their abilities to form complexes with an essential metal 
ion (probably zinc)in the transcriptase (Cload &  Hutchinson. 
1983; Hutchinson 1985). Thus (U I. X  =  Y  =  H ) forms 
only weak complexes with zinc ions at physiological pH 
while ( I I I.  X  =  Y  =  C l)  forms considerably stronger com­
plexes. This behaviour is paralleled in their inhibitory 
activities and (III. X  =  Y  =  C l)  is a good inhibitor of the 
RN A transcriptase activity while ( I I I .  X  =  Y  =  H ) is a poor 
inhibitor.
The metal chelating properties o f  inorganic pyrophos­
phate are affected if  oxygen atoms are replaced by sulphur. 
Oxygen is a ‘hard’ centre o f the Pearson Hard and Soft 
Acid and Base Scale while sulphur is a ‘soft’ centre (Pearson. 
1968). Thus, thiopyrophosphates might be expected to 
bind to Z n J* ions in a manner different to that observed 
with pyrophosphate. We have shown by 31P n.m.r. that 
bisthiopyrophosphate ( V I)  appears to bind to Zn 2* through
sulphur while it binds to Mg2* through oxygen (Hutchinson 
et a!.. 1985). Mono- (V ) and bis-thiopyrophosphate (V I)  
form strong complexes with Z n 2* ions under physiological 
conditions. They are as good inhibitors of the RN A tran­
scriptase activity of influenza vim s A  as compounds ( I ) - ( I V )  
and are better inhibitors of the transcriptase than inorganic 
pyrophosphate. Mono-and bis-thiopyrophosphate inhibit 
the replication of influenza vim s A  in  M D CK cells and do 
not appear to be cytotoxic to these cells after 3 days at 
concentrations which cause marked inhibition of vims 
replication.
Lipid-soluble pyrophosphate analogues should be taken 
up by cells more readily than highly polar compounds, 
e.g. (I)—(III) - The presence o f an electron-withdrawing 
group on the bridge carbon atom o f methylene bisphos­
phonates is necessary if  these bisphosphonates are to be 
good inhibitors of the R N A transcriptase of influenza 
vims A (Cload &  Hutchinson. 1983). We have developed 
a method for the synthesis o f C-alkylated monochloro- 
bisphosphonates ( V II)  in high yield:
(R'0 ),P (0)CH ClP <O X O R ' h
(H O )jP(0)C R JClP (O X O H  h
The key steps in our synthetic route are the use of 
thalliumd) ethoxide as base to form the anion from a 
tetra-alkyl ester of monochloromethylene bisphosphonate 
followed by reaction with an a lk y l iodide and de­
esterification with trim ethylsilyl bromide (Hutchinson 
& Semple, 1985). In this way ( V II )  can be prepared in 
over 8 0 % yield overall. I f  the -sodio- or lithio-salts of 
the monoanion of the tetra ester o f monochloromethylene 
bisphosphonate are used in the alkylation step or if  de- 
esterification is carried out b y  hydrolysis with concen­
trated acid, marked reductions in the yield of (V II)  occur. 
In preliminary experiments, we have shown that ( V II ,  
R =  Me, n-Pr, n-Bu, n-Hex) are effective inhibitors of
1985
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the RNA transcriptase activity of influenza virus A  as 
this activity is inhibited by more than 5 0 % when the 
analogues are present at a concentration of 250jiM.
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The major P ’ .I^-bis-iS'-adenosylMetraphosphate-binding protein in Anemia 
is a protein kinase
M AR K P R ESC O TT and A L E X A N D E R  G . MCLENNAN 
Department o f  Biochenusm>, Univenity o f  Liverpool.
P.O. Box 14 7. Liverpool L69  3BX. U.K.
Several acid-soluble nucleotides act as specific signals in the 
regulation of metabolic reactions (Tomkins, 1975). The 
past decade has seen a considerable growth in interest in 
the novel purine nucleotide P1 ,P*-bis-(5'-adenosyl)-tetra- 
phosphate (Ap«A). This apparently ubiquitous component 
of living cells has been shown to alter its intracellular con­
centration up to 1000-fold during the G i  to S progression 
o f a synchronized cell cycle (Weinmann-Dorsch et a!.. 
1984). It may be involved in a number of metabolic processes 
in the cell including the initiation of DNA replication 
(Weinmann-Dorsch et al.. 1984) and stimulation of pro­
cessing of ADP-ribosylated proteins (Surowy &  Berger. 
1983). It is synthesized by the aminoacyl-tRNA synthetases 
in the presence of Zn 2* ions(Goerlicheta!.. 1982). Evidence 
to date suggests a role as a messenger molecule in cellular 
proliferation.
As part of our investigations into the function of Ap4A 
we have previously examined the levels of this nucleotide 
during development of the brine shrimp Artemia. When 
ametabolic encysted gastrulae of Artemia  resume develop­
ment they do so in the total absence of DNA replication 
and cell division until the point of hatching (16  h) although 
protein and R N A synthesis proceed unhindered. Upon re­
initiation of development, a 125-fold rise in the intracellular 
concentration of Ap«A was observed, the maximum level 
t coinciding with hatching and the onset of DNA synthesis 
(McLennan &  Prescott, 1984).
In order to clarify the relationship between Ap4A, DNA 
synthesis and cellular growth and division we have sought 
to identify the intracellular target proteins of this nucleo­
tide. We report here that the major protein isolated from 
newly hatched larvae which is capable o f binding Ap4A  is 
a protein kinase.
When extracts of larvae are analysed by sucrose density 
gradient sedimentation analysis and the binding of 
(J H)Ap4A determined in each fraction by a nitrocellulose 
filter binding assay, a major binding protein o fM ,  93 000 
(4.8S) is observed which co-sediments with an enzymic 
activity capable of incorporating [“ Pjorthophosphate 
into histone H2B using [7 -32 P] ATP as substrate.
By contrast, no evidence has been obtained to suggest 
that this binding protein may be associated with the DNA 
polymerase—a-hdoenzyme complex in this organism, as 
has been reported previously for Ap4A-binding proteins 
from calf thymus (Grummt. 1978) and He La cells (Rapa- 
port eta l.. 1981).
The Artemia  binding protein has been partially purified 
from newly hatched larvae by ammonium sulphate pre-
Abbreviationused: Ap.A.P'.P'-biM S'-adenosyD-tetraphosphate.
cipitation. Mat rex Blue and DEAE-cellulose chromatography 
and A cA  34 gel filtration. This scheme was designed to 
remove phosphodiesterases and all other enzyme activities 
capable of degrading the ligand, thus allowing a more 
detailed study of the protein. The purified Ap4A-binding 
protein still possesses protein kinase activity.
Using histone H 2B  (the preferred substrate) and [7 - 
32 P] A TP  of medium specific activity ( 1.4 Ci/mmol), stimu­
lation of the kinase activity was observed in the presence 
of 1/iM -cyclic AMP and 1 mM-cyclic GMP (2.1 and 2.0- 
fold respectively). However, at similar concentrations, 
Ap4A  had no detectable effect on kinase activity. 
Calmodulin and C a2* were also without effect.
The preparation was found to possess endogenous 
acceptor polypeptides when fr -^ P jA T P  of high specific 
activity was used Ç> 5000Ci/m mol). After separation 
on a 10 %  (w/v) polyacrylamide gel. four major acceptor 
species of M t 35 000. 40000. 42 000 and 72 000 were 
observed. These polypeptides all appear to be part of a 
single protein complex, as shown by their co-sedimentation 
on a 5—20 %  sucrose gradient. Since most protein kinases 
undergo autophosphorylation in vitro when incubated 
with [7 -32 PI ATP of high specific activity (de Jonge & 
Rosen. 1977), such a mechanism may be responsible for 
the incorporation observed here. The precise subunit 
composition of the native kinase is at present unclear, but 
our observations may be the result of partial proteolysis 
of a larger precursor. Such an observation has been made 
by several investigators (Kuo &  Shoji, 1982).
The polypeptides of Afr 35 000 and 40000 or 42 000 
may represent the proteolyti'. products of the M t  72 000 
polypeptide which, when associated with the third poly­
peptide of low molecular weight, yields the native kinase 
of M t 93 000.
This interpretation is supported by the fact that auto­
phosphorylation of crude extracts in the presence of 
sodium fluoride, an ATPase and protein phosphatase 
inhibitor, yields only the polypeptide of M , 72000 on 
sodium dodecyl sulphate, polyacry lamide gel. This poly­
peptide co-sediments with the native Ap4A-binding protein 
of M ,  93 000 on sucrose gradients.
Cyclic  AMP (1/iM ) or cyclic GMP ( IjiM ) completely 
suppress the phosphorylation o f the bands of M , 42 000 
and 40000 while cyclic GMP also reduces phosphorylation 
of the polypeptides of M r 72 000 and 35 000. The possible 
role of this kinase in growth regulation and development 
in Artemia  and the significance of Ap4A  binding are 
currently under investigation.
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The role o f an upstream sequence in the transcription o f  a human transfer RNA gene
JOHN P. GOD D ARD .* A IL E E N  MCLAREN.*
TOM C A R R .*  MARI AN N  B IE N Z + and JOHN D. SM ITH* 
•Department o f  B iochemism•. In h e rs in  o f  Glasgow. 
Glasgow G12 8QQ, Scotland. U K ..  andTM.RC. Laboratory 
o f  Molecular Biology. HU Is Road. Cambridge CB2 2QH. U.K.
A 2.4 kilobase / / in J il l  fragment of human genome DNA 
which hybridized tRNA was isolated from a larger fragment 
cloned in X Charon 4 A  and subcloned into the plasmid 
p A T 153. This recombinant was found to be of remarkably 
high transcriptional activity when microinjected into 
Xenopus oocyte nuclei, producing more tRNA than a 
comparable cloned cluster o f seven active Xenopus tRNA 
genes (Clarkson et al.. 1978). Southern blot analysis 
(Southern. 1975) of restriction fragments and determination 
of the sequence (Sanger et al.. 1980) of 125 0  residues 
within the 2.4 kilobase fragment revealed the presence of a 
single tR N AG,u gene (residues 356—427 inclusive of the 
sequenced fragment) in the middle of the 2.4 kilobase 
fragment. Immediately preceding this gene there is a 
sequence which can be folded into a tRNA-like structure 
(Goddard era/.. 1983).
The separation o f the intragenic promoter elements of 
eukaryotic tRNA genes is variable. This variability would 
be eliminated, to allow common recognition and binding 
of R N A polymerase I I I  and/or transcription factors, if 
the gene itself adopted a higher-order tRNA-like structure 
(Hall et a!.. 1982). These observations, together with the 
finding that the 5 -flanking, or upstream, sequence o f some 
tRNA genes inhibits transcription (see. e g.. Dingermann 
et a!.. 1982; Hipskind &  Clarkson. 1983). led us to ask 
whether the potential for a tR N A -like structure within die 
upstream sequence of this very active human t R N A ° u 
gene serves to enhance transcription of the gene. We there­
fore constructed a series o f recombinants in which parts of 
the upstream sequence were deleted and present below 
our initial results and tentative conclusions on the tran­
scriptional activity of some o f these.
The tR N A °lu gene, cloned as a 937 base-pair fragment 
in M13mp9 for sequence analyses, was subdoned further 
as a 489 base-pair £ c o R I—A'ael fragment in the same 
vector. There were no suitably positioned restriction sites 
to allow simple deletion o f only the tRNA-like upstream 
sequence (residues 285—3 5 5 ). However, a unique SsrI 
site (2 9 7 -3 0 2 )  in the recombinant allowed access to this 
region for sequential removal of nucleotides by partial 
digestion with Bal3l exonuclease. Subsequent cleavage by 
Srul at another unique site after nucleotide 15 1 upstream 
from the SsrI site, resulted in  deletions which contained 
a common sequence (residues 1 — 15 1)  of human genomic 
DNA before the deletion. With no hydrolysis by Stu 1, 
deletions were confined largely to the tRNA-like flanking 
sequence.
The extent o f deletion in each of the generated mutants 
was estimated from the size o f  the fragments released on 
digestion of the DNA with Smal ( <  259 base-pairs or 
<  404 base-pairs in the absence of digestion by S /u I). A 
suitable range of deletions were selected and characterized 
by sequence analysis Supercoiled replicative form RNA. 
free of contaminating host D N A . was prepared from these 
recombinants and quantified spectrophorometrically.
D NA (10  ng per oocyte) was co-injected with [ a - P ] -  
G T P (4 10 C i/n m o l;0 .5 ¿rC ip e r oocyte) into Xenopus oocyte 
nuclei ( 10  oocytes per recombinant) and incubated over­
night (Bienz &  Gurdon. 1982). Total RN A was extracted 
from the ten pooled oocytes and separated on 10 %  poly­
acrylamide gels containing 4 M-urea (Kressman et a!.. 1978). 
The newly synthesized R N A  was detected by autoradio­
graphy of the gel. The amounts of RNA transcribed from 
three different recombinants was quantified by measure­
ments of the radioactivity o f  the tRNA and pre-tRNA in 
the gel bands. These recombinants were Glu6. containing 
the intact sequence. D5 from which residues 15 2 —305 
inclusive had been deleted to remove the first arm of the 
potential tR NA -like upstream sequence, and D7 where the 
potential for the first two arms of that structure had been 
destroyed by removal of residues 1 5 2 -3 1 1  inclusive. The 
decrease in R N A  produced from 100% (Glu6) to 4 2 %  
(D S) to 19 %  (D 7) indicates that deletion of increasingly 
large portions of the tR N A -like structure in the upstream 
sequence of this human tR N A Glu gene gradually decreases 
the transcriptional activity o f that gene. Since these pre­
lim inary results support the hypothesis that transcription 
of the gene is enhanced by this unique upstream sequence, 
we are pursuing further studies on the transcriptional 
activity of a wider range o f  the characterized deletion 
mutants.
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Fast Atom Bombardment Mass Spectrometry of Salts of Substituted Methylene Bisphosphonic Acids and Other Analogues of Pyrophosphoric Acid
Hutchinsoot and Grume Semple
of Chemistry and Molecular Sciences. University of Warwick. Coventry CV47AL UK
IN TR O D U C TIO N
Analogues of pyrophosphoric acid are of 
chemotherapeutic interest as they can inhibit the re p li­
cation of viruses. 1 W hile the esters of these analogues 
can be identified and analysed by ammonia chem ical 
ionization mass spectrometry.2 the free acids, which 
are the active antiviral agents, are not sufficiently 
vo latile for analysis by this technique. Few  other 
analytical techniques, e.g. 'H  o r " P  N M R  y ie ld  m uch 
inform ation on these compounds, hence we have de­
veloped conditions for the analysis by fast atom b om ­
bardment mass spectrometry (F A B M S ) of salts of 
these acids.
Both positive and negative F A B M S  have been 
used to analyse sim ple inorganic salts' and these 
techniques have recently been shown to give good 
spectra with sim ple nucleotides.4 The latter, however, 
have the advantage that they possess m olecular 
weights in  excess of 350 and hence the spectra are 
com paratively easy to interpret as there is little inte r­
ference caused by peaks arising from the solvent m at­
rix. Inorganic pyrophosphate has a m olecular weight 
of 17 8  and hence care must be taken in  the choice of 
counterion for this acid and its analogues in  ord er to 
obtain positive F A B  spectra which contain ions of 
sufficiently high m olecular weight to avoid interference 
by intense peaks due to the matrix. W e now report 
that the potassium salts of the analogues of 
pyrophosphoric acid give very satisfactory positive 
F A B  spectra.
EXPER IM ENT A L
A ll  compounds are com m ercially available as salts 
unless otherwise stated. Ion exchange chromatography 
on Dow ex 50 resin was used to interchange the salts 
with the corresponding acids. Tetraethyld im ethyl- 
t Author to whom correspondence should be addressed.
amt no methylene bisphosphonate was obtained from  
Lancaster Synthesis L td  and was hydrolysed w ith con ­
centrated hydrochloric acid to give the free a c id  (5) 
which was recrystallized from m ethanol before 
analysis. T h e  tetraisopropyl esters of d ichk>ro-(3) and 
dibrom o-m ethylene (4) bisphosphonic acids were p re­
pared by the method of Q u im b y' and were converted 
into their free acids by hydrolysis with concentrated 
hydrochloric acid. Ca rb on yl bisphosphonic acid  (6 ) 
was prepared as described6 and the free acid  obtained 
by ion exchange using Dow ex 50 resin (H* form ).
F A B  mass spectrometric analysis of com pounds 1-8 
was carried out by m ixing an aqueous solution of the 
free acids (15  p i, 0.3  m ) with 2  m  sodium  o r potassium  
hydroxide solution (10  p i) .  T h is  m ixture w as sus­
pended in  glycerol (35 p i) ,  giving an ov erall concen­
tration of 0.0 75 m  pyrophosphate analogue in  6 0 %  
glycerol which contained four equivalents of counter­
ion. Alte rnatively F A B  mass spectra were obtained 
from solutions in  6 0 %  glycerol/water which were ap­
proxim ately 0 . 1  m  in  acid after the addition of potas­
sium  hydroxide solution to give the required p H .
The mass spectra of the salts were obtained on an 
M S  80 mass spectrometer fitted with a  standard, com ­
m ercially available, F A B  gun (Kratos A n a ly tica l In ­
struments) and data were analysed using a  D S 5 5  data 
system. T h e  prim ary argon beam energy w as 4  k e V  
with a gun current of 300 p  A  and all spectra were 
taken with the sample probe at room  tem perature 
using a resolution of 1000. T h e  mass spectra of the 
free acids were recorded on a Finnigan M od el 3300 
mass spectrometer fitted with an Ion T e c h  B I IN F  
saddle field gun, 7 and using xenon as the bom barding 
gas at 8  k e V  and 40 p  A  gun current.
RESULTS A N D  DISCUSSION
F A B  mass spectra of the free acids of com pounds 2 , 7  
and 8 were successfully obtained, the general species 
observed being [M  +  H  +  n glycerol]' (where n = 0 ,  1,
CCC-0030-493J085/0020-0143$01.50
©Wiley Heyden Ltd. 1985 ORGANIC MASS SPECTROMETRY. VOL 20. NO. 2. 1986 149
D W. HUTCHINSON AND G. SEMPLE
TaMc I. Analogue* of »organ ic pyropfcoapboric odd
(11 Pyrophoaphoric acid h4c v>, 178
bisphosphonic acid CH,(OH)C(POjHj), 206
(3) Dichloromethylene
bisphosphonic acid 
bisphosphonic acid
ajcvoju, C H / W » 244. 246. 248
Br,C(POjHjlj C H A /V . 332. 334. 336
(S) Dimethylaminomethylene
bisphosphonic acid (CHj)7NCH(POjH,I, 219
(61 Carbonyl bisphosphonic
acid OC(PO,H,)j C H A P , 190
(7) Phosphonoacottc acid HOOCCHyPOjHj CjHjOjP 140
(•) 3-Phosphonopropionic acid HOOC(CH2),PO,H, 154
2 , 3). D ue to the low  m olecular weights of these acids 
(Table 1) these p eaks appear in the region of the mass 
spectrum w hich is  dom inated by abundant ions due to 
the glycerol m atrix. T h e  intensities of the peaks due to 
the oligomers [(g ly ce ro l),H ]' become less with in ­
creasing x which suggested the use of m etal ion salts 
to produce peaks above m /z 300. In  general we have 
found that w hile sod ium  salts of the pyrophosphoric 
acid analogues do not produce ions with a sufficiently 
high mass (T ab le  2). the potassium salts give good 
F A B  mass spectra o f the analogues (F ig . 1 ,  T a b le  3). 
In  the tables the intensities of the most abundant 
sample ion has been taken to be 1 0 0 % .  In  a ll cases the 
peaks due to the m etal salts of the pyrophosphoric 
acid analogues accounted for 0 . 5 - 3 %  of the total ion 
current ( T IC ) . A s  can be seen from T a b le s  2  and 3  a 
series of ions separated by ( Y - l ) u  is  observed in 
each spectrum (where Y  =  atomic mass of the counter­
ion). T h e  series corresponds to the successive replace­
ment of a proton in  the protonated free acids by a 
counterion. T h e  intensities of the peaks due to the 
salts do not necessarily correspond to the com position 
of the salt in  the so lid  phase as free exchange between 
the acids and the counterions occurs on the probe. In 
a ll cases g lycerol adducts of ions due to the 
pyrophosphoric acid  analogues were observed, e.g. 
[M  +  H  +  Na„ +  glycerol]*, but these were m uch less 
abundant than the series listed in T ab le s 2  and 3. In 
the case of carbonyl bisphosphonic acid (6 ) a  second 
series of peaks can be observed in  the F A B  mass 
spectrum 18  u  h ig h er than those due to 6  (F ig . 2). T h is  
is due to hydration o f the carbonyl group in  6  which 
has been postulated b y Q u im b y .6 In o u r experim ents, 
the relative concentration of the two species are ap­
proxim ately equal below  p H  6 . U nder m ore a lkalin e 
conditions the carb on yl compound (6 ) predom inates. 
W e have replaced glyoerol by triethanolam ine o r  trigol 
in  some experim ents but there was no effect on the 
intensities of the p eaks due to the analogues. A s  both 
these compounds are of higher m olecular weight than 
glycerol, their o ligom ers cause greater inference with 
the peaks due to the salts of the analogues of 
pyrophosphoric ac id  and hence we do not consider 
that they offer any advantage over g lycerol. W e  have 
also observed negative F A B  spectra for the sodium  
salt of pyrophosphoric acid (1 ), where ions were ob ­
served at 2 6 5 . 2 4 3  and 2 2 1  u corresponding to the 
ions [M  -  H „ +  N a ,  in  —3, 4, 5). H ow eve r, these
ions on ly  carried 0 . 0 1 %  of the T I C  and were difficult 
to reproduce. T h u s, we advocate the use of positive 
F A B  mass spectrometry for the analysis of analogues 
of pyrophosphoric acid.
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Abstract
Analogues of inorganic pyrophosphate can inhibit the DNA polymerase of 
herpes simplex virus I. or the RNA transcriptase activity of influenza virus 
A Structural features of the pyrophosphate analogues which are essential 
for their inhibitory activity are discussed and these are related to the ability 
o f the analogues to bind zinc ion.
Introduction
A  number o f nucleoside analogues such as acyclovir (1J and 
(E>-5-brom ovinyl-2'-deoxyuridine ( B V D U )  [2] have recently 
been shown to possess antiviral activity and much effort has 
been spent recently on the synthesis o f nucleoside analogues 
which might have better therapeutic properties than these two 
compounds. Both acyclovir and B V D U  inhibit the synthesis 
o f D N A  in  herpes-infected cells. In it ia lly  these two compounds 
are phosphorylated by virus-induced enzymes to give their 
5 -monophosphates; these are then converted into the 5'- 
triphosphates which inhibit D N A  synthesis in  the virus- 
infected cells. Thus, the analogues must be metabolized before 
they can exhibit their antiviral properties and they are only 
active against a narrow range of viruses o f the herpes family.
Compounds which inhibit nucleic acid synthesis in virus- 
infected cells without the necessity o f  a  metabolic step might 
be expected to be active against a wider range of viruses than 
acyclovir or B V D U  and might have clin ical value so long as 
toxicity problemscan be overcome. One such class of inhibitors 
are analogues o f inorganic pyrophosphate which can inhibit 
the reaction
p p p X = ± (p X )n +  pp,
Phosphonoacetic acid ( I )  [3] was the first member of this 
fam ily to be shown to possess antiviral activity and the related 
compound phosphonoformic acid (2) [4] is also an active 
antiviral agent. Both ( I )  and (2) inhibit D N A  synthesis in cells 
which have been infected by herpes viruses and these 
compounds inhibit the D N A  polymerases induced by these 
viruses.
<H0),P(0)C00H (H0),P(0)CHtC00Me MeCXHCXPtOiCH.COOH
(2) (3) (4)
(H0),P(0)CHtCHlC00H (HO.PtOCR1 R*P(OXOH)t 
(5) (4)
The antiviral properties o f a  number of analogues o f ( 1)  and 
(2 ) have been examined and it has been observed that 
esterification o f either the phosphoryl or the carboxyl groups 
to give, for example, (3) or (4) leads to a marked reduction 
in  the antiviral activity [5]. Moreover, insertion o f extra 
methylene groups between the phosphoryl and carboxyl 
groups as in  (5) also reduces the antiviral activity. Enzyme 
kinetic [6] and other data [7] indicate that these compounds 
inhibit the herpes-induced D N A  polymerases by acting di­
rectly on the enzymes without prior conversion into an active 
compound and that ( I )  and (2 ) probably act by chelating with 
an essential metal ion in  the D N A  polymerases induced by 
herpes viruses. Pyrophosphate analogues can also be effective 
inhibitors o f the R N A  transcriptase activity o f influenza virus 
A . Initiation o f m R N A  synthesis does take place in the 
presence o f phosphonoformate (2) but elongation of the R N A  
chain does not occur [8].
W e have studied a variety of pyrophosphate analogues and 
believe that their a b ility  to inhibit nucleic acid synthesis in 
cells which have been infected with either herpes or influenza 
viruses is related to their a b ility  to form stable chelates with 
a  metal ion (probably zinc) at the active centres of the enzyme 
systems [9]. W e have shown that there is a good relationship 
between the ability  o f the analogue to bind zinc ion at p H  8 
and its effectiveness as an inhibitor of influenza m R N A  
synthesis [7], W e determine the binding constant of the 
analogue to zinc ion by a  simple gel-filtration method at the 
p H  optimum o f the transcriptase reaction and from this derive 
the term p K d , which we define as — log ,0 (dissociation 
constant of zinc ion — pyrophosphate analogue complex). The 
ionic species o f the analogue which binds to the zinc ion is 
not defined in our term pKa as this merely refers to the ability 
o f all ionic species present to bind zinc ion under given 
conditions, i.e. the conditions of the transcriptase assay. We 
find that i f  a  pyrophosphate analogue has a pKa >  6 under 
these conditions then the compound is a  good inhibitor of the 
transcriptase, on the other hand compounds with a pK^ <  5 
are, in general, poor inhibitors of the transcriptase (Table I).
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Fig. I Phosphonoacetic acid (1).
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T a b ic  I. Inhibitory effect o f  phosphonoacelic acid analogues 
and methylene bisphosphonates on the R N A  transcriptase o f  
influenza virus A and calf-thymus D N A  polymerase a  [7]
Compound*
PA.
<Za**>
Coocn. (ptt) 
producing 50*.
Influenza RNA 
transcriptase
DNA
polymerase a
RCH.COOH s.s 275 45
RCOOH 56 35 35
RCH.CH.COOH <4 >500 >500
Rl HMcCOOH -5 500 >500
RCONH, <4 >500 >500
(Et0»,P»0>CH,C00H <4 >500 >500
ROR S.7 125 >500
RNHR 5.7 50 >500
RCH.R 5.J >500 >500
RCHC1R >6 85 >500
RCCl.R >6 75 >500
RCBr.R >6 10 350
RCOR 5.4 20 100
• Where R = (HO),P(Ol
The exact nature of the metal ion at the active centre of the 
transcriptase system has not been determined unequivocally. 
Addition o f excess magnesium or manganese ion to the 
transcriptase assay system fails to affect R N A  synthesis and 
hence it is unlikely that these are the essential metal ions. It 
has been proposed [10] that most polymerase enzymes require 
zinc for activity and it has been shown that the influenza 
viruses do contain zinc [ I I] ,  Addition o f zinc ions to the 
transcriptase assay, which has been partially  inhibited by a 
pyrophosphate analogue, restores the enzymic activity to a 
limited extent. However, zinc ion is toxic to the enzyme at high 
concentrations [ 1 2 ] and when excess zinc ion is added to the 
system fu ll enzymic activity is not restored.
The results of our studies on pyrophosphate analogues can 
best be summarized by considering phosphonoacetic acid as 
the archetype pyrophosphate analogue and considering in 
turn the changes in  biological activity which are brought 
about by varying the carboxyl, methylene and phosphoryl 
groups.
(a ) Variation o f  the carboxyl group
A s mentioned earlier, esterification o f the carboxyl group in 
(1 ) leads to a  loss of an tivira l activity in cell-free systems and 
a sim ilar loss in activity is observed when the carboxyl group 
is replaced by an amide group. In animals, however, some 
carboxylic esters do have anti-herpes activity, presumably 
because these esters are hydrolysed in vivo to liberate the free 
acid [5]. Replacement o f the carboxyl group by a phosphoryl 
group gives rise to methylene bisphosphonic acid (6 , 
R 1 =  R* =  H ). W hile the parent compound is devoid of 
antiviral activity, as w ill be discussed later, replacement of 
hydrogen by an electron withdrawing group leads to com ­
pounds (e.g. 6 , R 1 =  R 2 =  C l) , which are good inhibitors of 
the R N A  transcriptase o f influenza virus but which have little 
o r no anti-herpes activity.
Analogues of am ino acids in which the carboxylic acid 
residue has been replaced by a IH-tetrazole residue have pKm 
values which are close to those o f the parent am ino acids and
Fig. 2. Heterocyclic analogues of phosphonoacetic acid.
the tetrazole moiety has been used as an isostere for the 
carboxylic acid group in  m any pharmaceutically active com ­
pounds [13], The recent report that 3-phosphonomethyl 
tetrazole (7) has anti-herpes activity [14] prompted us to 
synthesize a range o f heterocyclic analogues o f phosphono­
acetic acid [15]. Treatm ent o f 5-(chlorom ethyl)-IH-tetrazole 
with triethyl phosphite gave the diethyl ester o f A'-ethyl- 
5-(phosphonomethyl)-tetrazole, presumably due to intramole­
cular attack by the tetrazolc ring on the intermediate formed 
in  the Arbusov reaction. T h e  esterifying groups o f the phos- 
phonic acid residue c ould  be removed by acid  but iV-ethyl- 
5-(phosphonomethyl)-tetrazole (10) was a  very poor chelator 
o f zinc ion and had no effect on the transcriptase o f influenza 
virus. The ethyl group could  not readily be removed from the 
tetrazole ring in this synthetic route, so we protected this ring 
with the benzyloxymethyl group before the A rb u so v reaction. 
The diethyl groups and the benzyloxymethyl residue were 
readily removed from the Arbusov product with acid and 
5-(phosphonom ethyl)-1H-tetrazole (7) was obtained in high 
yield. The 5-(phosphonoethyl) analogue (9) was obtained in 
a sim ilar fashion. It  is  interesting that the Arbusov reac­
tion between 3-<chlorom ethyl)-1H-1,2,4-triazole proceeded 
smoothly without any intram olecular a lkylatio n o f the tri- 
azole ring. The bistetrazolc (12) and the carboxylic acid (11) 
were prepared by standard methods.
W e find that com pound (7) and its triazole analogue (8) are 
weak inhibitors o f the D N A  polymerase induced by H S V -1 .  
The 5-phosphonoethyl tetrazole (9) and the A'-alkylated 
analogue (1 0 ) show no inhib itory activity against this enzyme. 
O f  the four com pounds, only (7) has significant inhibitory 
activity against the R N A  transcriptase o f influenza. The 
carboxylic acid (1 1 ) and the bistetrazole (1 2 ) do not inhibit 
either the D N A  polymerase o f H S V -I  or influenza R N A  
transcriptase. O nly com pound (7) binds zinc to an appreciable 
extent ( p — 5.6) and hence this parameter again is a 
pointer to the antiviral activ ity  of these com pounds (Table II).
(b ) Variation o f  the methylene group
The homologue o f phosphonoacetic acid without a methylene 
group is phosphonoformic acid (2 ), a com pound which is in 
general a more active an tiv ira l agent than (1). The homologue 
o f ( 1)  with two methylene groups is 3-phosphonopropionic 
acid (3) a compound w ith little antiviral activity. The effective­
ness of these compounds as inhibitors ofinfluenza transcriptase 
is again reflected by their a b ility  to bind zinc ion (Table I). 
One reason for the g radation in pKa values is that compound 
(2 ) forms a chelate w ith a five-membered ring, ( I )  forms a 
chelate with a six-mem be red ring and (3) forms a chelate with
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Table II. Inhibitory effect o f  pyrophosphate analogues and heterocyclic methylene phosphonates on the RN A  transcriptase o f  
influenza virus A  and the D N  A polymerase o f  HSV-1
P*a
(Zn**)
Conen (¿im) 
producing 50°,
Influenza A 
RNA
transcriptase
„ inhibition
HSV-I
DNA
Helerocyclic analogue*
5-<Pho*phonomelhyl -tetrazole (7) 5.6 275 220
3-<Phosphonomelhy 1 )-1,2.4-tnazole (8) 4.7 580 385
S-<PhosphonoethylMetrazole (9) 4.6 550 > 1000
.V-ethy 1- S-<phosphonomethy 1 »-leirazóle ( 10) <4 >1000 870
Tetrazole 5-ethanoic acid (II) <4 > 1000 > 1000
5.5 -Methylene bivtetrazole (12) <4 >1000 > 1000
Other*
Monothiopyrophosphate (14) 5.4 60 >500
Bisthiopvrophosphatc (15) >6 33 >500
H vpophosphale (16) S.l >500 ISO
Peroxydiphosphonate (17) 4.8 -500 n.d.
Arsonoacetate (18) 4.7 > 500 n.d.
Methylenebi*ar*enate ( 19) -5 >500 n.d.
n.d.. No* determined
(•) (bJ (c)
Fig y  Metal chelate* of (a) phosphonoformic. (*) phosphonoacetic and <r> 
.t-phosphonopropionic acid*
a seven-membered ring. It is well known that the order of 
stability o f cyc lic  metal chelates is 5 >  6  >  7 [16]. Substitution 
of the methylene group with an alkyl or aryl group can lead 
to a  loss o f activity as a transcriptase inhibitor in cell-free 
systems. However, an increase in activity can be observed in 
tissue culture, probably because these compounds arc more 
lipop hilic than the parent and are taken up more readily by 
cells [17]. Replacement o f the two hydrogen atoms o f the 
methylene group in  ( I)  by two chlorine atoms has a marked 
effect on the properties of the carboxyl group. The ability of 
dichlorophosphonoacetic acid  to bind zinc ion is low 
(pK a <  4) and the compound does not inhibit the R N A  
transcriptase o f influenza virus.
A s  mentioned above, methylene bisphosphonate (6 . 
R 1 =  R* =  H )  has little or no antiviral activity. Replacement 
of the bridge hydrogen atoms in (6 ) by electron withdrawing 
groups such as halogen increases the ability  of these com ­
pounds to bind zinc ion and markedly increases their antiviral 
activity [7]. Replacement of the bridging methylene group by 
a carbonyl group (13) also leads to a good chelator o f metal 
ions with both anti-herpes [18] and anti-influenza activity [7]. 
The presence o f at least one electron withdrawing group on 
the bridging carbon atom in  (6 ) and the observation that 
lipophilic pyrophosphate analogues are often more effective 
as inhibitors o f v ira l replication in tissue culture than the polar 
parent com pounds has led us to prepare [19] a number of 
C -a lk y l monochloromethylene bisphosphonates. As m ay be 
seen in  Tab le  I I I .  these compounds are inhibitors of the R N A  
transcriptase o f influenza virus A  in  cell-free systems 
are inhibitors o f viral replication in  M D C K  cells.
Table I I I .  Inhibitory effect o f  C -a lky l monochloromethylene 
bisphosphonates R C C I(P O ,H t ) t on the RNA transcriptase o f  
influenza virus A and on the replication o f  influenza virus A in 
M D C K  cells
R
pK,
/ «.(% > PR*.<%>
H >6 97 22
Me n.d 54 n.d.
Et n.d. 61 n.d.
n-Pr n.d. 55 34
fi-Bu >6 64 37
>6 59 83
CH,Ph >6 58 60
PAA( 1 ) 5.5 35
n.d.. N ol determined
lM  _  *o inhibition of transcriptase at phosphonate concentration of 
2S0/iM.
P R ^  =  °„ reduction of PFU (virus control =  7.7 x 10*) caused by phos­
phate at a concentration of 500 fiu.
W hile the a b ility  o f these com pounds to inhibit the transcrip­
tase appears to be independent o f  chain length, the hexyl- and 
benzyl-substituted bisphosphonates are the most effective 
inhibitors o f  v ira l replication in  cell culture. A ll  are more 
effective than phosphonoacetic acid in both inhibitory 
systems.
(c) Variation in the phosphoryl group
Inorganic pyrophosphate at a sufficiently high concentration 
will in h ib it  R N A  synthesis by the influenza transcriptase 
system (T a b le  I) [7]. Replacement o f one or both phosphoryl 
groups b y a thiophosphoryl group leads to m ono- (14) and 
bis- ( 15 )  thiopyrophosphate. Both these com pounds are 
considerably more effective than the parent pyrophosphate in 
inh ib it in g  the replication o f influenza virus A  in  M D C K  cells 
and the synthesis o f R N A  by the transcriptase system [20]. 
Sulp hur is  a  ‘ soft ' centre and oxygen is a * hard ' centre on the
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Table IV. Effects o f  pyrophosphate analogues on  either the 
haemagglutinin litre or the virus yield reduction assay o f  
influenza virus A grown on M D C K  cells (mean o f  two 
assays) [20]
HAU
Compound (log,, U/ml) pfu/ml
Cell control <2.0 «10
Vini» control J.65 4.77 * 10’
14 2.64 I.OSxlO*
15 2.10 4.2x10*
Pearson ‘ hard and soft' acid and base scale [9]. Both (14) and 
(15) are good chelators of zinc ion and it is possible that the 
increased antiviral activity shown by the thiopyrophosphates 
is related to the formation of stronger metal chelates 
in the transcriptase system of influenza virus than with 
pyrophosphate.
Removal of the oxygen between the phosphoryl groups of 
pyrophosphate gives rise to hypophosphale (16). While this 
has been shown to be an inhibitor of the D N A polymerase 
of herpes-infected cells [18]. we have shown it to have little 
or no effect on the transcriptase of influenza virus. Similarly, 
peroxydiphosphonate (17) is inactive against the transcriptase 
and the inactivity of (16) and (17) can be correlated with the 
abilities of these compounds to bind zinc ions (Table II). In 
these latter two compounds, the change in distance between 
the two chelating phosphoryl groups may also be important
Replacement of the phosphoryl group in (1) by the arsonate 
group to give arsonacetate (18) leads to a compound with 
anti-herpes activity [21 ] and with some anti-influenza activity. 
Methylene bisarsonate (19) also shows little antiviral activity. 
Furthermore, toxicity problems associated with these arsen- 
icals and with hypophosphate make them unattractive for 
clinical use.
(HOl.nOfl.'OPlOKOH », fIs55X (HO),P<S)OP(SMOH)t
(13) (14) (IS)
(HO),P(OlP(OxOH), (HO),P(0)OOP(OMOH), H,0,AsCH,COOH
(16) (17) (IS)
CH,(AsO,H,l,
(1*)
Discussion
We believe that the evidence presented above strongly supports 
the suggestion that nucleic acid synthesis in cells which have 
been infected by either herpes or influenza viruses can be 
inhibited by pyrophosphate analogues which act by forming 
very stable chelates with an essential metal ion in the 
polymerase/transcriptase enzyme systems induced by the 
viruses. Before pyrophosphate analogues are adopted for 
clinical use. however, there are obvious toxicity problems to 
be overcome as many processes in the host cells involve the 
liberation of pyrophosphate and these may be affected by the 
presence of pyrophosphate analogues. One such problem is 
the accumulation of certain pyrophosphate analogues in 
bones and teeth [22]. This problem may be obviated by using 
these compounds topically to treat, for example, herpes 
infections. Another way in which this accumulation in bone 
might be overcome is to incorporate bulky groups into the
analogues as this should make them less compatible with the 
hydroxy apatite lattice of bones [23] and hence make them less 
likely to be incorporated into this lattice.
It isencouraging that many of the pyrophosphate analogues 
which inhibit virus-induced processes do not seem to be highly 
toxic to cells. For example, the thiopyrophosphates (14) and 
(15) inhibit the replication of influenza A virus in MDCK cells 
at concentrations which do not appear to affect the viability 
of the cells after 48 h [20]. Furthermore, substituted methylene 
bisphosphonalcs inhibit the transcriptase of influenza virus A 
at concentrations at which they have little or no effect on the 
DNA polymerases of HSV-I or -2, the DNA polymerase a 
[17] of mammalian cells (Table I) and the DNA and RNA 
polymerases of Escherichia co li [7].
Recently, the effect has been studied of a large number of 
derivatives of phosphonoacetic acid on the D N A polymerase 
induced by HSV-2 and on the replication of HSV-2 in tissue 
culture [24]. The results of these investigations broadly agree 
with those outlined above except that it was observed that 
carboxylic esters of low-molecular-weight alcohols inhibited 
the D N A polymerase. This result is in contrast with obser­
vations with HSV-1 [25] and our observations with the RNA 
transcriptase of influenza. The reason for this difference is not 
dear and deserves further investigation.
The hypothesis that pyrophosphate analogues inhibit virus 
replication by virtue of their chelating with an essential metal 
ion should lead to the design of compounds with significant 
biological activity but which incorporate features which 
reduce their toxicity or which lead to an increase in the uptake 
of the analogue into a particular region of the host.
Experimental
Materials
Arsonoacetate and methylene bisarsonate were gifts from Dr 
H. B. F. Dixon. Cambridge University. UK. hypophosphate 
was a gift from Dr B. V. L. Potter. Leicester University. UK, 
and peroxydiphosphonate was a gift from Professor 
N. J. Leonard, Univerity of Illinois at Urbana-Champaign, 
USA. C-Alkyl monochloromethylene bisphosphonates [19] 
and heterocyclic methylene monophosphonates [15] were 
prepared as described.
Biological assays
The influenza virus strain used in these experiments was 
A/X49, a cross between A/England/864/75 and A/PR/8/34 
with the H3N2 surface antigens of the A/England strain. 
RNA transcriptase assays and the determination of the 
antiviral activity of compounds in Madin Darby Canine 
Kidney (M D CK) cells were carried out as previously described 
[20]. The herpes-simplex-1 virus strain used was KOS. The 
inhibition by pyrophosphate analogues of the DNA poly­
merase induced by this virus was carried by the method of 
Powell and Purifroy [26] and the DNA polymerase a assays 
were carried out by the method of Sabourin et at. [27]. The 
determination of pK& values related to the strength of the 
binding of zinc ion to the pyrophosphate analogues was 
determined by a gel-filtration method [7],
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>S Y N T H E S IS  A N D  B IO C H E M IC A L  P R O P E R TIE S  O F  S O M E  P Y R O P H O S P H A T E  
A N A L O G U E S
O . W . H U T C H IN S O N . G .  S E M P L E  A N D  D . M . T H O R N T O N
D e partm ent of C h e m is try . U n iv ersity  of W a rw ick. C o v en try . C V 4  7 A L . U .  K.
S U M M A R Y
A n a 'o g u e s  of In o rg a n ic  pyro ph osphate  have been p re p a r e d  by the 
m odification of tetraesters  of m ethylene b ls p h o s p h o nlc  a c id  o r  by the
M fc h a e lls -B e c k e r re a c tio n . T h e  yields of pro du cts  obtained by a lk ylatio n  of the 
m ono anio ns of tetraesters  of m ethylene b ls p h o s p h o nlc  acid  d e p e n d s  both on the 
size  of the esterlfying g ro u p s  and o n  the co u n ter Ion u s e d . T h e  antiviral 
pro perties  of the p yro ph o s p h a te  an alo g u e s  appe a rs  to d e pe n d  o n  th eir m etal 
chelating  pro perties and  th is c a n  be altered by the introduction of a  th lo ph o s ph o ry l 
g ro u p  Into the a n a lo g u e s . T h e  th lo ph osph oryl derivatives a re  m o re  effectlvo
Inhibitors of viral n u cle ic  a c id  synthesis than their oxygenated p a re n ts .
IN T R O D U C T IO N
A n a lo g u e s  of In o rg a n ic  pyro ph osphate  have interesting  p ro p e rtie s  as 
p yro ph osphate  is Involved In m any b io ch e m ica l p ro ces s e s. T h u s ,  p yro ph o s p h a te  
a n alog ues ca n  ( a )  Inhibit th e  rep licatio n  of v iruses Cref. 1 ) .  C b) h a v e  an tlam o e bic 
activity Cref. 2 ) .  <c> h ave  h e rb ic ld a l activity Cref. 3 ) and C d) b e  b o n e -s e e k in g  
c o m po u n d s  Cref. 4 ) .  W e have been  Interested In the a n tiv ira l activity of 
p yro ph osphate  analo g u e s  as It should be possible  to Inhibit n u c le ic  a c id  synthesis  
In ce lls  w h ich  have b e en  infected  by v iruse s w hen th ey m ight In h ib it the follow ing 
pro ces s :
ppX * ------- ♦ < p X )n ♦ PP,
To xicity p ro ble m s  m u st o b v io u s ly  be o v e rco m e  as the h o st c e lls  are  also 
synthesising n u cle ic  a c id s . H o w e v e r, the m e ch a n is m  of n u c le ic  a c id  synthesis 
by v lra lly -ln d u c e d  e n zym e s  c a n  differ from  those of the host C ref. 5 )  a n d  In these 
c a s es  the p yro ph osphate  a n a lo g u e s  m ig h t have s o m e  th erapeu tic  v a lu e  o r  m ight be 
used as pro be s  to u nravel s o m e  of the stages In viral n u c le ic  a c id  s ynthesis . 
P h o sp h o n o a ce tlc  acid  P A A  (11 was the first p yro ph osphate  a n a lo g u e  to  b e  show n to 
possess antiviral p ro pe rties  Cref. 6 ) .  and  both P A A  a n d  the related
pho s p h o no fo rm ic a c id  P F A  (21 (r e f .  7 ) Inhibit the rep licatio n  of s e v e r a l v iruses by
a,
inhibiting n u cle ic  acid  s y n th e s is  (r e t .  8 ) .  It is e n co u ra g in g  that neither P A A  nor 
P F A  a p p e a r to be p a rticu la rly  toxic to host c e lls . Th e  antiviral activity ot a n u m be r 
of a n a lo g u e s  ol c o m p o u n d s  (11 and (21 h a v e  been exam ined and  som e s tru c tu re -
function re lationships e m e rg e  (r e t .  1 ) .  W h ile  there is s o m e  co ntro versy o v e r the 
effect of esterifying the ca rb o xylic  acid re s idu e s  on the antiviral activity of these 
c o m p o u n d s . It a p ea rs  that the antiviral activity is greatly  re d u ce d  w hen the 
p h o s p h o ryl hydroxyl g ro u p s  a re  esterified ( r e f .  9 ) .  Th e re  h as been one  report 
that s im p le  carboxyl e sters  of P A A  do have s o m e  Inhibitory activity against the O N A  
p o lym e ra se  of H S V -2  (r e f .  1 0 ) .  It m a y b e  that In this c a s e  som e hydro lysis  of 
the e ste rs  o c c u rs  to re le a s e  the free a c id .
W e  have been  s tu d yin g  the effects of pyro ph osphate  a n a lo g u e s  both o n  the 
R N A  tra ns crip ta s e  activity of Influenza v iru s  A  and o n  the re p lica tio n  of this v iru s  In 
M O C K  c e lls .  W hen we ha ve  found in h ib ito ry  activity, we ha ve  also  studied th eir 
effects of the O N A  p o ly m e ra s e  of H S V -1  and on  O N A  p o ly m e ra s e -a  from  
m a m m a lia n  c e lls . W e c h o s e  to study the R N A  transcriptase  of influenza v irus  A  on 
a c c o u n t of the rather u n u s u al m e ch a n is m  of R N A  synthesis s how n by this system . 
T h r e e  d is tin c t steps a re  th o u g h t to o c c u r , ( a )  a v iru s -c o d e d  e n d o n u cle a se  clea ves  
ce llu la r m R N A  at a site 1 0 -1 3  nu cle o tide s  from  the caped 5 * -e n d . ( b )  a G M P  
re sidu e  is in co rp o ra te d  at th e  3 '-e n d  of th e  o ligonu cleo tide  fra g m e n t. (c >  this now  
b inds to th e  viral R N A  a n d  elo ngation  takes place  (r e f .  1 1 ) .  S in c e  o u r w ork
b e g a n , it h as been s h o w n  th at P F A  in te rfe res  with this final e lo ngation  step after 
the In c o rp o ra tio n  of an  ad d itio n a l 10 o r 12 nu cle o tide s  (r e f .  1 2 ) .
W e  have stu died  a variety  of pyro ph o s p h a te  a n a lo g u e s  and believe that 
th eir a b ility  to Inhibit n u c le ic  a c id  synthesis  in  ce lls  w hich ha ve  been infected with 
e ith e r h e rp e s  or influ enza  v iru s e s  is re lated  to th eir ability to form  stable ch elates 
with a  m e ta l Ion (p r o b a b ly  z in c )  at the a ctiv e  ce n tre s  of the e n zym e  s yste m s. We 
have s h o w n  that there is a g o o d  re lationship  betw een the ability  of the a n a lo g u e  to 
b ind z in c  Ion at pH 8 a n d  its effectiveness as an Inhib itor of Influenza m R N A  
syn th e s is  ( r e f .  1 3 ).  W e  d e te rm in e  the b ind in g  co nstant of the a n alog ue  to zin c  
Ion by a  sim ple g e l-f lltra tlo n  m ethod at the p H  optim um  of the transcriptase  
re a ctio n  a n d  from  this d e rive  the te rm  pKd - .  w hich  w e  define as - l o g i g  
(d is s o c ia t io n  co nstant of z in c  Io n -p y ro p h o s p h a te  a n alo g u e  c o m p le x ).  T h e  Ionic  
s pe cie s  of the a n alo g u e  w h ic h  b ind s  to the z in c  Ion Is not de fin ed  In o u r term  p K ^. 
as this m e re ly  refers to the ability of a ll Io n ic  s pe cie s  p re s e n t to b ind zin c  Ion 
u n d e r g iv e n  c o nd itio n s. I . e .  the co nd itio n s  of the tra ns crip ta s e  ass a y. W e find 
that If a pyro ph o sp h a te  a n a lo g u e  has a pK d . > 6 u n de r th ese  co nditio ns th en the
( H O ) 2 P ( 0 )  C H 2C O O H ( H 0 ) 2 P ( 0 ) C 0 0 H
P A A  (11 P F A  (21
co m po u n d  is a g o o d  inhibitor ot the tra n s c rip ta s e , on  the other hand c o m p o u n d s  
with a pKd - < 5 a re . In g e n e ra l, poor inh ib ito rs  ot the tra ns crip ta s e  (T a b le  1 ) .
T h e  exact n a tu re  ot the m etal Ion  at the active  c e n tre  ot the tra ns crip ta s e  
system  h as not b e en  d e te rm in e d  u n eq u ivo ca lly . A dditio n  of excess m a g n e s iu m  o r 
m a n g a n e s e (ll)  iion  to the tra ns crip ta s e  a ss a y system  fails to affect R N A  s ynthesis  
and h e n c e  it is u n like ly  that these a re  the essentia l m eta l ions. It h as been  
pro po sed ( r e f .  14) that m o s t p o lym e ra se  e nzym es re q u ire  zin c  for activity and  it 
has been  s h o w n  that the influ enza  v iru s e s  d o  co nta in  z in c  ( r e f .  1 5 ).  A d d itio n  of 
zin c io n s  to the tra n s c rip ta s e  a s s a y , w hich  has b e en  partia lly inhibited  by a 
p yro ph osphate  a n a lo g u e , res to re s  the e n zy m ic  activity to a lim ited extent. H o w e v e r, 
z in c  ion is toxic to the e n zym e  at h igh  co n ce n tra tio n s  (r e f .  16) and w hen excess 
zin c  ion is a d d ed  to th e  system  full e n zy m ic  activity is not re s to re d .
W e ha ve  p re p a re d  and  studied a large  n u m b e r of pyro ph o sp h a te  a n a lo g u e s  
as inhibitors  of vira l re p lica tio n  and s o m e  of o u r re c e n t w ork  is outlined belo w .
D IS C U S S IO N
C -A lk v l h a lo o e n o m e th vl b ls p h o s o h o n ic  a c id s  [31. W e h ave  been in te re s te d  in 
these c o m p o u n d s  fo r a n u m b e r of re a s o n s , ( a )  co u ld  a ctive  antiviral c o m p o u n d s  
be p .e p a re d  w h ich  d o  not b ind  to b o n e ? , ( b )  co u ld  the ra n g e  of v iru s e s  inhibited  
by p yro ph o s p h a te  a n a lo g u e s  be e x te n d e d ? , ( c )  co u ld  an  affinity p ro be  d is c o v e r 
w hich  of the p ro te in s  of the influ enza  v iru s  b inds the a n a lo g u e ?
( H 0 ) 2P ( 0 ) C X R P ( 0 > ( O H )  2 
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In T a b le  1 . it m ay be s een  th at m o n o c h lo ro m e th y le n e  b ls p h o s p h o n ic  a c id  
(p K d - » 6 )  is a n  a ctive  in h ib ito r of the R N A  tra ns crip ta s e  of influ enza  v iru s  A  w hile  
the pa re n t m e th yle n e  b is p h o s p h o n ic  a c id  (p K d . 5 . 3 )  is n o t. T h u s , the p re s e n c e  
of at least o n e  e le c tro n -w ith d ra w in g  g ro u p  on the c e n tra l c a rb o n  atom  a p p e a rs  to 
be re q u ire d  b efore  th e  c o m p o u n d s  s h o w  inhibitory  activity a g a ins t th is e n zym e  
system . In an a ttem p t to p re p are  c o m p o u n d s  w h ich  w ould still inhibit the 
tra ns crip ta s e  but w h ic h  m ig h t not b ind to b o n e , we ha ve  p re p a re d  C -a lk y la te d  
m o n o c h lo ro m e th y le n e  b ls p h o s p h o nic  a c id s  as we w ished  to Investigate w h e th e r a 
bulky s u bstituent o n  th e  c e n tra l c a rb o n  atom  m ight h in d e r the b ind in g  of the 
a n alo g u e  to the h ydro xyapatite  lattice of b o n e .
T e tra e s te rs  of m o n o b ro m o - and  m o n o c h lo ro - m e th yle n e  b ls p h o s p h o n ic  a c id  
are  diffficult to p re p a re  by d ire ct c h lo rin a tio n  of m e th yle n e  b ls p h o s p h o n ic  a c id  
esters as m ixtu res of p ro d u c ts  a re  o b ta in e d  and the m o n o c h lo ro  c o m p o u n d s  Is o n ly  
form ed In low y ie ld . W e have found that the m ost efficient ro ute  to te tra e sters  of 
m o n o h a lo g e n o m e th y le n e  b isp h o s p h o n ic  ac ids  Is to p re p a re  the
d ih a lo g e n o -c o m p o u n d  and  then to rem o ve  o n e  of the h a lo gens with the aid of an 
a lk y l-lith lu m  (r e f .  17. 1 8 ).  In this w a y . tetraisopropyl m o n o c h lo ro - and
m o n o b ro m o -m e th y le n e  b ls p h o s p h o na tes  have b e en  pre p are d  in h igh  yie ld . W hile 
this m etho d  is not a p plicab le  for the d e -flu o rln a tlo n  of dlfluorom ethylene 
b isp h o sp h o n lc  acid  esters as C - P  bond c le a v a g e  o c c u rs  re a d ily  with these 
co m p o u n d s  in  the p re s e n c e  of n u c le o p h ile s . W hen we attem pted to p repare  
tetraesters of b ro m o flu o ro m e th yle n e  b is p h o s p h o n ic  acid  th ese  w ere  d e -b ro m ln a te d  
in situ . T h is  is . th erefo re , a  sim p le  ro ute  to m ono flu o ro bis p h o s p h o n a tes  w hich 
avo ids the u se  of v ig o ro u s  re a g e n ts  s u c h  as p e rc h lo ry l fluo ride .
Alkylation of te tra iso propyl m o n o ch lo ro m e th yle ne b is ph o s ph ate s  with sodium  
o r lithium  as the co u n te rio n  p ro c e e d e d  in o n ly  m oderate  yie ld s . H o w ev e r, when 
the th a llio -d e riv a tive  w as p re p a re d  by a d d itio n  of th a lliu m (l) ethoxlde to the 
tetra iso propyl e s te r, v irtually quantitative y ie ld s  of alkylated p ro du cts  co u ld  be 
obta ined  with p rim a ry  alkyl iod ides a lthou gh y ie ld s  w ere  lo w er with s e c o n d a ry  alkyl 
io d id e s. In te re s tin g ly , the s ize  of the esterifying  g ro u p s  on ph o s p h o ru s  has a 
m arked effect on the yie lds  of p ro du cts  ( r e f .  1 8 ).  W h e n  the tetraethyl o r 
tetram ethyl esters w e re  used in this alkylation re a c tio n , lo w  yie ld s  (<  2 0 % ) w ere 
obtained with a  ra n g e  of p rim a ry  alkyl Io d id e s. F u rth e rm o re . ®*P n . m . r .  studies 
sh o w  that the rate  of alkylation of tetra iso propyl m on o ch lo ro m e th yle ne  
b ls p h o s p h o na te  w as faster than th e  rate with th e  tetraethyl este r. n . m . r .
studies o n  the a n io n s  of tetraesters  of m o fio ch lo ro m e th y le n e  b isp h o sp h o n lc  acids 
su g g e st that the c e n tra l atom  is s p ^  h yb rid is ed  and  that the negative  c h a rg e  is not 
extensively d e lo calise d  o v e r the P = 0 g ro u p s . T h is  is in co ntra s t to the ca s e  with 
the anio n  of triethyl p h o s p h o n o a c e ta te . w h e n  *3C  n . m . r .  In d icates that th ere  Is 
extensive d e lo calisa tio n  of the negative  c h a rg e  o v e r the ca rb e th o xy g ro u p . O ne 
explanation of the variatio n  In yie lds  of alkylated p ro du ct with the size of the
esterifying g ro u p  is that the bulky Isopro pyl g ro u p s  prevent the o rb ita ls  of the P = 0
g ro u p s  and  the n egative  c h a rg e  o n  the c e n tra l ca rb o n  atom  from  o ve rlap p in g  so 
th ey d o  not a c h ie ve  c o pla na rity . T h e  s m a lle r ethyl and m ethyl g ro u p s  allow  g rea ter 
co pla na rlty  to be a ch ie ve d  and th ere  Is s o m e  de lo calisa tio n  of the negative c h a rg e  
o v e r the P * 0 g ro u p s . T h u s ,  th e  negative  c h a rg e  Is m o re  a c c e ss ib le  for attack 
by e le ctro p h iles  In the te tra iso propyl e s te rs . S im ila r a rg u m e n ts  Involving
diffe re n ce s  In the c o p la na ritle s  of a n io n s  of p -d lk e to n e s  have been  used to explain 
d iffe re n ce s  In the reactivities  of th es e  c o m p o u n d s  tow ards e le ctro p h ile s  (r e f .  1 9 ).
U s in g  the th a lllo -d e rlva tlve  of tetra iso propyl m o n o ch lo ro m e th yle ne  
b is p h o s p h o n lc  acid  we have p re p a re d  a n u m b e r of C -a lk y la te d  m o n o ch lo ro m e th yle ne  
b is p h o s p h o n lc  a c id s , in c lu d ing  the benzyl derivative  ( 3 .  R = C 6 H 5C H 2 . X » C I)  by 
d e -e s te rlfy in g  the e sters  with b ro m o trlm e th y ls lla n e . a p ro c e s s  w hich  g o e s  In 
v irtually quantitative y ie ld . T h e  re s ultin g  C -b e n z y l  free a c id  had a pKd - > 6  and 
inhibited the R N A  tra ns crip ta s e  of In flu e n za  v iru s  A  by 5 0 %  at 180 pM .
H o w ev e r, it b inds to c h n o tlu m -9 9  to bone in the p re s e n c e  ol t in (l l )  c h lo rid e  and 
he n ce  (h e  benzyl gro u p  is not sufficiently bulky to prevent the b inding  of this 
c o m p o u n d  to b o n e  (r e f .  2 0 ) .
T h e  th a llio -d e riv ative s  ol tetra iso propyl m o n o ch lo ro m e th yle ne  and  m ethylene 
b ls p h o s p h o na tes  have been  u sed  to p repare  a n a lo g u e s  (4! of the antiviral agent 
A rild o n e  w h ich  inhibits the re p lica tio n  of rh in o v iru s e s . Like A rild o n e  these 
a n a lo g u e s  have no  activity a g a ins t influenza v irus  re p lica tio n  but th ey are  being 
Investigated as inhibitors  of rh in o v iru s  replicatio n.
R
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W e  have used this ro ute  to synthesise an  affinity probe to a sc e rta in  w hich 
of the p ro te ins  in  the R N A  tra n s c rip ta s e  co m plex  of influ enza  v iru s  A  w as the site 
of the b in d in g  of the p y ro p h o s p h a te  a n a lo g u e s . T h e  synthesis is outlined In
S c h e m e  1. C o u p lin g  of the te tra h yd ro py ra n yl io d id e  C51 with tetraisopropyl
m o n o c h lo ro m e th y le n e  b isp h o sp h o n a te  gave (61 in h ig h  yield. R em o va l of the 
te tra h yd ro py ra n yl g ro u p  with a c id  a n d  the iso p ro pyl g ro u p s  with bro m o trim eth ylsilan e  
left (71. w h ich  w as oxidised to the a lde h yd e  (81 with th e  O ess M artin  p eriodinane  
(  1 .1 .  l - t r l a c e t o x y -2 .  l -b e n z o x lo d o l-3 (3 H > o n e  ( r e f .  2 1 ) > . T h e  a ld e h y d e  (81 w hich 
was o b ta in e d  In g o o d  yield  w as a n  effective in h ib ito r of the R N A  tra n s c rip ta s e . Th e  
a lde h yd e  w as c h o s e n  as pyridoxal pho s p h a te  w as u s e d  as an affinity label In an 
e a rlie r Investigatio n  (r e f .  2 2 ) for th e  tra ns crip ta s e  of fowl p lagu e  v ir u s , a sim ilar 
v irus  to influ e n za . Pyridoxal p h o s p h a te  w as a reversib le  In h ib ito r of the 
tra n s c rip ta s e  a n d  w hen the p yrid o xa l pho s p h a te  w a s  Incubated  with the virus 
follow ed by treatm ent with (3 H l-b o r o h y d r ld e .  the p ro te in  P B j w as preferentially
la b e le d . W e have ca rrie d  ou t a s im ila r  s eries  of e x pe rim e n ts  with o u r  a ldehyde  (81 
and  In flu e n za  v iru s  A / X 4 9 . P o lya c ry la m id e  g e l e le ctro p h o re s is  of the viral 
p ro te ins  after In cubatio n  with the a ld e h yd e  (81 a n d  re d u c tio n  with ( 3 H l-b o ro h y d rld e  
show s th at o n ly  the P A  and P 8  p ro te in s  a re  la b e lle d . T h e s e  p ro te ins  a re  Involved 
In R N A  s yn th e s is . N o  la b e llin g  of n e u ra m in id a s e  o r  o th e r virus p ro te in s  o c c u rs .
F in a lly , we have b e en  In te re s te d  In the effects on the m e ta l chelating 
p ro p e rtie s  of pyro ph o s p h a te  a n a lo g u e s  of In tro d u c in g  s u lp h u r, a 'soft* atom  on the 
P e a rso n  H S A 8  s c a le  (r e f .  2 3 ) . In to  the m o le c u le . In itially , w e  exam ined the

Inhibitory activ ity  ot m o n o - (9 ] and b is -th io p yro p h o s p h a te  (1 0 ) on the rep licatio n  of 
influenza v iru s  A  in M O C K  c e lls . Both (91 and (101 a re  g o o d  chelators of z in c  ion 
( pKd . > 6 )  and  are  m o re  effective inhibitors  of the re p lica tio n  of influenza virus 
than
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p yro ph o s p h a te  itself ( r e f .  2 4 ) .  It is not known w h e th e r the s u lphu r is in the 
th lo n o - o r th lo lo -fo rm  but 3 1 P n . m . r .  evid e n ce  s u g g e sts  th at the zin c Ions b ind to 
sulphu r u n lik e  m a gnesiu m  io n s . T h e  th io pyro pho sph ates a p p e a r to be nontoxic to 
the M O C K  c e lls  after 3 d a ys  e x po s u re , possibly b e c a u s e  the th io pyro pho sph ates are 
readily h yd ro ly se d  to in o rg a n ic  pyro ph o s p h a te . E n c o u ra g e d  by these ob s e rvatio n s , 
we have e xam in e d  the th lo -a n a lo g u e s  of P F A  (111 and  P A A  (121 (T a b le  2 )  (r e f .  
2 5 ) .  C o m p o u n d s  (11) and  (12) w e re  pre p are d  by M ic h a e lis -B e c k e r reactio ns 
between th e  s o d lo -d e rlv a tive  of diethyl th lophosphite  a n d  ethyl ch lo ro fo rm a te  or 
c h lo ro a c e ta te . the P -O E t  g ro u p s  w e re  rem o ved with iodo trim eth ylsilane  at high 
te m peratu re  o v e r 48 h o u rs . As m a y be seen in T a b le  2 .  the th lo -a n a lo g u e s  of 
P F A  and  P A A  a re  m ore  effective in h ib ito rs  of p o lym e ra se s  than their oxygenated 
c o u n te rp a rts , as Is the th lo -a n a lo g u e  of m ethylene  b isp h o sp h o n ic  a c id . Th e  
tetraethyl e s te r  of the latter was p re p a re d  by a p h o to -a c tiv a te d  M ic h a e lis -B e c k e r 
reaction b e tw e en  the s o d lo -d e rlv a tive  of diethyl th lo ph o s ph ite  and  d lb ro m o eth a n e. 
W e believe th at this in c re a s e d  Inhibitory activity a ga ins t p o ly m e ra s e s  justifies further 
Investigation Into th lo -p h o sp h o n a te s  as potential antiviral a g e n ts .
W e w ish to th ank O r .S .  M as s o n  of the U n iv e rs ité  d e  C a e n  for the 
p reparation  of the th lo ph o s ph o n a te s . a n d  O r. M . N a ylo r for ca rry in g  ou t s o m e  of 
the e n zym e  a ss a ys .
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T A B L E  l
Z in c  ch e la tin g  pro perties of som e p yro p h o s p h a te  a nalog ues a n d  their inhibitory  
effect o n  the R N A  tra ns crip ta s e  of influenza v ir u s  A
C o m p o u n d PKa -
C o n c n .  (pM > p ro d u c in g  5 0 %  Inhib ition  of 
R N A  transcriptase  O N A -p o ly m e r a s e -a
( H O ) 2 P < 0 ) C B r 2 P ( 0 )  (O H )  2 >6 10 350
( h o ) 2 p ( o >c c i 2 p ( 0 )  c o h >2 >6 75 >500
( H O )  2 P ( 0 ) C H C I P ( 0 )  (O H )  2 >6 85 >500
( H O ) 2 P ( S ) O P ( S )  (O H > 2 >6 33 >500
( H O ) 2 P ( 0 ) 0 P ( 0 >  ( O H ) 2 5 . 7 125 >500
( H O ) 2 P < 0 ) C O O H 5 .6 3 5 35
(  H O ) 2 P< O )  C H 2C O O H 5 .5 2 7 5 45
P h o s p h o n o m e th y l-
tetrazole
5 .6 2 7 5 220
( H O ) 2 P C O ) C O P ( 0 )  ( O H ) 2 5 .4 20 100
( H O ) 2 P < 0 ) C H 2 P ( 0 )  ( O H ) 2 5 .3 >500 >500
(  H O ) 2 P< O )  C H 2C O N H 2 <4 >500 >500
(  h o )  2 p  < O )  c h 2 c h 2c o o h <4 >500 >500
(  E tO ) 2 P C O ) C H 2C O O H <4 >500 >500
N -e t h y l-p h o s p h o n o m e th y l-
tetrazole
<4 >500 >500
TA B LE  2
C o m p a ris o n  of the in h ib ito ry  effects of phospho nates and thiophosphonates on  the 
B N A  transcriptase  activ ity  of Influenza v iru s  A / X 4 9 . the D N A  polym erase  in du ce d  by 
H S V -1  (K O S ) and  c a lf thym us O N A  p o ly m e ra s o -a  (f ro m  ref. 25 )
*®/
C o m p o u n d PV
R N A
tra ns crip ta s e
'50
( p M ) a
H S V -1
O N A
polym erase
'so a
( p M ) a
C alf thym us 
O N A
polym erase
'so
(p M ) a
(  H O )  2 P< O ) C H 2C O O H 5 .5 350 10 40
(  H O )  2 P (  S )  C H g C O O H >6 135 16 75
( H O )  2 P ( 0 ) C 0 0 H 5 .7 30 12 50
( H O ) 2 P (S )C O O H >6 45 9 150
I ( H 0 ) 2 P ( 0 ) ) 2C H 2 5 .3 >500 >500 >500
( ( H O ) 2 P ( S ) ) 2C H 2 >6 350 >500 >500
( ( H 0 ) 2 P ( 0 ) ] 20 5 .7 125 >500 >500
( ( H O ) 2 P (S )1 2 0 >6 33 >500 >500
C o n c e n t r a t io n s  p ro d u c in g  5 0 %  of e n z y m ic  activity.
